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ABSTRACT 
This thesis begins in Chapter One with a discussion of the role 
of electrophilic cyclisation in the synthesis of tetrahydrofurans. 
Chapter Two begins with a discussion of the synthesis of iodo-o-
lactones, by the iodolactonisation of f3-silyloxy-o-alkenoic acids 
(Scheme A). It will show how the potential of this chemistry has 
been expanded by proving the absolute stereochemistry at the iodine 
centre. 
Scheme A 
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Chapter Two goes on to consider the stereospecific synthesis of 
2,3,5-trisubstituted iodo-tetrahydrofurans by the related iodo-
etherification of homoallylic alcohols (Scheme B). This is facilitated 
by the use of anhydrous conditions. 
Scheme B 
OH 
NaHCOg 
The synthesis of 2,3,5-trisubstituted iodo-tetrahydrofuranacetic 
acid esters and 2,3,5-trisubstituted hydroxy-tetrahydrofuranacetic 
acid esters by the iodocyclisation of geometrically pure (E)- and ( Z ) - ~ ~
hydroxy-o-alkenoates was then developed and the stereochemical 
outcome of the reactions was proven (Scheme C). 
Scheme C 
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Targets were chosen which illustrated the utility of the key 
cyclisations of ~ - h y d r o x y - o - a l k e n o a t e s . . Chapter Three discusses the 
synthesis of muscarine 93. It was chosen to synthesise muscarine 
from the cyclisation of the ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e e 146. This 
synthesis is particularly versatile as it not only allows the 
preparation of muscarine itself, but also of various potentially highly 
biologically active analogues 146a. 
C02Me H O ~ ~N ~ e 3 r r '. · ~ e 3 r r
Me R 0 
(93) (146) (146a) 
The second target selected was Goniofufurone 170. 
Approaches to this molecule will be discussed in Chapter Four. 
Model work in the synthesis of goniofufurone began with the 
cyclisation of the ( E ) - ~ - h y d r o x y - o - a l k e n o a t e e 53b, which indeed, led to 
the facile synthesis of the iodolactone 204. However, early attempts 
to incorporate the natural side chain met with limited success. 
Ph 
(170) 
o 
OH 
(53b) (204) 
Chapter Five discusses an approach to the 2-oxabicyclo-[2.2.11-
heptane ring system, which has been synthesised by the radical 
cyclisation of various ~ , ' Y - u n s a t u r a t e d d tetrahydrofurans of the 
general form shown in Scheme D. 
SchemeD 
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Electrophilic Cyclisation as a Route to Saturated 
Oxygen Heterocycles 
(I) Introduction 
The stereocontrolled synthesis of saturated oxygen 
heterocycles is one of the key challenges of modern organic synthetic 
chemistry. The preparation of highly substituted tetrahydrofurans 
(THFs) and tetrahydropyrans (THPs), along with f3-, 'Y- and 8- lactones, 
of defined stereochemistry, is of great importance, due to the vast 
array of biologically important natural products which contain this 
type of functionality. 
OH 
" ' ~ ~1._. 
(1) 
1 
The polyether antibiotics (eg Monensin 1) are extremely 
important because they have the ability to transport metal ions across 
biological membranes l -2 and consequently, the range of their possible 
biological activity is extensive.3 They are anti-microbial agents4 and 
are known to provoke cardiovascular responses. 5 The key structural 
features of these molecules are THFs and THPs. Naturally there has 
been much synthetic interest in these natural products due to their 
biological and commercial importance and also due to the huge 
synthetic challenge which they present. Despite this, there have only 
been a few total syntheses reported.6-11 There are also a wide range of 
other natural products which contain THFs as important sub-units, 
including steroids, C-nucleosides and marine natural products such 
as the Halichondrins 2 and Eunicellin diterpenoids 3. 
OH OAc 
HO ~ R R
.. 
(2) (3) 
Lactones are also present in a wide range of natural products 
with various different roles in nature. Actinobolin 4 was isolated from 
Streptomyces cultures, whereas (+)-Nepetalactone 5 is a pheromone 
found in aphids. 
2 
HO 
H2\-
H H N ~ O O
OH 0 
(4) (5) 
(II) Electrophilic Cyclisation 
One of the most important routes to saturated oxygen 
heterocycles of known stereochemistry is the electrophilic cyclisation 
of unsaturated molecules containing internal nucleophiles. There are 
many electrophiles which allow this reaction to take place and there 
are a huge variety of examples of this process in synthesis. This 
section will outline the main types of electrophilic cyclisation and will 
give an idea of their scope in terms of organic synthesis. 
The electrophilic cyclisation reaction follows the general 
equation shown in Scheme 1. As with most cyclisation processes the 
reaction can either take an exo or endo pathway. In most cases, 
these processes will broadly follow the empirical rules laid down by 
Baldwin12 for the geometry of transition states and the balance of 
steric and electronic factors: ie 4-exo, 5-exo and 6-exo are favoured 
over 5-endo, 6-endo and 7-endo. In the cases of some of the reactions 
3 
which will be described, the transition state involved does not have 
even charge distribution and is therefore not equivalent to a normal 
double bond. This means that it will not be constrained by the 
stereo electronic forces used by Baldwin when formulating his rules. 
In particular, in the cases of electrophiles which do not form standard 
"onium" complexes with the double bond, other factors can determine 
the mode of cyclisation. 
The cyclisation generally gives the opportunity to generate 
new stereocentres at sites band c (Scheme 1). In most cases, the 
stereochemistry of centres band c will be determined by the geometry 
of the double bond as there will normally be overall anti addition of 
nucleophile and electrophile to the double bond. The extent to which 
the stereochemistry of the new stereocentres is determined by the 
cyclisation process, and also the extent to which the stereochemistry is 
induced by other substituents, allows the usefulness of the individual 
cyclisations to be assessed. 
(A) Electrophilic Lactonisation 
The electrophilic lactonisation of unsaturated acids to give 
functionalised lactones with generally excellant levels of stereocontrol 
4 
is, perhaps, the most important method of lactone synthesis available 
to organic chemists, beyond the simple intramolecular condensation 
of hydroxy-acids. This section will discuss some of the range of 
electrophiles available for such processes and the extent of their 
usefulness. 
cn Phenylselenolactonisation.13 
Selenium mediated cyclisation has become popular due to the 
usefulness of the phenylselenenyl (PhSe) group which is incorporated 
into the resulting lactones. The PhSe group is versatile and can be 
easily manipulated. It can be oxidatively (H20 2) or reductively 
(Bu3SnH) removed to give unsaturation and saturation respectively. 
The first reagent used in phenylselenolactonisation was 
phenylselenenyl chloride, and, in cyclic systems, this generally gives 
good stereocontrol. However, the rate of this reaction, even at -78°C, is 
usually so rapid that it probably does not allow thermodynamic 
control, so in the lactonisation of acyclic substrates, the stereo control 
is not high. The introduction of N -phenylselenophthalimide (NPSP)14 
brought much more reversibility into the lactonisation reaction and 
allows much better stereocontrol. (Scheme 2). 
Scheme 2 
o 
5 
R Reagent Conditions Yield cis :trans Ref. 
Me PhSeCI 69% 1:1 15 
Ph PhSeCI 54% 2.7:1 16 
Ph NPSP 75% 15:1 16 
The mode of cyclisation in the phenylselenolactonisation 
reaction is not so much controlled by Baldwin's rules as by the ability 
of the two possible sites to stabilise a carbonium ion. 
Scheme 3 
COOH Yield 
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6 
In general, the ring closure occurs at the carbon most able to 
stabilise a positive charge, although subsequent rearrangements are 
often possible. Empirical observations suggest that 5-membered 
lactones are prefered over the 4- and 6-membered alternatives. Some 
examples are shown in Scheme 3. 
The oxidative removal of the PhSe group is particularly 
useful as the elimination proceeds selectively in a syn fashion and 
away from the oxygen atom. This directing effect is explained as the 
polar selenoxy function will tend to align anti-parallel to the oxygen 
lone pairs in order to minimise repulsion. 17 Interestingly, 
selenolactonisation can be reversed using sodium in liquid ammonia 
to reductively remove the selenium function. This enhances the power 
of this reaction as it can potentially be used as a protection step. 
(ii) Halolactonisation 
Halolactonisation is by no means a new process. As early as 
1908, Bougault18 investigated the process, but it is only recently that 
the full stereochemical and regiochemical subtleties have been 
studied. Early work suggested that only 5- and 6-membered lactones 
could be synthesised in this way, but this proved to be untrue. Indeed, 
according to Baldwin's rules and Markovnikov orientation,4-exo 
lactonisation is the favoured process under kinetic conditions.19 The 
cyclisation shown in Scheme 4 illustrates the type of strained systems 
which can be constructed in this way. 
7 
H02 
Scheme 4 
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Halolactonisation, unlike selenolactonisation, usually follows 
Baldwin's rules fairly closely. 
Bartlett20 brought a new dimension to the halolactonisation 
reaction when he advocated the use of thermodynamic conditions [12, 
non-basic solvent (usually acetonitrile)], instead of kinetic conditions 
[presence of base, NaHC03(aq)] or limiting the concentration of 
halonium ions (i.e. N-iodosuccinimide, CHC13) (Scheme 5). 
Scheme 5 
I I 
.. I 
OH 0 0 
0 0 
yield trans ClS trans ClS 
NIS, CHCl3 75 2 2 3 1 
12, Et20, NaHC03 73 3 1 0 0 
12, CH3CN 77 >20 1 0 0 
The use of thermodynamic conditions allows the equilibration 
of the less thermodynamically stable cis lactone via protonation of 
the first lactone formed. This requires a certain amount of free 
8 
protons to be available. Iodine/ether/aqueous bicarbonate allows some 
equilibration (i.e no 6-endo cyclisation products are seen but there is 
no equilibration of cis-Iactones to trans-Iactones). In the formation of 
o-lactones under thermodynamic conditions, 1,2- and 1,3- asymmetric 
induction can be achieved because of the well-defined "chair-like" 
transition state involved, but 1,4-induction is not generally very good 
(Scheme 6).21 
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The use of 2,4-disubstituted substrates ensures good 
9 
asymmetric induction and this was used by Bartlett in his synthesis of 
Multistriatin22 and Serricornin.21 
Chamberlain23 and Katzenellenbogen24 have also studied the 
effect of having a free hydroxyl function upon stereoselection in this 
reaction. In both cases, high selectivities for the cis-lactones were 
observed, this time in the case of y-lactones (Scheme 7). In these 
examples, there is sterlc control over the cyclisation by the free 
hydroxyl group and only the isomers shown were isolated. 
Scheme 7 
OH 
~ C 0 2 H H 12, Et20 
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OH 
OH 
Halolactonisation has been applied to a wide range of 
substrates. The spirolactonisation (Scheme 8) used by Wovkulich et 
a125 in the approach work to a synthesis of Mevinolin illustrates this 
particularly well. 
Scheme 8 
Medium rIng lactones can also be synthesised by 
10 
halolactonisation methods, as long as the substrate contains either 
hydroxyl or gem-dimethyl substituents.26 Such substituents restrict 
the rotation of the substrate and give a much greater chance of 
cyclisation (Scheme 9). 
Scheme 9 
bis(sym-collidine) 
Iodine(1) hexafluoro 
phosphate 
I 
Nitrogen substituted unsaturated acids can also be 
halolactonised with good asymmetric induction (Scheme 10). The 
high stereoselection is rationalised by the possibility of nitrogen 
stabilising the transition state creating the kinetically more favourable 
transition state 6.27 
Scheme 10 
N-Bromo 
succinimide (NBS) 
THF 
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H 
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o 
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It is also possible to halolactonise unsaturated amides; 
indeed, this process is favoured over the alternative mode of cyclisation 
11 
in which the nitrogen acts directly as the nucleophile (Scheme 11).28 
Scheme 11 
R 
NBS 
Knapp29 has, however, demonstrated that upon protection of 
an amide with two equivalents of trimethylsilyl trifiate, the N,O-bis-
(trimethylsilyl)imidate can be induced to iodocyclise, via the nitrogen, 
to give the iodo-y-Iactam. (Scheme 12). 
Scheme 12 
OTMS 
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(B) 5-exo-trig Electrophilic Cycloetherification. 
One of the key routes to the synthesis of THFs of controlled 
stereochemistry is the 5-exo-trig cycloetherification of y,8-unsaturated 
alcohols. This is by far the most common use of cycloetherification 
and it has therefore been studied extensively using a variety of 
different electrophiles. In this section the range of electrophiles and 
12 
the scope of the process will be discussed. 
(i) Haloetherification 
This approach was developed ten to fifteen years ago by 
Bartlett and his colleagues. so He found that y,B-unsaturated alcohols 
cyclised under thermodynamic conditions (iodine/acetonitrile) to give 
trans 2,5-disubstituted THFs with moderate selectivity (Scheme 13), 
whereas when the corresponding ethers were cyclised under the same 
conditions, cis 2,5-disubstituted THFs, the thermodynamically more 
stable isomers, were formed with moderate to good selectivity 
depending on the ether group used. The best stereoselectivity was 
obtained using sterically bulky ether groups, but some groups were 
found to be so bulky that they hindered cyclisation and led to much 
reduced yields. 
Scheme 13 
12, CHsCN ».·· .. ''''-1 .. Yield I 
R=H 1 2 66% 
R=Bz 2 1 60% 
R=DCB 21 1 63% 
Bartlett found that the 2,6-dichlorobenzyl group (DCB) gave 
the best selectivities as it had the best balance of beneficial stereo- and 
electronic effects. More recently, NormantS1 found that the use of 
13 
tbutyl ethers gave an even better stereoselection (28:1 cis:trans ratio); 
these ethers are also easier to form than the corresponding DCB 
ethers. The rationale for these selectivities is shown in Scheme 14. 
,f;= 
I 
R 
Scheme 14 
TT ~ ~ . ; . .~ , , ~ ~
.: °H ~ ~ )( I 
---M+ ,Q I -- _# I ~ ~ ...... / ~ ~ )( · · · " ' / ~ ~ ° 
H ° H R 
Scheme 15 
OAc 
cis-2,5-Disubstituted THFs are the major products when the 
ether group is bulky because there is a transition state available where 
the steric interactions are minimised, whereas both possible 
transition states that would result in the corresponding trans-2,5-
disubstituted THFs being formed have an unfavourable interaction 
between one of the substituents and the ether group. There are vast 
14 
numbers of examples of these reaction in synthesis; Bartlett32 has 
exemplified the process in the synthesis of Davanone 7 (Scheme 15) 
R 
Many other halogen sources have been used in this process. 
Kishi33 used an NBS mediated cyclisation as part of an approach to the 
right-hand half of Monensin 1 and obtained a stereochemically pure 
2,5-trans disubstituted THF (Scheme 16). This stereoselectivity is 
surprising in the context of Bartlett's work, but the effect of the 3-
methyl substituent must be large. 
OH 
Scheme 16 
NBS, CH3CN 
As early as 1970, Rhoads34 used NBS in refluxing carbon 
tetrachloride to effect the cyclisation of an unsaturated alcohol 
(Scheme 17) under thermodynamic conditions, although the 
stereochemical purity was low. 
Scheme 17 
OH NBS, CCl4 
Br 
Torr35 used 2,4,4,6-tetrabromocyclohexa-2,5-dienone (TBCD) 
as a source of bromonium ions in the 5-exo cycloetherification of a 
polyhydroxylated substrate with reasonable c is- s e Ie cti vi ty 
15 
(Scheme 18). 
Scheme 18 
BnO TBCD 
OBn 
The use of bis-(sym-collidine)iodine(I) perchlorate, as 
devised by Schauble,36 allows the formation of cyclic ethers of ring size 
3-7 with high regioselectivity (generally consistant with Baldwin's 
rules), and is consequently of great interest in the synthesis of 
epoxides and oxetanes of controlled stereochemistry. 
Incorporation of an extra free hydroxyl function into the 
substrate, other than that which cyclises, was pioneered by Yoshida.37 
It was found that 1,3-syn diols gave high stereoselectivity for 2,5-
trans-THFs (95%), whereas 1,3-anti diols gave a poorer selectivity of 
2:1 trans:cis (Scheme 19). This was rationalised by proposing the 
transition states shown (Scheme 20). 
Scheme 19 OH 
P h ~ ~ 12, NaHC03, Et20 I .. 
- H20, 0.5h, 95% .' .. ' OH OH P h ~ ~
OH 
P h ~ ~ 12, NaHC03, Et20 
...... LJ .. 
- H20, 10h,80% OH OH 
16 
Ph 
Transition state 
from syn isomer 
Scheme 20 
Transition state 
from anti isomer (8) 
The transition state that gives the trans-THF from the syn-
diol is favoured due to the lower steric hindrance, so the cyclisation is 
fast and selective, whereas the corresponding transition state from the 
anti-diol has serious steric hindrance preventing one-step cyclisation 
to the cis-THF. It therefore rotates to give the transition state 8 which 
cyclises to give the trans-THF preferentially. This stereochemical 
outcome is also seen in the work of Williams38 where the benzyl ether 
9 was cyclised with a similar stereochemical outcome (Scheme 21). 
Scheme 21 
OR OR 
M E M O ~ ~
". 
12, N aHC03(aq) 
CH3CN 
(9) 
Another example of note in this field is the work of Reitz39 in 
which the glycoside derivative 10 was cyclised. It was shown that NBS 
in dimethylformamide (DMF) gave a slightly better selectivity for the 
trans-THF than iodine!rHF/sodium carbonate (Scheme 22). 
17 
Scheme 22 
OBn 
OH OBn 
(10) 
NBS, DMF (X = Br) 
12, NaHC03(aq) THF (X = 1) 
BnO 
89:11 
82:18 
H 
OBn 
Labelle40 investigated the mechanism of allylic control in 
stereoselection and found that the effect varied with the nature of the 
substituent (Scheme 23). It was shown that the effect was in the order 
F > OH > Me. The transition state 11 was postulated to be the most 
favourable and leads to a 2,3-cis relationship between the 
substituents. It should be noted that in all the favoured transition 
states, the allylic substituent is positioned pseudoaxially. 
Scheme 23 
(11) 
Where it is possible for both 5-exo and 5-endo iodo-
etherification to occur, the faster 5-exo process occurs exclusively 
(Scheme 24).41 
18 
Scheme 24 OR 
RO 
CHaCN 
AI 
R O ~ 1 R R~ ~
.:' 
o I 
5-exo-Trig iodoetherification has also been used by several 
groups to synthesise 2,3-dihydrofurans (Scheme 25).42-44 The electron 
withdrawing group E is necessary, as these reactions involve the 
iodocyclisation of the corresponding enol. It is therefore important 
that a high proportion of the enol form is present in the reaction 
conditions. 
OR 
(13) 
Scheme 25 
CHaCN 
E = C02Me 
S02Ph 
C(O)Me 
Scheme 26 
19 
Kurth45 showed that the difference in energy between halo-
lactonisation and haloetherification is exceptionally small, by 
cyclising the stereoisomers 12 and 13; this illustrated that either 
process can occur exclusively at the expense of the other, on purely 
stereochemical grounds (Scheme 26). 
(ii) Selenoetherification 13 
Selenium mediated electrophilic etherification has been 
widely used in synthesis, and as mentioned earlier, the incorporation 
of the PhSe group is a great advantage in synthetic terms. It is, in 
many ways, complementary to the haloetherification reaction and the 
controlled elimination away from oxygen provides an excellent route to 
allylic ethers. 
5-exo-Selenoetherification was first introduced by Clive46 in 
1977, initially for the cyclisation of phenols and subsequently for more 
general cyclisations. Phenylselenenyl chloride induces phenylseleno-
etherification rapidly at -78°C. The methodology is therefore tolerant 
of a wide range of functionality (Scheme 27). Although in cyclic 
systems selenoetherification gives good stereocontrol, in the 
etherification of acyclic substrates, there is little stereoselectivity, 
although the addition of a mild base such as potassium carbonate can 
increase this in some cases.47 
Scheme 27 
OH 0··· .. /\ 1'0 J-SePh .' j'H 0···· 
Yield 
83% 
o 
o 
80% 
SePh 
82% 
HO ~ ~ .. ~ ~ ~ PhSe ~ O + +.:-.' .•••• S ~ ~ 86% 
OR OR 
The work of Ley in this area is also worth noting. His group 
has shown that hydroxy-ketones can be cyclised to give the spiroacetals 
shown, with moderate stereocontrol, using NPSP as the selenium ion 
source (Scheme 28).48 More recently, Ley49 has extended this idea to 
include a THF synthesis in which the enolic hydroxy group of a ~ - k e t o o
ester acts as a nucleophile in selenoetherifications leading. to an 
ylidene THF (Scheme 29). Asymmetric induction from the allylic 
substituent was observed and a facile reduction furnished the 
corresponding 2,5-cis-THF exclusively. 
21 
Scheme 28 
NPSP, ZnBr f'I 
d ~ · · d o ~ s e P h h
Scheme 29 
o OTBDMS NPSP I2(cat) 
(iii) Sulphenyl Etherification 
OTBDMS 
SePh 
.'01111/ 
OTBDMS 
H SePh 
~ ~! 
cis.trans 
3:7 
Sulphur is not as commonly used in electrophilic cyclisations 
because it is less able to stabilise a positive charge and so the necessary 
sulphonium ion sources are less easily obtained. There are, however, 
a large number of sulphur reagents for 5-exo-trig electrophilic 
cyclisation now available. 
In 1981, Capozzi5o used methyl bis(methylthio)sulphonium 
(MBMT) salts to cyclise ortho-allylic phenols, with some success, in 
the synthesis of a-thiomethylbenzofurans (Scheme 30). 
Scheme 30 
SMe 
22 
Cava51 used dimethyl(methylthio)sulphonium tetrafluoro-
borate and base in acetonitrile to effect 5-exo-trig cyclisations of 
various y,o-unsaturated alcohols. Although the stereochemistry of the 
products from acyclic substrates was not addressed, the stereocontrol 
in. cyclic systems was good (Scheme 31). 
Scheme 31 Yield 
H O ~ ~ SMe 76% 
OH 0·· .. ,,/\ 80% 
Brownbridge52 used N-(phenylthio)morpholine as a source of 
phenylsulphonium ions and carried out various 5-, 6- and 7-exo 
cyclisations. This reagent was also used to repeat the work of Capozzi 
in significantly improved yields. Again there was no attempt to effect 
stereo control or define stereochemistry. 
Scheme 32 
CI 
PhSCl ~ ~ ~ ~
~ O H H • ( "'" -OH 
ipr2NEt SPh 
Fallis53 used phenylsulphenyl chloride and base to perform a 
number of sulphenyletherifications. It is interesting to note tha.t when 
a homoallylic alcohol was subjected to the cyclisation conditions, an 
overall addition of phenylsulphenyl chloride was observed (Scheme 
32). This illustrates the favourability of the 5-exo process over the 5-
endo process because the attack of chloride occurs preferentially to 
cyclisation. 
Recently, CapozziS4 demonstrated that the cyclisation of 
acyclic y,o-unsaturated alcohols using MBMT salts proceeds with very 
little stereoselectivity, illustrating how much more development is 
needed before this process becomes viable in stereoselective synthesis. 
(C) "5-endo-trig" Electrophilic Cycloetherification 
The electrophilic cyclisation of homoallylic alcohols is a 
potentially attractive route to 2,3,5-trisubstituted THFs and higher 
homologues of defined stereochemistry, as a single stereo centre can be 
used to generate two more, and is therefore of potentially significant 
synthetic importance. In recent years, there have been a number of 
examples using a range of electrophiles. This section will deal with 
the various types of reaction known so far, and their scope. It will also 
tackle the stereochemical aspects of the cyclisation. 
CD Halocyclisation 
OR 
(13) 
Scheme 33 
CH3CN 
I 
(14) 
In 1978, Bartlett20 made what was then an isolated 
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observation, that the a-hydroxy ester 13 cyclised in a 5-endo-trig 
fashion to give the iodo-THF 14 as the only product (Scheme 33). The 
stereochemistry of the product was not proven, but since only one 
product was isolated, it was assumed to be the most 
thermodynamically stable isomer. The iodocyclisation of the 
corresponding methyl ether gives 33% of the iodo-THF 14. 
In 1984, Mechoulam55 introduced a novel source of 
presumably iodine(l) for electrophilic cyclisation, by reacting sodium 
iodide with m -chloroperbenzoic acid, although most of the 
regiochemical outcomes were similar to those in established 
iodoetherification reactions. (E)-3-Hexen-1-o1 however was also 
succesfully cyclised, effectively via a 5-endo-trig process (Scheme 34). 
Scheme 34 
mCPBA,NaI ~ O H H ~ ~
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Schauble36 also observed the same reaction when he treated 
(E)-3-hexen-1-ol with bis(sym-collidine)iodine(l) perchlorate, another 
source of anhydrous iodonium ions. He noted, however, that other 
homoallylic alcohols cyclised via the "4-exo-trig" pathway under 
these conditions to give iodomethyl-oxetanes. 
Takano 56 used a 5-endo-trig bromoetherification in his 
synthesis of intermediates from Mycinamycin (Scheme 35). This 
example is unique as it occurs in the presence of water where one 
might expect the intermediate bromonium ion to be opened 
25 
intermolecularly by water. The authors make no comment as to the 
unusual nature of this cyclisation. 
BnO 
Scheme 35 
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In 1992, Lipshutz and Barton57 were the first to report 
detailed work on the stereochemical nature of the iodoetherification of 
homoallylic alcohols. As part of their investigations of an approach to 
the THF portion of Tetronasin 16, it was envisaged that such a 
cyclisation could be useful (Scheme 36). 
Scheme 36 
H 
:> OMe 
(16) 
It was found that the stereochemistry of the products varied 
with the choice of electrophile. The results were also unusual in that 
there appears to be an overall syn addition of the electrophile and the 
hydroxyl oxygen to the double bond (Scheme 37). This suggests that a 
complex mechanism may be involved. These results are difficult to 
explain in terms of a simple transition state and, as yet, the authors 
have offered no explanation. The results differ from others in the area 
in terms of the stereochemical outcome. 58 One possible explanation is 
the presence of the ~ - m e t h y l l substituent. Interestingly, when NBS 
was used for these cyclisations, the expected stereochemistry resulting 
from anti addition to the double bond was obtained (Scheme 38). 
Scheme 37 
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Scheme 38 
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Recently Kang59 has also examined the 5-e ndo -trig 
iodoetherification ofhomoallylic alcohols. The investigation was, however, 
restricted to substrates wherein the olefin is in conjugation with an 
aromatic system (ie. where a 5-endo-trig cyclisation is favoured by the 
possibility of an allylic carbocation existing). It was found that tre.atment 
of the substrates in the presence of potassium carbonate at -78°C in 
diethyl ether with iodine led to up to a 65:1 ratio of 2,5-trans: 2,5-cis 
THFs under slow addition conditions (Scheme 39). 
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(ii) Selenoetherification 
Nicolaou 13 noted some time ago that selenium mediated 
cyclisations can be used to form five membered rings preferentially 
over four membered rings and also that the selenoetherification of 
homoallylic alcohols led to the formation of 2,3,5-substituted THFs by a 
"5-endo-trig" cyclisation (Scheme 40). 
Scheme 40 
SePh 
PhSeCI 
87% 
Mihailovic60 also noted an isolated example of this reaction in 
acyclic homoallylic alcohols (Scheme 41) during studies of electro-
chemical selenoetherification. 
Scheme 41 
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Mihelich61 showed that 5-endo-trig selenoetherification of 
acyclic substrates was an extremely viable process when he generated 
the selenodiols 17 by treating the epoxy alcohols 18 with sodium phenyl 
selenide. 
OH OH OH 
R ~ s e P h h R ~ ~
(17) (18) Rl 
The selenodiols were then induced to form selenonium ions 
by treatment with acid (HCl04 , THF) and these intermediates 
underwent facile 5-endo-trig cyclisation to give THFs (Scheme 42). 
OH OH 
~ R l l
R ~ ~
SePh 
/'I .. ,\SePh 
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Scheme 42 
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In the first three cases, the selectivity results from the 
formation of a single selenonium ion. The final result has been 
rationalised by suggesting that the intermediate generates an olefin by 
elimination and then reforms the alternative selenonium ion 
intermediate. This suggests that the cyclisation must be highly 
stereoselective and that the cyclisation of the transition state which 
eliminates the selenium moiety must be highly disfavoured (Scheme 
43). 
H 
R 
H 
Scheme 43 
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Lipshutz and Barton57 found that phenylselenenyl chloride 
can be used to induce stereoselective 5-endo-trig cyclisations of 
homoallylic alcohols (Scheme 44). The stereochemistry obtained from 
these was different from that obtained by iodocyclisation (vide supra). 
It is interesting to note that when Lipshutz generated the transition 
state analogous to that found to be disfavoured by Mihelich (with the 
extra methyl group in the 2-position) smooth cyclisation was observed. 
One possible explanation is the fact that Mihelich used acidic 
conditions for the cyclisations and therefore the rearrangements may 
have been acid catalysed. 
Kang62 has also investigated 5-endo-trig selenoetherification 
although his studies were limited to cases in which the olefin was in 
conjugation with an aromatic system. High stereoselection was 
obtained at -78°C under Lewis acid catalysis (Scheme 45). The 
cyclisation of the corresponding silyl ethers was also investigated63 
(Scheme 46), and these were found to cyclise at 20°C in the absence of 
catalysis and in the presence of potassium carbonate to give even better 
stereoselection. 
Ph U R 
Scheme 45 
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Scheme 46 
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(iii) Sulphenyl etherification 
Williams64 developed a route to 2,3,4,5-tetrasubstituted THFs 
Vla the sulphur-mediated 5-endo-trig cyclisation of 2-methyl-3-
thiophenyl-1,4-diols. The process probably involves the formation of an 
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intermediate episulphonium ion, by the elimination of methanol, upon 
treatment with dimethyl sulphate in dichloromethane at O°C (Scheme 
47). 
a . . . ~ M e e Scheme 47 
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This was carried out on both stabilised (a-phenyl) and 
unstabilised sulphonium ions without any trace of 4-exo-trig 
products. Good stereochemical purity was maintained throughout 
and there were no anomalous results similar to those found by 
Mihelich in the selenium-based work. 
Warren 65 found that this reaction could be extended to 
tertiary thioethers, as long as the stereochemistry of the molecules 
was favourable, and thus was able to construct spiro-THFs (Scheme 
48). 
Scheme 48 
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Brownbridge 52 observed an example of a 5-endo-trig 
sulphenyletherification using N-(phenylthio)morpholine (Scheme 49); 
32 
Fallis53 did not observe a similar reaction, although the presence of 
chloride ions in the latter reaction may explain this. 
Scheme 49 
~ O R R__ : ~ h S b b
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(iv) Other Electrophiles 
H U 66 used aryltellurinyl acetates to effect 5-endo-trig 
cyclisations of 3-alkenols (Scheme 50). Interestingly, iodoetherification 
of this molecule resulted in 4-exo-trig cyclisation.36 
Scheme 50 
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Thallium triacetate has also been used to mediate 5-endo-
trig cyclisations of alkenols by Ferraz67 with good stereochemical 
purity (Scheme 51). 
Scheme 51 
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(III) Other Routes to 2,3,5-Trisubstituted Tetrahydrofurans 
Although electrophilic etherification is an important route to 
substituted THFs, there are many other routes available; in this 
section, some of the major approaches will be briefly outlined. 
Comprehensive reviews of this topic have been published.68 
(A) Michael Addition Processes 
Homoallylic alcohols possessing a sulphone group at the 3-
position undergo cyclisation when treated with potassium hydride in 
THF at RT to afford a 2,2,4-trisubstituted THF, as shown by Normant69 
(Scheme 52). 
Scheme 52 
More recently, Craig70 has prepared 2,3,5-trisubstituted 
THFs by the same strategy, using potassium tbutoxide in tbutanol; the 
products have a 2,3-anti configuration. The cyclisation leads to a 
moderate selectivity for 2,5-trans-THFs over 2,5-cis-THFs. The 
selectivity is much greater in the case of the (E)-isomers than in the 
case of the (Z)-isomers (Scheme 53). 
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Cha 71 used a similar idea in the approach to Verrucosidin 
(Scheme 54). 
Scheme 54 
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(B) Epoxide Q p e n i n ~ ~ Methods 
This route involves the acid catalysed 5·exo-tet opening of a 
y,o-epoxide by an alcohol and it has increased in popularity due to the 
obvious compatability with Sharpless72 epoxidation methodology. This 
approach is, in many ways, complementary to the use of electrophiles 
such as halogens because the stepwise cyclisation will lead to a 
different stereochemistry (Scheme 55). Kishi73 used this approach as 
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part of his work towards the Halichondrins (Scheme 56). 
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(C) Condensation of Diols 
Scheme 55 
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Condensation of 1,4-diols under acidic conditions has been 
used extensively in the synthesis of substituted THFs (Scheme 57). 
Fleet74 has used the ring contraction of o-lactones with leaving groups 
as Cl-substituents (ie 1,4-diols) extensively in carbohydrate chemistry, 
to generate highly substituted THFs (Scheme 58). Mulzer75 used a 
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similar approach when he cyclised benzyl ethers with y-leaving 
groups to give 2,5-substituted THFs of defined stereochemistry 
(Scheme 59). 
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Overman 76 has developed a concise route to 2,3,5-substituted 
THFs by the rearrangement of trans-vinylic-1,2-diol acetals (Scheme 
60). He has used this approach in the synthesis of the Kumausallenes 
(eg trans-Kumausallene). 
Scheme 60 
o 
SnC4 
.. 
• •• 1111 \ 
OR 
H 
AcO,1. 
'" :::O··· .. ~ ~- ~ " "... , 0 Br 
trans -Kumausallene 
(E) Oxidative Cyclisation of 1.5 Dienes77 
Potassium permanganate can be used under mildly alkaline 
conditions to generate 2,5-cis-disubstituted THFs in which the 
stereochemistry at the positions ex to the THF ring is defined by the 
geometry of the starting diene (Scheme 61). These highly oxidative 
conditions can be a little too harsh to use in the course of synthesising 
complex multi-functional molecules, but they do give THFs of predictable 
stereochemistry. This was among the first routes to allow such 
stereocontrol. 
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New Stereoselective Routes to Tetrahydrofurans 
(I) Valerolactone Chemistry 
Work concerning electrophilic cyclisations began within our 
group as a part of the approach to analogues of the mevinic acids, 
Compactin 19 and Mevinolin 20 (Scheme 62), which are among the worlds 
best selling pharmaceuticals in their role as inhibitors of cholesterol 
biosynthesis in man. 
Scheme 62 
H0'(r0 
~ ~ i i
(+ )-Compactin R=H (19) 
(+)-Mevinolin R=Me (20) 
The active o-lactone portion in its open chain form acts as a 
mImIC of mevalonic acid, a crucial intermediate in the terpenoid 
biosynthetic pathway leading to cholesterol. The mevinic acids act as 
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potent inhibitors of the pathway by blocking a major rate limiting step, the 
conversion of HMGCoA [3-hydroxy-3-methylglutaric acid co-enzyme A] 
into mevalonic acid. The mevinic acids block the action of HMGCoA 
reductase presumably by occuping the active site of the enzyme. One 
possible synthetic approach to the mevinic acids which has been studied at 
Nottingham is the electrophilic lactonisation of a ~ - h y d r o x y y or silyloxy-B-
alkenoic acid (Scheme 63). 
Scheme 63 
OR OR 
o 
This led to the requirement of a chiral route to such molecules. 
Bennett78 used baker's yeast reduction of the corresponding ~ - k e t o o esters 
as a route to the hydroxy-acids 21. Bennett78 then used selenolactonisation 
of the hydroxy-acid 21 to prove the absolute stereochemistry produced by 
the enzymes in baker's yeast (Scheme 64). 
The non-stereoselective selenolactonisation gave the lactones 22 
and 23. The selenium group was reductively removed to give a mixture of 
hydroxy-Iactones which were then chromatographically separated and 
individually converted into the R- and S-enantiomers of natural para sorbic 
acid 24 and 25. From the optical purity of these isomers the optical purity 
and the absolute stereochemistry of the yeast reduction product was 
deduced. 
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Detailed analysis of the coupling constants in the lactones after 
the removal of the selenium function showed that the less polar isomer 
derived from 22 exhibited resonances at OH 4.38 (br quin, J = 3.7) and at 
4.87 (ddq, J = 11.3, 6.4 and 3.1). Assigning these resonances by COSY 
experiments as the 4-H and 6-H respectively and assuming that the 
methyl group is likely to adopt the equatorial position, led to the conclusion 
that this was the trans isomer which exists in conformation 26 (Scheme 
65). The more polar isomer derived from 23 exhibited the corresponding 
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resonances at OH 4.25 (dddd, J = 9.1, 7.6, 5.8 and 5.6, 4-H) and 4.37 (dqd, J 
= 11.7, 6.2 and 3.0, 6-H). These data are consistent with the corresponding 
cis isomer which adopts conformation 27 in which both 4- and 6-protons 
are in axial positions. 
Scheme 65 
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As the absolute stereochemistry and optical purity of the 4-centre 
in the lactones is transfered to the 6-centre, the stereochemistry of the 
yeast product can be deduced. The trans lactone gave unnatural (R)-
parasorbic acid 24. This implies that the yeast product must have had the 
S-configuration as shown above. From measurements of optical rotation 
an optical purity of lactones 24 and 25 78% was deduced for the initial 
product 21. 
By contrast the corresponding silyl ethers of the hydroxy-acid 21 
could be iodolactonised, with good stereoselectivities, to give 
predominantly trans-iodolactones. The stereoselectivity increased with 
increasing bulk of the silicon protecting group; indeed, a selectivity of 
5.5:1 was achieved using the triisopropylsilyl group. In the case of the 
homologous acids with a cis stereochemistry at the double bond, even 
higher selectivities of up to 10.5:1 were observed (Scheme 66).79 
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Scheme 66 
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R trans ClS Yield (%) 
H H 2.4 1 23 
TBDMS H 3 1 84 
TBDPS H 4 1 87 
TIPS H 5.5 1 81 
TIPS Bu 10.5 1 93 
The selectivity of 10.5:1 observed in the cyclisation of (Z)-3-
triisopropylsilyloxy-dec-5-enoic acid was seen to improve even further in 
the cyclisation of the corresponding (E)-isomer 28 in an isolated 
observation by a previous researcher. 80 Cyclisation gave a single isomer of 
the valerolactone 29 which differed from the major product of the 
cyclisation of the corresponding (Z)-isomer only in the configuration at the 
iodine centre. However, when this reaction was repeated as part of this 
present project, selectivities of around 8:1 were observed (vide infra) 
(Scheme 67) 
Scheme 67 
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44 
Elaboration of these trans iodo-Iactones provides an efficient 
route to mevinic acid analogues. The trans selectivity, although 
important in the synthesis of such compounds, was not the expected result 
from these iodolactonisations. 
Scheme 68 
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The stereoselectivity obtained is higher than that found by 
Bartlett21 in the iodocyclisation of acid 30 (Scheme 68) and, more 
remarkably, it gives predominantly the trans- and not the cis-
iodolactone (ie. it is overriding the "normal" selectivity). The selectivity 
which Bartlett observed is consistent with the adoption of a 'chair-like' 
transition state in which the methyl group will be predominantly in an 
'equatorial' position (Scheme 69). 
Scheme 69 
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This implies that the stereo selectivity in the cyclisation of ~ ~
hydroxy-8-alkenoic acids is the result of iodolactonisation via a transition 
state 31 in which the silyloxy function is predominantly in the axial 
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position. 
(31) 
The suggested reason 79 for the predominance of transition state 
31 is hydrogen bonding between the acid group and the oxygen of the 
silyloxy function. This provides stabilisation for the transition state 31 to 
such an extent that it becomes favourable to have the silicon group in the 
axial position. 
This explanation IS deficient in that it does not explain the 
increasing selectivity associated with the increasing bulk of the silicon 
protecting group, unless increasing electron density at silicon causes an 
increase in electron donation to the oxygen atom enabling it to hydrogen 
bond more efficiently. There are also only a few examples of the 
involvement of silyl ethers in hydrogen bonding of this sort.S! There have, 
however, been no alternative explanations proposed so far. 
This project began with these results in hand. In order to 
enhance the utility of the iodolactones, it was necessary to determine the 
stereochemistry of the iodine centre in these lactones. Previous workers 
had generally removed the iodine reductively as a first step after 
iodocyclisation. However, it was envisaged that the iodine could be used to 
enable the introduction of additional functional groups with known 
stereochemistry into the side chain, as well as provide other synthetic 
opportuni ties. 
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The approach used in this project to determine the 
stereochemistry at the iodine centre was the synthesis of the (Z)- and ( E ) - ~ ~
hydroxy-5-alkenoic acids 32 and 28 in such a way that pure geometrical 
isomers were obtained. The geometrical purity was required to ensure 
that the stereoselectivity with which the iodine centre was formed was a 
true reflection of the stereoselectivity of the reaction. These acids were 
investigated separately as it was anticipated that the geometry of the olefin 
would be important. It was envisaged that the stereochemistry at the 
iodine centre could be determined as follows: iodolactonisation 78 of the 
acids 33 and treatment of the resulting lactones 34 with sodium carbonate 
in methanol was expected to give just, the epoxy methyl esters 35;20 by 
methanolysis of the lactone ring; base induced cyclisation of the resulting 
iodohydrin completes the sequence. It was anticipated that the 
stereochemistry of these epoxides could then be determined by NMR 
studies allowing the original stereochemistry at iodine to be deduced 
(Scheme 70). 
Scheme 70 
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The alkyne 36 was prepared by a method to be described later (p. 
73) and silylated in good yield using triisopropylsilyl chloride and 
imidazole in dimethylformamide. The resulting silyl ether 37 was Lindlar 
reduced, using 5% palladium on barium sulphate, poisoned with 
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quinoline in ethyl acetate,82 to furnish the (Z)-ester 38, which was 
saponified to give the desired (Z)-acid 32, in high yield, as a single 
geometrical isomer (according to 13C NMR). The silyl ether 37 was itself 
saponified to give the acid 39 in good yield. Reduction of the acetylene 
function in the acid 39 using lithium in ammonia83 gave the desired (E)-
acid 28 as a single geometrical isomer (by 13C NMR), in high yield 
(Scheme 71). Cyclisation of the ( Z ) - ~ - h y d r o x y - o - a l k e n o i c c acid 32 (in 
aqueous acetonitrile, at QOC, using 3 equivalents of iodine and 3 
equivalents of sodium bicarbonate, for 3 hours) led to the iodolactone 40, 
whereas cyclisation of the corresponding ( E ) - ~ - h y d r o x y - o - a l k e n o i c c acid 28 
in the same way led to the iodolactones 41 and 42 in a ratio of 8:1. 
(36) 
(39) 
LilNH3 
tBuOH ! 95% 
OTIPS 
B u ~ C 0 2 H H
(28) 
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The relative stereochemistries of these lactones were determined 
primarily by consideration of coupling constants; the major lactone 41 
exhibited a narrow resonance for the 4-H with couplings to the adjacent 3-
Hax and 5-H ax which indicated it was in an equatorial position and 
therefore trans to the clearly axially positioned 6-H. The minor lactone 42 
showed data indicating that both 4-H and 6-H were axially positioned. All 
three iodolactones were converted into the corresponding epoxides 43,44 
and 45 as described above. 
Scheme 72 
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Analysis of the 400 MHz 1 H NMR spectra of the three epoxides 
allowed the 5-H to 6-H (cross epoxide) coupling constant [Js,s] to be found 
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in each case, by determining which coupling was present in both the 5-H 
and 6-H resonances. In epoxide 43 derived from the (Z)-acid 32, J s 6 was , 
4.6 Hz, whereas in the epoxides 44 and 45, derived from the (E)-acid 28, 
J S 6 was 2.3 and 2.7 Hz respectively. These values correspond to literature , 
values for such epoxide coupling constants; cis epoxides show cross 
epoxide coupling constants of 4-6 Hz whereas trans epoxides have 
corresponding values of 2-3 Hz.84 This demonstrates that the (E)-acids 
lead to trans epoxides and (Z)-acids lead to cis epoxides. This enables the 
assignment of the stereochemistry at the iodine centres to be deduced as 
shown (Scheme 72). 
The stereochemistry proven to exist at the iodine centre is 
consistent with the transition state 31 and also shows that the expected 
overall anti addition of iodine to the olefin has occurred. This provides 
evidence for the transition states shown in Scheme 73 (vide supra). 
Scheme 73 
+ 
-----H 
Transition state for 
cyclisation of the (E)-
Isomer 
Bu 
+ 
---Bu 
Transition state for 
cyclisation of the (Z)-
isomer 
H 
(II) Tetrahydrofurans By Overall 5-endo-trig Cyclisations 
During the course of his work on selenolactonisation, Bennett 
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used hydroxy-acids because the silicon protecting groups used in the 
iodolactonisations were incompatible with the use of selenium. In these 
reactions, he noted the occurrence of side products which were identified 
as the seleno-THFs 46. There was little stereoselection observed under the 
conditions used (Scheme 74). 
Scheme 74 
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Bennett also iodocyclised the hydroxy acid 47 and obtained the 
THF acids 48 and 49 exclusively. This can be explained by the fact that 
lactonisation would require a positive charge to be effectively generated ~ ~
to the aryl system and is therefore disfavoured relative to overall "5-endo-
trig" cyclisation via a stabilised positive charge in a benzylic position 
(Scheme 75). 
Scheme75 
(47) 
7:1 ratio 
Also, whilst working on the foregoing iodolactonisation 
reactions, Bennett78 noted the occurrence of the THF acids 50 as trace by-
products (less than 5%). 
51 
(50) 
It was assumed that these compounds arose from loss of the 
silicon group and subsequent cyclisation of the hydroxyl function in a 5-
endo trig fashion. It became obvious that to further investigate these 
reactions, ~ - h y d r o x y - o - a l k e n o a t e e esters needed to be synthesised. By 
blocking the lactonisation process and favouring the etherification 
process, it was thought that the "5-endo-trig" cyclisation process could be 
induced to occur to a greater or even exclusive extent. Unexpectedly, 
when the methyl ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e e 51a was cyc1ised under the 
standard kinetic conditions developed by Bartlett, the hydroxy-THF 52a 
was obtained as a single diastereoisomer (Scheme 76). Bedford8o had 
carried out a small number of these reactions in aqueous acetonitrile and 
had obtained somewhat lower yields of the hydroxy-THFs. He also cyclised 
( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s under anhydrous conditions but obtained a 
mixture of hydroxy- and iodo-THFs. 
Scheme 76 
NaHC0 3(aq) 
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Bennett85 synthesised the benzoate ester of the hydroxy-THF 
product 52a and also of its epimer (synthesised by Mitsunobu inversion).86 
The spectral data from these compounds were compared to the examples 
52 
gIven by Williams87 for similar systems and the stereochemical 
assignments thus derived were consistent with those derived from NOE 
irradiation data (Scheme 77). 
Scheme77 
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The situation was further complicated by the fact that upon 
treatment of the (E)-J3-hydroxy-8-alkenoate 53a in aqueous acetonitrile with 
3 equivalents of iodine and 3 equivalents of sodium bicarbonate at O°C, good 
yields of the iodo-THF ester 54a were obtained with very high 
stereo selectivity (Scheme 78).80 
OH 
R ~ C 0 2 M e e
(53a) 
Scheme 78 
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With these results in hand, it was decided to investigate the 
generality of this process. Bedford8o had attempted to cyclise the 
homoallylic alcohols 55 and 56 under aqueous conditions and recovered 
regio- and stereoisomers of the iodohydrins resulting from the addItion of 
water to the iodonium ion; significant regioselectivity was observed 
(Scheme 79). 
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It was against the background of these somewhat confusing 
results that the present project began. There were three primary 
objectives: (i) To establish a consistent pattern for the iodocyclisation o f ~ ~
hydroxy-8-alkenoates and a mechanistic rationalisation, (ii) To attempt to 
extend this to give a pattern for homoallylic alcohols in general, and (iii) 
To devise efficient routes to the cyclisation precursors. 
The observation of iodohydrin formation In the attempted 
cyclisation of homoallylic alcohols 55 and 56, presumably by the attack of 
water upon the iodonium ions, suggested that the removal of all the water 
from the reaction mixture would lead to interesting results. This was 
achieved using Aldrich HPLC grade ace toni trile, distilled under an 
atmosphere of nitrogen from P20 S (Super dry acetonitrile), as the solvent. 
The use of molecular sieves or the addition of dried magnesium sulphate 
was considered, but it was decided to postpone these investigations, as it 
was felt that the use of such additives could complicate the results still 
further. It has been discovered that the cyclisation of ( Z ) - ~ - h y d r o x y - 8 8
alkenoates to give a hydroxy-THF is an unusual and so far unique result 
54 
which was in some ways misleading during the early stages of this work. 
As the first part of this present project, it was established that 
the 5-endo-trig cyclisation of ( E ) - ~ - h y d r o x y - o - a l k e n o a t e s s 53b is relatively 
insensitive to the presence of water. The ester 53b was obtained as a single 
geometrical isomer by a route to be described later (p. 76). A single sample 
of the ester 53b was divided into two equal portions and one was 
iodocyclised using anhydrous conditions as described above and the other 
was iodocyclised using acetonitrile containing 10% water. The iodo-THF 
54b was obtained as a single diastereoisomer in high yield in both cases, 
although a slightly higher yield was obtained in the former case under 
anhydrous conditions (Scheme 80). This finding proved to be extremely 
significant. 
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The cyclisations of a variety of homoallylic alcohols in super dry 
acetonitrile have been investigated, and it was pleasing to find that 
generally good yields of a variety of iodo-THFs have been o b t a i n e ~ . . (E)-
Hex-3-en-1-ol 57 underwent a facile cyclisation in less than 5 min at O°C or 
in under 2 hours at -25°C to give the iodo-THF 58 in equally high yield in 
either case (Scheme 81). There was absolutely no trace of any other 
55 
products upon work up and a crude l3C NMR showed only resonances 
assignable to the iodo-THF 58 (Figure 1). The data obtained for this 
compound corresponded to those quoted by Schauble et al. 36 Further 
investigation by NOE experiments proved the trans stereochemistry of the 
product obtained. (Z)-Hex-3-en-1-01 59 cyclised only slowly at O°C, but 
under the anhydrous conditions, and with periodic addition of iodine, 
reasonable yields of the iodo-THF 60 were eventually obtained, using either 
nucleophilic (NaHC03) or non-nucleophilic (MgO) bases. Detailed NMR 
studies of the product revealed that it was definitely a THF and not the 
corresponding iodomethyloxetane which would result from an overall "4-
exo-trig" cyclisation. This was proven by the use of l3C_l H correlation 
experiments which identified the proton resonance which was related to 
the easily identifiable carbon bonded to iodine (ie the resonance is shifted 
significantly upfield in the l3C spectrum); this was a me thine .QHI and 
comparison of its couplings in the lH-IH COSY spectrum showed that it 
was coupled to the resonances of the CH2 protons in the ring and to the 2-
C H 0 resonance. There was no coupling to the side chain proton 
resonances as would be observed in the case of an iodomethyloxetane. In 
compound 60, there is also a significant upfield shift of the resonance 
resulting from the 2-CH 0, which is observed at ()H = 2.80. This 
phenomenon has yet to be fully explained but it could result from the 
strained configuration of the molecule. Cyclisation of 4 - m e t h y l p e ~ t - 4 - e n n
1-0161 gave no THF products, probably because the expected educt, being a 
tertiary iodide, underwent rapid decomposition. The black oily nature of 
the crude reaction product and its IH NMR spectrum suggested this had 
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occurred. The secondary alcohols 55 and 56, which Bedford used to 
produce iodohydrins, were cyclised under the present anhydrous 
conditions to give the iodo-THFs 62 and 63 respectively; the 
stereochemistries of which were proven by NOE experiments. The (E)-
isomer again underwent a much smoother cyclisation, which was 
complete after 16 hours. In reality, the cyclisation was probably over in 
about 2 hours (cf cyclisation of primary homoallylic alcohols); crude 1 H 
NMR showed a single product which was isolated in 80% yield after 
chromatography. In the case of the (Z)-isomer, cyclisation required a 
longer period of time but proceeded in a reasonable yield, after 
chromatography, of 70%. 
The tertiary alcohol, (E)-2-methyl-hept-4-en-2-01 64, was found to 
cyclise in equally high yield in less than 1 hour to give the 5,5-
dimethyliodo-THF 65 which showed data appropriate to the structure 
shown. Comparison with the data for iodo-THFs 58 and 60 showed that 
the 2,3-trans relationship was obtained. Disubstituted double bonds could 
also be incorporated. For example, 4-methylpent-3-en-l-01 66 was found to 
cyclise in less than 1 hour, and in high yield, to give the 2,2-dimethyliodo-
THF 67 (Scheme 81). The determination of structure and stereochemistry 
for the iodo-THF systems involved analysis of 400 MHz IH, 13C, IH-IH 
COSY, 13C-IH COSY and NOE spectra. As an example, the structural 
and stereochemical information for the iodo-THF 62 is analysed (Figure 2 
a-j) [the IH spectrum of the iodo-THF 63 is included for comparison 
(Figure 3)] to illustrate how the structures of all the THFs synthesised 
during the course of this project were deduced. 
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Conditions Yield 
~ O H H 12, MeCN, NaHCOg EXI .. 90% 5 min, O°C 
(57) ):> 12, MeCN, NaHCOa ~ ' . .~ O H H ... 90% 
2h, -25°C Et 0 
(57) (58) 
C:0H 12, MeCN, NaHCOg EXI .. 60% 72h,O°C 
(59) (60) 
~ O H H 12, MeCN, MgO EXI .. 63% 72h,O°C 
(59) (60) 
~ O H H 12, MeCN, NaHCOg .. 0% 
(61) I6h,O°C (b.Et 
I OH 12, MeCN, NaHCOg Et ... 70% 
Bu 72h,O°C 
(55) (62) 
~ : o o12, MeCN, NaHCOg '. ~ E t t  ... 01 Et Bu ... 80% 
OH I6h,O°C Bu 
(56) (63) I ' ~ ~E t ~ ~ 12, MeCN, NaHCOg 90% ... 
OH Ih,O°C Et 
(64) (65) 
~ O H H 12, MeCN, NaHCOa h> 80% .. Ih,O°C 
(66) (67) 
58 
(62) 
Analysis of the 13C_IH COSY spectrum (Figure 2e) allowed the resonances 
at oe = 32.35 and ~ ~ = 4.40 to be assigned as those corresponding to the 5-C 
and 5-H respectively; the large upfield shift in the resonance due to the 
carbon bonded to iodine means that it can easily be identified. Comparison 
with the IH-IH COSY spectrum (Figure 2d) showed that the 5-H resonance 
exhibited coupling to the resonances at OH = 2.76 and 2.92. The fact that 
there is no coupling apparent to the side chain allows the isomeric oxetane 
product of the cyclisation to be discounted. The resonance at ~ ~ = 2.76 was 
assigned as the 6-H because it was related to the l3C signal in the l3C_lH 
COSY at oe = 81.60, and therefore it was known to be a me thine !lHOR; the 
coupling to the 5-H resonance proved that it was not the 3-H. The 
resonance at OH = 2.92 was related to the l3C signal in the 13C-lH COSY at 
oe = 43.90, and therefore it was known to be part of a methylene QH2; the 
coupling to the 5-H resonance suggesed that it was the 4-HA (ie the proton 
on the same face of the molecule as the 5-H). The 6-H resonance showed 
couplings to the side chain resonances at ~ ~ = 1.69 and 1.83, as well as to 
the 5-H in the IH-lH COSY. Both of these side chain resonances were 
related to the l3C peak at oe = 36.99 and these signals were therefore 
assigned as the 7-CH2• The 4-HA showed a strong geminal coupling to the 
resonance at OR = 2.31 in the lH-lH COSY, suggesting that the latter was 
the 4-HB. This was confirmed by the fact that both of these resonances 
were related to a single l3C signal at Oc = 43.90. The remaining C,H signal 
in the l3C spectrum was thought to be the 3-H and this was confinned by 
the fact that the corresponding lH resonance at OR = 3.87 showed coupling 
to the 4-HA and 4-HB in the lH-lH COSY. Having assigned the relevant 
l3C and 1 H resonances, the coupling constants (determined from the 400 
MHz 1 H NMR), and subsequently the NOE data, were analysed. 
Resonance OR multiplicity J values 
4-HB 2.31 ddd 14.6, 6.4 and 3.0 
6-H 2.76 ddd 6.4, 6.4 and 4.0 
4-HA 2.92 ddd 14.6,8.0 and 7.0 
3-H 3.86 dddd 8.0, 6.4, 6.4 and 6.4 
5-H 4.40 ddd 7.0, 4.0 and 3.0 
These coupling constants give a great deal of information about 
the stereochemistry of the product. During these studies, it has been 
found that those systems in which the iodine has a cis relationship to the 
adjacent CHOR, the coupling constants observed for the adjacent CHOR 
are of the pattern J= -7,4-7 and -3. Those systems in which the iodine 
has a trans relationship to the adjacent CHOR, the coupling constants for 
the adjacent CHOR are again of the pattern J= -7,4-7 and -3. However, 
in the case of the cis example, the smallest coupling is between the CHI 
and the CHOR whereas in the case of the trans examples, the smallest 
----, , 
coupling is between the CHOR and one of the side chain protons closest to 
the iodine atom (Figure 4). 
R 
.' ~ " . .,\: 
~ H H
7,3 
Figure 4 
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~ ~
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These coupling constants therefore suggested a cis relationship 
between the 6-H and 5-H, as the coupling constant was 4.0 Hz, whereas the 
couplings to the side chain were both 6.4 Hz. The 4-HA appears to be on the 
same face as both the 5-H and the 3-H, as it has large couplings to both of 
these resonances. NOE data (Figure 2f-j) confirmed this as shown, 
suggesting an all-cis stereochemistry for the iodo-THF 62. The strong 
enhancement of both the 3-H and the 5-H, by irradiation of the 4-HA, shows 
that these three protons share the same face of the molecule. The 
enhancement of 6-H, by irradiation of the 5-H, confirms an all-cis-
stereochemistry. 
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The dithiane derivative 68 cyclised smoothly but in somewhat lower yield 
due to in situ hydrolysis of the dithiane unit. This resulted in the 
formation of a significant proportion of the aldehyde 69 which was 
produced along with corresponding dithiane 70 in 49% overall yield 
(Scheme 82). 
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Further examples included various ( E ) - ~ - h y d r o x y - 8 - a l k e n o a t e s s
which were synthesised as part of the work towards a general synthesis of 
the cyclisation precursors. These molecules underwent fast cyclisation to 
give the iodo-THF esters with at least as good stereo control as in the 
cyclisation of ester 53b. The tbutyldiphenylsilyloxy group was shown to 
survive the cyclisation conditions, although a tbutyldimethylsilyloxy group 
was cleaved. A THF containing a remote phenyl substituent 54c was also 
synthesised; the aryl function could be a potential synthetic equivalent of 
an acid moiety upon oxidation (Scheme 76).88 NOE data and comparison 
to the data from iodo-THF 54b was used to confirm the stereochemistries 
shown. 
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Scheme 84 
When ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s were cyclised by stirring under 
the standard iodoetherification conditions using anhydrous acetonitrile 
for 72 hours, hydroxy-THFs were obtained in high yields (Scheme 84). 
Bedford8o also cyclised ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s in dry conditions but 
obtained a mixture of hydroxy- and iodo-THFs. This result has since been 
attributed to impurities consisting of ( E ) - ~ - h y d r o x y - o - a l k e n o a t e s s in the 
starting materials. Examples of the cyclisations were repeated as part of 
this present project using geometrically pure (Z)-methyl 3-hydroxy-dec-5-
enoate 71 (one isomer by l3C NMR) in 0%, 1%, 5%, 10% and 50% aqueous 
acetonitrile (Scheme 85) to give hydroxy-THF 72 but no iodo-THF products. 
The reactions proceed with good stereoselectivities for the isomer shown 
over its 3-epimer of around 10: 1. [An exception was the case of R = Me 
where a stereoselection of around 8:1 was obtained in subsequent studies 
(see p 104).] 
Various (Z)-methyl ~ - h y d r o x y - o - a l k e n o a t e s s have been synthesised 
as part of this project and all the examples cyclise in high yields under 
these conditions [eg (Scheme 86)]. However, both the butyl and benzyl 
esters corresponding to the ~ - h y d r o x y - o - a l k e n o a t e e 71 underwent 
cyclisation in much lower yields (Scheme 87). This result has not been 
explained; there were no signs of valerolactone products from ester 
cleavage in the case of the benzyl ester, but there were various impurities, 
apparently resulting primarily from iodohydrin formation. 
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It is assumed that the cyclisation of ( E ) - ~ - h y d r o x y - S - a l k e n o a t e s s
proceeds through a 'chair like' transition state (Scheme 88). The reason 
that the cyclisations are insensitive to the presence of water could be that 
the hydroxyl function has increased nucleophilicity due to the fact that it is 
intramolecularly hydrogen bonded to the ester function. The electron 
donating effect of this hydrogen bonding, and the consequent weakening of 
the O-H bond, allows cyclisation to take preference over the attack of water 
upon the iodonium ion. This explanation is closely related to the 
explanation of the unusual stereochemical outcome of the iodo-
lactonisation reactions (cftransition state 31) (Scheme 89). 
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The proposed transition states for the 5-endo-trig cyclisations of 
general homoallylic alcohols in anhydrous acetonitrile are postulated to be 
'chair like', and are related to the foregoing transition state for the 
cyclisation of ( E ) - ~ - h y d r o x y - S - a l k e n o a t e s s (Scheme 90). The transition state 
for (E)-homoallylic alcohols 73 is favoured as there are no large steric 
interactions, whereas the corresponding transition state 74 for (Z)-
homoallylic alcohols has a great deal of steric hindrance. This is 
consistent with the observation that the cyclisation of the trans isomers is 
ffi 
much smoother than that of the cis isomers. In transition state 74 the 
approach of the hydroxyl to the iodonium ion is blocked by the substituent 
Rl and the transition state has a "boat" like eclipsed conformation. This 
would lead to a slow cyclisation, consistent with the observations made 
earlier. The stereochemistry of the substituents on the iodo-THF products 
are derived from the transition states as drawn and these also correspond 
to the products observed in these reactions. This provides good evidence 
for intermediacy of a "chair like" transition state. 
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The hindered nature of transition state 74 also helps to explain 
perhaps the most unusual result in this field, namely the cyclisation of 
( Z ) - ~ - h y d r o x y - 8 - a l k e n o a t e s s to give hydroxy-THFs. 
At first, the more obvious mechanistic explanations for the 
formation of hydroxy-THFs from the iodocyclisation of ( Z ) - ~ - h y d r o x y - 8 8
alkenoates were investigated, in two isolated studies by Bedford.8o The 
possibility of hydroxy-THFs arising from an SN2 substitution at an initially 
formed iodo-THF was discounted because when the all-cis-iodo-THF 75 
was subjected to the reaction conditions, no substitution was observed 
(Scheme 91). 
Scheme 91 
NaHC03 (aq) 
A second possible explanation is the in situ formation and ring 
opening of epoxides 76 to give hydroxy-THFs. This was discounted because 
when such an epoxide was subjected to the reaction conditions, no THF 
products were observed (Scheme 92). 
Scheme 92 
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These results led to the consideration of the possible involvement 
of the ester function at an early stage of the cyclisation. The hi.ndered 
nature of transition state 74 causes direct cyclisation to be a slow process, 
but in the case of general (Z)-homoallylic alcohols there are no alternative 
pathways. In the case of ( Z ) - ~ - h y d r o x y - O - a l k e n o a t e s , , it is proposed that the 
mechanism shown (Scheme 93) operates in preference to direct cyclisation 
due to the steric strain involved in transition state 74. 
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Attack of the ester function upon the iodonium ion 75 in an 6-
exo-fashion, would yield the stabilised carbocation 76. Attack of an 
external oxygen nucleophile (eg water) upon this carbocation. would 
furnish the ortho-ester 77 which could then collapse, regenerating the 
methyl ester and giving rise to the iodo-diol 78, as a single isomer. The 
enhanced nucleophilicity of the hydroxyl function in ~ - h y d r o x y - o o
68 
alkenoates, which is a key feature of the insensitivity of the cyclisation of 
( E ) - ~ - h y d r o x y - o - a l k e n o a t e s s to the presence of water, allows displacment of 
the iodine intramolecularly to give the hydroxy-THF 72. When the 
cyclisation was stopped after 3 hours, an intermediate consistent by 1 H 
and l ~ C C NMR and IR with the iodo-diol 78, was isolated as the major 
product. This intermediate was converted quantitatively into the hydroxy-
THF 72 upon treatment with sodium carbonate in acetonitrile proving that 
iodine was unnecessary for this final step. Although the final step of the 
process has now been proven to be a fairly slow displacement of iodine, the 
mechanism of the iodo-diol formation remains somewhat open to 
speculation, although the proposed route certainly does account for the 
observed stereochemistry. 
The cationic nature of these processes means that they are only 
formally exceptions to Baldwin's rules, which were not intended for use in 
cationic processes. An interesting test case was chosen as part of the 
initial work of this project. The g e m - d i m e t h y l - ~ - h y d r o x y - o - a l k e n o a t e e 80 
was synthesised in order to see whether steric hindrance would make it 
behave like a ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e e or whether the extra electron 
donation to the iodonium ion would stabilise a positive charge sufficiently 
to favour a direct cyclisation in a 5-endo-trig fashion. Unsaturated acid 
81 was prepared by a literature procedure89 and was converted into its acyl 
imidazole derivative before being treated with the magnesium chelate 
Grignard reagent from methyl hydrogen malonate to give the ~ ~ keto ester 
82. The ester was then reduced using borane-tbutylamine complex to give 
the hydroxy ester 80. To our surprise, this molecule underwent 
iodocyclisation to give the iodo-THF 83 in good yield, despite the effects of 
steric hindrance. This serves to emphasise the pronounced effect that 
stabilisation of a cation can have upon the cyclisation of ~ - h y d r o x y - o o
alkenoates (Scheme 94). 
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(III) Generation of the Cyclisation Precursors 
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Prior to the beginning of this project, various different routes had 
been used by previous researchers in our group to synthesise the 
homoallylic alcohols required as cyclisation precursors; there was, 
however, no general or particularly efficient route available.8o 
The potential sensitivity of the ~ - h y d r o x y - o - a l k e n o a t e s s to acid and 
base meant that a mild route for their preparation was required. It was 
decided to seek routes to these compounds which would not only yield pure 
geometrical isomers, to ensure the results of the cyclisations were clear 
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and to maximise the synthetic utility of the products, but which would also 
prove amenable to the incorporation of chirality into the system, which 
would be vital in later projected natural product target syntheses. An 
appropriate approach would therefore involve the generation of the chiral 
centre in the cyclisation precursor in a controlled way. 
The use of methyl 3,4-epoxybutanoate 84 has allowed all of these 
goals to be achieved. Previous workers80 had found this molecule difficult 
to prepare in usable quantities due to its high volatility (bp =110°C) and its 
extreme acid and base sensitivity (Scheme 95). As shown below, the 
acidity of the a. protons is reasonably high and even treatment with 
carbonate will cause rearrangement to the unsaturated ester 85. Acid 
also triggers ring opening of the epoxide. However, it was found that with 
the use of low boiling solvents and mild conditions, the epoxide could be 
prepared in 90% overall yield in 2 steps, in quantities of up to 20 g. Vinyl 
acetic acid was esterified using the DCC/DMAP method 90 in 
dichloromethane and the resulting ester epoxidised using buffered urea-
hydrogen peroxide complex and trifluoroacetic anhydride (Scheme 96).91 
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The corresponding butyl ester was prepared as part of the early 
work of this present project, in order to reduce the volatility problems, but 
the failure of the (Z)-butyl ~ - h y d r o x y - o - a l k e n o a t e s s formed to cyclise in high 
yield meant that this approach was not continued. 
Treatment of the epoxide 84 with an appropriate nucleophile 
then leads to a convergent route to the required ~ - h y d r o x y y esters. The use 
of (E)-vinyl anions would give the ( E ) - ~ - h y d r o x y - o - a l k e n o a t e s s whilst 
treatment with acetylide anions, and subsequent Lindlar reduction would 
lead to the ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s (Scheme 97). 
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Possible viable sources of non-basic vinyl anions appropriate for 
epoxide opening include vinyl alanate complexes92 and vinyl cuprates, 
whereas simple lithio acetylides can be used to open epoxides. 
Chiral ethyl 3,4-epoxybutanoate has been synthesised in .5 steps 
from (S)-malic acid by Larcheveque93,94 who demonstrated that it was 
opened highly regioselectively by various nucleophiles, especially vinyl 
cuprates (Scheme 98). 
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The methyl ester has also been resolved using pig liver esterase.95 
(A) (Z)-6-Hydroxy-&-alkenoates 
The general approach adopted to all the ( Z ) - ~ - h y d r o x y - & - a l k e n o a t e s s
synthesised in this project has been the coupling of acetylide anions, 
generated using butyl lithium, with the (+)-epoxy ester 84 in the presence of a 
stoichiometric amount of boron trifluoride etherate. The original procedure 
was developed by Yamaguchi.96 The approach used during this project was 
adapted because the excess acetylene used in the original procedure also 
attacked the ester function of the substrate at the carbonyl site to give the 
dialkynyl ketone 86 as a side product. The coupling was carried out for 15-20 
minutes at -78°C which gave high yields of the ~ - h y d r o x y - & - a l k y n o a t e e 87 and 
minimal ketone formation (Scheme 99). 
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Lindlar reduction of these acetylenes was accomplished in high 
yield to give the ( Z ) - ~ - h y d r o x y - 8 - a l k e n o a t e s s as single isomers according to 
l3C NMR spectroscopy. The commercially supplied Lindlar catalyst 
(Aldrich) proved unreliable and so the catalyst was prepared from 5% 
palladium on barium sulphate by poisoning with quinoline, prior to each 
reduction.82 
(B) CE)- and CZ)- Homoallylic alcohols 
These molecules can generally be accessed by a coupling 
reaction of an acetylene and an epoxide under boron trifluoride catalysis, 
as described by Yamaguchi.96 
The acetylenes produced can be reduced specifically to give (E)-
or (Z)-homoallylic alcohols as single geometric isomers. Lindlar 
reduction, as previously described, gave the (Z)-isomers in high yield, pure 
by l3C NMR spectroscopy, whereas reduction by refluxing with lithium 
aluminium hydride bis-tetrahydrofuran in toluene over 48 hours, 
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afforded the corresponding (E)-isomers in approximately 75% yield, again 
as single isomers according to l3C NMR spectroscopy (Scheme 100). 
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Overall, this provides routes to homoallylic alcohols which are 
applicable to many systems and can be applied to asymmetric synthesis. 
(C) (E)-6-Hydroxy-&-alkenoates 
The synthesis of ( E ) - ~ - h y d r o x y - & - a l k e n o a t e s s has provided many 
more problems than the routes to the other homoallylic alcohols. The use 
of lithium aluminium hydride to reduce an acetylene is obviously not 
compatible with the ester function. The work of Alexakis97 led to the 
consideration of the use of vinyl alanates as the source of vinyl anions. 
This work comprised the first use of vinyl alanates in the synthesis of ~ ~
hydroxy-esters. The (+ )-epoxy-ester 84 was treated with the vinyl alanate 
complex derived from 1-hexyne [by treatment with diisobutylaluminium 
hydride in hexane at 50°C for 2 hours, and reaction of the resulting vinyl 
alane with methyl lithium] in the presence of boron trifluoride etherate, to 
give the ( E ) - ~ - h y d r o x y - & - a l k e n o a t e e 53b in high yield, as a single isomer, 
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according to l3C NMR spectroscopy (Scheme 101). This pure hydroxy-ester 
53b proved extremely useful in the investigations of the iodocyclisations 
(Scheme 80). 
Scheme 101 
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(ii) epoxide 84 (53b) 
However, when this new approach was extended to the 
alkylation of 4-phenylbutyne, smooth vinyl alane formation was not 
observed, except over 48 hours at 50°C in the presence of 
diisobutylaluminium hydride. Subsequent vinyl alanate formation in this 
system was not observed. Although this methodology is probably 
extendable to the coupling of enynes98 to the (+)-epoxy-ester 84, it is also 
limited in that smooth (E)-vinyl alane formation is not observed in the 
presence of heteroatoms.99 Other methods of coupling to the (±)-epoxy-
ester 84 were therefore sought. 
Vinyl cuprate chemistry proved very unreliable in the generation 
of vinyl anions and in the subsequent coupling reactions required. The 
results obtained by Larcheveque94 could not be repeated. (E)-l-Iodo-hexene 
was prepared92 and used in the formation of the corresponding vinyl 
lithium via halogen metal exchange. This vinyl lithium was used in the 
attempted cuprate formation with copper (I) iodide and with copper (D 
cyanide and also in the formation of higher cuprates using l i t ~ i u m m 2-
thienylcyanocuprate.lOO However, none of these reagents were found to 
couple with the epoxy-ester 84. One reason for this could be the extreme 
base sensitivity of the epoxide; the major product isolated from these 
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attempted couplings was the ester 85 (Scheme 102). This simply results 
from the potential nucleophile acting as a base rather than as a 
nucleophile. Further work on the use of vinyl cuprates is decribed later (p. 
130). 
Scheme 102 
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Direct transformation of vinyl alanes into vinyl cuprates was 
advocated by Ireland101 but this method carries with it the restrictions 
which apply to the generation of vinyl alanates. At this point, it was 
decided that the adoption of less elegant routes to the ( E ) - ~ - h y d r o x y - o o
alkenoates was necessary. The first approach considered was the use of 
the aforementioned acid 28 (p. 48); this compound was treated with 
diazomethane to give the silyl ether 88 in good yield. Deprotection of this 
molecule with tetrabutyl-ammonium fluoride in tetrahydrofuran gave the 
( E ) - ~ - h y d r o x y - o - a l k e n o a t e e 53b (Scheme 103) which was easily identified by 
comparison to earlier samples. Although this method is fairly general, it 
is relatively lengthy and is also incompatible with aromatic functionality 
which would be reduced (Birch) during the lithium in ammonia step, 
which is used to generate the (E)-double bond. 
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It was necessary to find a functional group to act as an equivalent 
of the ester grouping. This group needed to be simply convertible into a 
methyl ester group, and also needed to be stable to lithium aluminium hydride 
reduction at high temperatures. The dithiane group was investigated with 
this in mind, because the epoxide 89 had been prepared in homochiral form by 
Benechie.102 The racemic epoxide 89 was prepared by literature methodsl03 
and was coupled in reasonable yield to 4-phenylbutyne under standard 
Yamaguchi conditions96 to give the dithianyl acetylene 90. This was reduced 
using lithium aluminium hydride bis-tetrahydrofuran in toluene to furnish 
the alkene 68, in high yield, as a single geometrical isomer by l3C NMR. This 
alkene was treated with excess methyl iodide in wet acetone, at reflux in the 
presence of sodium carbonate, to give the aldehyde 91 in good yield. Addition 
of further portions of methyl iodide to the mixture was necessary in order to 
obtain a good conversion. Hydrolysis of the dithiane group with N-
chlorosuccinimidelo4 was attempted without success; the dithiane 
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appeared to be stable to these reaction conditions. The aldehyde 91 was 
oxidised directly to the methyl ester 92 using pyridinium dichromate in 
dimethylformamide in the presence of methanol (Scheme 104).105 This 
involves direct oxidation of the dimethyl acetal which occurs rapidly; the 
m e t h ~ o l l solvent is only oxidised slowly under the reaction conditions and 
there was no oxidation of the secondary hydroxyl present in the substrate. 
The data for this pure geometrical isomer were compared to that of the pure 
(Z)-isomer (Scheme 86) and the two compounds were shown to be different. 
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Oxidation of the aldehyde to the corresponding acid was also 
attempted using potassium permanganate in tbutanol106 and also with 
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silvereD oxide,107 but with little success. The dithiane based approach 
proved to be fairly general but it is by no means ideal and other routes to 
accomplish the synthesis also need to be investigated. 
In conclusion, the synthetic importance of these reactions makes 
it s l i g ~ t 1 y y surprising that the iodocyclisation of homoallylic alcohols has 
not been explored before. The susceptability of these systems to solvolysis 
of the iodonium ion, and the fact that the cyclisation is formally a 5-endo-
trig process, goes some way to explaining this. The processes are, 
however, not strictly governed by Baldwin's rules due to their cationic 
nature, so the term 5-endo-trig is only an approximate description of the 
reactions. 
The synthetic utility of the iodoetherification of homoallylic 
alcohols is extensive. However, the cyclisation of the (Z)-isomers needs 
further optimisation because the water which is generated during the 
course of the reaction causes some solvolysis to occur. This leads to the 
somewhat lower yields. Higher yields may well be obtained if the water 
produced can be removed, perhaps by the inclusion of molecular sieves. 
The possibility that these processes occur via an initial 4-exo-
trig cyclisation to give an iodomethyl oxetane and subsequent dyotropic 
rearrangement to give the tetrahydrofuran, has been considered (Scheme 
105). These processes are known in lactone systems under Lewis acid 
catalysis; indeed Black108 has investigated them extensively. However, no 
evidence for the proposed oxetane intermediates has been seen, even when 
the reactions have been stopped after less than five minutes. Therefore, if 
these intermediates exist, their rearangement must be almost 
instantaneous. 
Scheme 105 
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The cyclisation of ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s is also a very 
synthetically useful process. An overall stereospecific trans-dihydroxylation 
of a double bond, controlled by a remote hydroxyl group, is achieved. This is in 
many ways complementary to the chiral cis-dihydroxylations introduced by 
Sharpless and others.109 The limitation of this process to ~ - h y d r o x y - e s t e r s s is 
still under investigation, but at this stage it does present a restriction of the 
synthetic utility of the process. The comparison of this technique to the 
Sharpless epoxidation of homoallylic alcohols is favourable, as only 
approximately 30% enantiomeric excess is obtained from such an 
epoxidation.110 
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CHAPTER THREE 
The Total Synthesis of Muscarine 
(I) Introduction 82 
(II) Approaches to Muscarine 84 
(III) (Z)-p-Hydroxy-8-alkenoates in the 
Synthesis of Muscarine 98 
The Total Synthesis of Muscarine 
(I) Introduction 
(93) 
L-( + )-Muscarine 93 was the subject of intense interestlll long 
before its structure was first determined by X-ray crystallography in 
1957.112 Indeed, the plot of a murder mystery novel, published in 1930, 
turned upon the difference between natural and synthetic 
muscarine. 113 
Muscarine IS the major toxic principle found in the well 
known mushroom Amanita muscaria (Fly agaric), a common, but 
dangerous feature of deciduous woodland in autumn. It is, however, 
not the only biologically active alkaloid isolated from this species. In 
fact, the related alkaloid muscimol 94 (Scheme 106) is responsible for 
the notorious hallucinogenic effects of the mushroom, which have led 
to its ritualistic use by the Shamen and medicine men of Siberian 
tribes, and to the cults of mushroom worship among South American 
indians. 114 Muscarine has also been isolated from Amanita 
phalloides (death cap mushroom) and certain species of Inocybe and 
Clitocybe. 
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The pharmacological action of muscarine upon smooth 
muscle so resembles that of acetyl choline that direct action on 
cholinergic receptors in the autonomic nervous system has come to be 
known as "muscarinic" action. Muscarine is a selective agonist of 
acetyl choline in the smooth muscles of the gastro-intestinal tract, eye, 
exocrine glands and heart. Recently, pharmacological investigations 
with selective antagonists evidenced distinct sub-types of muscarinic 
receptors. The receptors in the central nervous system and peripheral 
ganglia (M1 ), are distinguishable from the receptors of the cardiac 
cells (M2) and also from those of the smooth muscles and exocrine 
glands (M3 ). There is renewed interest in the muscarinic field 
because of the discovery of a relationship between cholinergic deficits 
in cortical and hippocampal areas and the pathology of Alzheimer's 
disease. Current activity in exploring compounds which may be 
specific agonists or antagonists of individual muscarinic receptors is 
intense. This means that a readily adaptable synthesis of muscarine 
and its analogues, particularly those where changes are made. at C-2 
(ie where the methyl group at C-2 is exchanged for another functional 
group) and which retain activity, would be of great synthetic value. 
Muscarine isolated from natural sources is frequently 
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contaminated with allo-muscarine 95 and its purification is tedious 
and impractical. For this reason, pharmacological studies are 
generally carried out using synthetic material. This means that short 
and efficient syntheses of L-( + )-muscarine are of utilitarian value. 
(95) 
(II) Approaches to Muscarine 
There have been numerous asymmetric total syntheses of 
muscarine, some of which are genuinely asymmetric while others 
involve the separation of enantiomers. There have also been a number 
of achiral syntheses. A wide ranging review of the area was published 
in 1984.115 As part of this chapter, all the syntheses of muscarine 
published to date will be evaluated in terms of flexibility (ie ease of 
incorporation of new functional groups to the muscarine skeleton), 
practicality (ie number of synthetic operations involved and the scale 
upon which these operations can be carried out), overall yield and 
stereo/enantioselectivity. A new synthesis of muscarine utilising the 
iodocyclisation of ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s s carried out as part of this 
project will also be described. 
L-(+)-Muscarine was synthesised, and its absolute 
84 
configuration finally proven, in 1957, as the culmination of an 
extensive amount of work in the field by Hardeggar and his colleagues 
in a twelve step synthesis starting from L-arabinose. 116 This 
pioneering synthesis used the diazotisation of glucose amino acid 96 to 
give the tetrahydrofuran 97, which was esterified and then converted 
into the amide 98. Amide 98 is a key intermediate, analogues of which 
have been used in a number of subsequent approaches to muscarine. 
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Regiospecific tosylation followed by lithium aluminium 
85 
hydride (LAH) reduction gave the amine 99, which were then 
methylated to give muscarine 93 in a low overall yield (Scheme 107). 
There is some scope for the synthesis of C-2 analogues of 
muscarine by this or by many of the subsequent carbohydrate-based 
approaches because the C-2 methyl group is obtained by degradation of 
a CH20H function in the original sugar. This functionality could be 
utilised to synthesise C-2 analogues, but this has not been attempted. 
Since 1957, a variety of other carbohydrate based syntheses 
have been developed: Pochet and Huynh-Dinh117 also synthesised one 
of the stereoisomers of the amine 99, this time in four steps from 2-
deoxyribose. The key reaction was again the reduction of an amide, 
this time compound 100. Both enantiomers of muscarine and allo-
muscarine were synthesised individually, but the number of steps 
required to synthesise 2-deoxyribose compromised the overall yield in 
each case (Scheme 108). 
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Joullie et al118 synthesised D-epi-allo-muscarine from D-
glucose in thirteen steps with a reasonable overall yield. The 
carbohydrate derived epoxide 101 was ring opened using a moderately 
regioselective LAH reduction. After a number of steps, the amide 102 
was synthesised, and another LAH reduction followed by methylation, 
furnished D-epi-allo-muscarine (Scheme 109), 
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Mubarek and Brown l19 improved this approach by 
synthesising the epoxide 103 in seven steps from D-mannitol and 
effecting a regiospecific ring opening using Red-Al©, Monotosylation 
of the diol 104 thus produced, and treatment of the resulting tosylate 
with trimethylamine, gave muscarine in a good overall yield of 30% for 
the last seven steps of the synthesis (Scheme 110). The use of dioll04 to 
access muscarine as first seen here, has become a common feature of 
many of the more recent approaches to muscarine. 
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Bandouzzi and Chapleur120 also synthesised the diol 104, this 
time in nine steps from D-gluconolactone 105. This approach featured 
the homologation of lactones using hexamethylphosphoramide 
(HMPA) in carbon tetrachloride to give the dichloride 106 (Scheme 111) 
which was converted into the diol 104. The toxicity of these reagents 
precludes their use on larger scales and this synthesis is again not 
amenable to the production of C-2 analogues of muscarine. 
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The first non-carbohydrate based synthesis of D - ( ~ ~ )-allo-
muscarine was published by Fronza et al. 121 The fermentation of 
cinnamaldehyde with baker's yeast gave the chiral diol 107 which was 
converted into the amide 108 in ten steps with low overall yield. The 
88 
OH 
amide was then converted into muscarine as before (Scheme 112). 
Again this approach is not easily adaptable to the synthesis of C-2 
analogues of muscarine because the methyl group originates from the 
ethanol produced by the fermentation process. 
Scheme 112 
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Shapiro et al122 identified the problem that there were "no 
general syntheses of analogues of muscarine with the natural (S) 
stereochemistry at C-2" which is required for biological activity. The 
large scale synthesis of analogues of muscarine was then addressed. 
The piperidine 109 was cyclised in a 5-endo-trig fashion using 
mercury(II) acetate to give the THF derivative 110, which furnished 
the C-5 analogue of muscarine 111 after a Mitsunobu inversion 
(Scheme 113). 
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These compounds are potentially highly biologically active 
because unlike muscarine itself, they have been shown to penetrate 
the bloodlbrain barrier. These authors did not however address the 
synthesis of C-2 analogues. 
Whiting et al123 developed a potentially flexible synthesis of 
L-(+) muscarine in 1972, via the pig liver esterase resolution of the N-
acyl amino acid 112 to give the chiral amino acid 113. Diazotisation of 
the amino acid 113 in the presence of methanol gave the methyl esters 
114 which were converted to the corresponding amides 115. These 
were then separated and individually converted as before to give a 
moderate overall yield of L-( + )-muscarine and L-( + )-allo-muscarine 
(Scheme 114). 
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Micheli et af124 synthesised all 8 enantiomers of muscarine 
00 
and allo-muscarine by using a chemoenzymatic reduction to resolve 
the iodoketones 116. The iodoalcohols 117 produced were converted in 
two steps into muscarines (Scheme 115). The iodoketones were 
synthesised using an extended reaction sequence in which the C-2 
methyl group was derived from methyl lactate. Obviously this 
substituent would be difficult to change without taking a higher 
homologue of lactate through the entire sequence. 
(116) 
Scheme 115 
enzymes 
I 
(117) 
I 
HO 
~ ~
(i) NHMe: " ..... Q 
(ii) Mel H ~ . . C H 2 N ~ e 3 3
~ ~
Adams et a[125 devised an elegant nine step route to the diol 
104 using alanine as the starting material and utilising a rhodium 
carbenoid insertion. The diazoketone 118 was obtained in good yield 
over three steps from homochiral bromopropionic acid, derived from 
alanine. Rhodium catalysed insertion into the C-H bond gave the 
ketone 119 in good yield. Removal of the benzyl protecting group was 
followed by a highly stereoselective reduction of the ketone using 
sodi um triacetoxy borohydride to invoke the directing effect of the 3-
hydroxyl. This procedure gives muscarine in an acceptable 7.3% 
overall yield and it is theoretically extendable to the synthesis of C-2 
analogues by using a different amino acid as the starting material 
91 
(Scheme 116). 
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A second, somewhat less flexible amino acid-based approach 
to muscarine, was developed by Chastrette et al. 126 The epoxide 120 
was synthesised in six steps from threonine and treated with vinyl 
magnesium bromide to give the homoallylic alcohol 121. Using the 
methodology for 5-exo-trig iodoetherification developed by Bartlett,30 
the alcohol was cyclised to give the iodide 122 In a highly 
stereoselective fashion. This compound was used to alkylate 
trimethylamine in a single step to give muscarine iodide (Scheme 117). 
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The rather unsatisfactory synthesis of epoxide 120 gives a rather low 
overall yield and does not allow the incorporation of C-2 substituents 
other than methyl, except by the use of substituted threonines. 
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Mulzer 127 greatly improved this approach when he 
synthesised the epoxide 120 in five steps from (R)-2,3-0-isopropylidine 
glyceraldehyde 123, which allowed the molecule to be accessed 
routinely in quantities greater than 10 g. Consequently, muscarine 
iodide was obtained in multi gram quantities. The C-2 substituent is 
incorporated using a stereoselective Grignard addition to the aldehyde 
123 (Scheme 118) and therefore the incorporation of C-2 substituents is 
potentially easy. This is a comparatively long route to muscarines and 
the separation of stereoisomers at the early stages of the synthesis 
reduces the overall yield. It does however rate as one of the most 
practical routes to muscarine to date. 
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Achiral syntheses of muscarine have been used by several 
groups to illustrate the utility of their own methodology. Still et al128 
[(a)] and Matsumoto et al129 [(b)] both synthesied the (+) amide 108 by 
related cyclisations and converted it, as previously, into muscarine 
(Scheme 119). Although both of these syntheses illustrate new 
methodology, they represent relatively lengthy approaches to 
muscarIne. 
Scheme 119 
OR 
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Pirrung130 synthesised (+)-muscarine uSIng the ring 
expansion of cyc1obutanones. The cyc1oaddition of a silyl enol ether 
9t 
with chloromethylketene followed by the removal of the halogen group, 
gave the cyclobutanones 124, which were separated. After a non-
stereoselective ring expansion, and treatment with 
cyanotrimethylsilane, the mixture of THFs 125 was obtained. 
Separation and reduction gave the amine 126 which was methylated to 
give muscarine iodide using methyl iodide and 1,2,2,5,5-pentamethyl 
piperidine (PMP). The low yields and lack of stereospecificity rather 
tends to reduce this to an illustration of the use of ring expansion 
methodology (Scheme 120). 
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Overmann 131 et al used the synthesis of L-( + )-muscarine to 
illustrate the acid promoted rearrangement of allylic diols as a route to 
THFs. It was found that the lactate derived allylic diol127 rearranged 
to give the ketone 128 stereospecifically. After cleavage of the benzyl 
ether, this ketone was oxidised using the Baeyer-Villiger reaction to 
give the corresponding acetate, which was cleaved to give the diol 104 
(Scheme 121). This compound was converted into muscarine as 
previously described. The overall yield for this synthesis was not high 
but its adaptability to allow the incorporation of a variety of functional 
groups makes this a potentially important route to THFs in general, 
and to the muscarines in particular. 
Scheme 121 
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Fleet et al132 also synthesised the diol 104 as part of an 
approach to L-( + )-muscarine. This synthesis involved the ring 
contraction of lactones 129 to give the diol 104 stereospecifically. They 
achieved a total synthesis of L-( + )-muscarine from L-rhamnose- 130 in 
nine steps and an overall yield of 10%; no protecting groups were used 
and remarkably 5.01 g of L-(+)-muscarine tosylate was isolated 
(Scheme 122). Although this is most certainly one of the most 
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practical routes to muscarine, it does not allow for easy expansion into 
syntheses of C-2 analogues. 
OR 
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Takano et al133 devised a highly flexible route to muscarine 
starting from (R)-Q.-benzyl glycidol 131; overall, 8 steps were used to 
access the natural product. The homochiral acetylene 132 was cyclised 
using potassium tbutoxide in dimethyl sulphoxide to give the 2,3-
dihydrofuran 133. Subsequent hydroboration and oxidative cleavage 
gave the alcohol 134, which was deprotected to give the known diol104 
(Scheme 123). This approach would allow the access of various C-2 
analogues of muscarine but the overall yield is lower than the other 
comparable approaches. 
(i) Lithium 
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acetylide 
(ii) BuLi 
(iii) Mel 
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Muscarine 
Despite the extensive amounts of work in this field, a gap still 
exists. The asymmetric synthesis of C-2 analogues of muscarine by a 
short synthetic procedure in high overall yield remains an exceedingly 
desirable target. The availability of hydroxy-THFs of the desired 
stereochemistry from the iodocyclisation of ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s , ,
as shown in Scheme 124, offers such a route. The efficiency with 
which these cyclisations occur has been demonstrated in Chapter 
Two. Multigram quantities of a variety of hydroxy-THF esters have 
been routinely obtained in a highly stereoselective manner. All of 
these facts pointed to the use of these hydroxy THFs to synthesise 
muscarine and its analogues. Such a synthesis would also be useful 
further proof of the structure and stereochemistry of the hydroxy-
THFs formed in the cyclisation reaction, by what appears to be a 
rather odd mechanism (p 68). 
R 
Scheme 124 
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The conversion of the cyclisation products into muscarine 
requires a one carbon degradation of the methyl acetate side chain as 
shown in Scheme 125. 
Scheme 125 
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Problems reported in the saponification of these ester groups 
by a previous researcher in this groupBO at first led to the consideration 
of the use of (Z)-benzyl ~ - h y d r o x y - o - a l k e n o a t e s , , which after cyclisation 
could be hydrogenolysed to give the corresponding THF -acids. These 
acids were considered to be vital intermediates in the approach to one 
carbon degradation. The outstandingly poor yields obtained from the 
attempted cyclisation of these benzyl esters caused this approach to be 
abandoned [see earlier (p. 64)]. A second approach also considered was 
reduction of the initial ester products to give the diol 135. 
Displacement of the primary alcohol with a selenocyanide function,134 
and subsequent elimination, should then result in the formation of the 
olefin 136. Ozonolysis with reductive (N aBH4) work up would then 
furnish the known diol 104 (Scheme 126). This approach was 
abandoned because the displacement of the primary alcohol was not 
effected efficiently. Information obtained in a concurrent part of this 
project (p. 123), showed that the saponification of these THF acetic acid 
esters proceeded in good yield, without epimerisation. 
Scheme 126 
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As the earlier results80 turned out to be misleading, the way 
was left open to use the (Z)-methyl p-hydroxy-o-alkenoates in the 
cyclisations. This allowed the high yielding reactions which were 
developed in the early part of this project to be utilised. 
Model studies towards the synthesis of muscarine then began 
in earnest. The alkene 71 was available in geometrically pure form 
according to l3C NMR spectroscopy, via the Lindlar reduction of the 
corresponding acetylene 36, in turn obtained in high yield by the 
alkylation of the epoxy ester (+) 84. Large scale cyclisations of the 
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alkene proceeded in high yield, as in the earlier experiments. The 
hydroxy-THF 72 was obtained with very high stereo selectivity; less 
than 5% of what was assumed to be the 3-epimer 137 was obtained 
(Scheme 127). 
Scheme 127 
(71) (72) +<5% (137) 
When the hydroxy-THF produced was purified by column 
chromatography, consistently high losses were observed. For this 
reason and since all the spectroscopic data had been obtained, it 
became common practice to silicon protect the crude reaction mixture 
with tbutyldimethylsilyl chloride (TBS-Cl) and imidazole in DMF. 
Even when an extended reaction time of over 72 hours was used, the 
yield of the silyl ether 138 was generally low; typically around 55% (in 
this case 54%). However, chromatographical purification of the silyl 
ether 138 was facile. Disappearance of the (OH) stretch in the infra 
red spectrum was noted (Scheme 128). 
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(72) 
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Scheme 128 
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Direct saponification was not attempted here for reasons 
described earlier. Instead, the sHyl ether 138 was reduced using diiso-
butylaluminium hydride in hexanes,135 at -78°C, over 2 hours. The 
aldehyde 139 was obtained in a low yield of 38% after chromatography. 
This was the result of cleavage of the silicon-oxygen bond during the 
reaction. Not only did this reduce the reductant available, but it also 
caused the substrate to be effectively removed from the reaction, by the 
insolubility of the aluminium complex formed in hexane, and this 
caused both deprotected starting material and over reduced diol 140 to 
be formed (Scheme 129). 
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The aldehyde 139 was then oxidised using the urea-hydrogen 
peroxidetrFAA method,91 to give the acid 141 in a reasonable 66% yield 
in what amounts to a Baeyer-Villiger rearrangement in which the 
proton migrates. One carbon degradation of this acid was first 
approached using the Curtius rearrangement. Incorporation of 
nitrogen at this stage of the synthesis seemed to be a favourable route 
to approach muscarine, particularly considering the work of 
Pirrung130 who converted the amine 126 into muscarine. The acid 141 
was treated with diphenylphosphoranyl azide136 to furnish the acyl 
azide which was heated in refluxing toluene to give the expected 
isocyanate. This intermediate was then hydrolysed by the addition of 
water to give the amine 142. Surprisingly, the reaction was found to 
proceed with concomitant desilylation. The loss of the silicon must 
occur at a late stage in the reaction because no products from the 
alcoholysis of the isocyanate by the free hydroxyl leading to the 
dimerisation product 143 were observed. Although the yield for the 
process was a moderate 38%, the effective accomplishment of two steps 
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in one offers some compensation for this shortcoming. 
TBSO"".I\...-ICHO 
BuAo/ -
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The amino alcohol 142 was treated with methyl iodide and 
PMP according to the procedure of Pirrung1aO but the separation of the 
muscarine analogue 144 formed from the hydrogen iodide salts of the 
quaternised base 145 did not prove possible; no details of how this could 
be achieved have been given by Pirrung (Scheme 130). 
The studies then continued with incorporation of the methyl 
side chain required for the synthesis of muscarine; in addition, 
necessary improvements were incorporated into the route. Alkylation 
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of the (+) epoxide 84 using propynyllithium was carried out using the 
Yamaguchi procedure.96 Certain modifications were made to the 
procedure to take into account the fact that propyne is a gas at ambient 
temperature. A large excess of propyne was condensed at -78°C and a 
measured amount of it was then distilled into cooled THF. Excess 
propyne was used to compensate for evaporative losses. A good yield of 
the acetylene 146 was obtained after chromatography. Lindlar 
reduction of this acetylene was carried out in the dark as l3C NMR 
analysis of samples hydrogenated using the normal procedure showed 
that greater than 50% isomerisation to the (E)-alkene had occurred. 
This has only been observed in the case of the methyl substituted 
alkene, so it may be that the energy barrier to isomerisation is lower in 
this case. However, excluding light during the reduction allowed the 
(Z)-alkene 147 to be isolated as a single geometrical isomer in excellent 
yield. Cyclisation of this alkene under the standard conditions led to 
an excellent 84% yield of the hydroxy-THF 148. The stereoselectivity 
however was somewhat reduced and 11% of another hydroxy-THF 149 
were observed (Scheme 131), perhaps due to the smaller methyl 
substituent exerting less stereocontrol. The corresponding silyl ether 
151 of this compound was proven to be the 3-epimer by NOE 
experiments, and was shown to differ as expected from the 
corresponding silyl ether 150 of the hydroxy-THF 148. 
Silicon protection of the crude cyclisation product was 
achieved in high yield using triisopropylsilyl triflate and 2,6-lutidine 
in dichloromethane137 over 3 hours at O°C. The silyl ethers 150 and 151 
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were readily separated by column chromatography. The 
triisopropylsilyl protecting group was chosen as it was thought likely 
that it would survive the Curtius rearrangement and lead to a higher 
yield from that step. 
Scheme 131 
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Direct saponification, using potassium hydroxide in 
methanol, led to the acid 152 in high yield, contrary to the results of an 
earlier project.80 The loss of the methyl ester resonances in the ~ ~H and 
l3C NMR and the change in the infra red spectrum confirmed this. 
There was no sign of any epimerisation by ring opening of the THF. 
Curtius rearrangement of this acid following the earlier procedure 
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yielded the amine 153 without loss of the silicon group; disappointingly 
though, there was little increase in yield (Scheme 132). 
T I P S ~ C 0 2 M e e
(150) 
Scheme 132 
The dimethylation of this amine using the Eschweiler-Clarke 
reaction with sodium cyanoborohydride and formaldehyde 138 was 
unsuccessful despite the success of this reaction on the model 
compound tetrahydrofurfurylamine 154 (Scheme 133). 
Scheme 133 
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The low yields obtained in this way led to the consideration of 
other methods to effect decarboxylation of the acid 152. It was then 
concluded that a Hunsdieker type decarboxylation was the most 
hopeful alternative. The traditional Hunsdieker reaction is 
1<17 
notoriously low yielding and inefficient; however, the modern 
approach features the use of the methodology for decarboxylation 
developed by Barton et ai. l39 The acid 155 concerned is converted to 
the corresponding thiohydroxamic acid ester 156 in the presence of a 
source of radicals. The decomposition of the ester formed leads to the 
carbon centered radical 157, which is trapped with the halogen radical 
to give the halide 158 (Scheme 134). 
(155) 
RX 
(158) 
Scheme 134 
CYX3 
x= Halogen 
Y = H or Halogen 
• 
... 
• 
R + C02 
(157) 
The acid 152 was converted into the acid chloride 159 using 
oxalyl chloride in benzene in the presence of catalytic DMF and 
pyridine,l4o without any of the expected acid catalysed ring opening. 
Treatment of this acid chloride with 2_mercaptopyridine-N-oxide, 
sodium salt and 4-dimethylaminopyridine (DMAP) in carbon 
tetrachloride at reflux, gave the chloride 160 in a good yield after 
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chromatographic isolation. Treatment of the chloride 160 with TBAF 
in THF for 24 hours then gave the chloro-alcohol 161 which showed a 
characteristic infra red stretch at 3450 em-I, together with appropriate 
NMR data (Scheme 135). 
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Treatment of the chloro-alcohol 161 with trimethylamine in 
methanol in a sealed tube at 90°C, 130°C and 150°C was unsuccessful 
in forming muscarine chloride. At temperatures of up to 130°C, no 
reaction was observed, and at 150°C the alcohol decomposed. This was 
disappointing, as trimethylamine had been successfully alkylated 
with tetrahydrofurfuryl chloride under the same conditions at 130°C 
(Scheme 136). The fact that the chloro-alcohol 161 is a ~ - c h l o r o o ether 
may explain its lack of reactivity. Alkylations using chlorides are 
known to occur under the conditions used in other circumstances.141 
The chloro-alcohol 161 is much more prone to decomposition than 
tetrahydrofurfuryl chloride, as it can be dehydrated at higher 
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temperatures. 
Scheme 136 
NMe3 
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The unreactivity of the chloride led to the consideration of the 
synthesis of the iodo-alcohol 163. This compound has been converted 
into muscarine by two previous groups.126,127 Two approaches were 
available for the synthesis of the iodo-alcohol; firstly a Finkelstein 142 
reaction of the chloro-alcohol 161 or alternatively, adaption of the 
Barton decarboxylation step to incorporate an iodine atom instead of a 
chlorine. The second option was thought to be preferable because it 
allowed the composition of the final product (ie muscarine iodide) to 
be certain; if some of the chloride was also converted into muscarine, 
the data for the final product would be confused. When the acid 
chloride 159 was refluxed in cyclohexene in the presence of DMAP, 
iodoform and 2-mercaptopyridine-N-oxide, sodium salt, the iodide 162 
was formed in reasonable yield. 139 Iodoform is used in the reaction 
because it decomposes to give the important chain carrying 
diiodomethyl radical (CHI2 ·) and an iodine radical upon heating. 
Cyclohexene is used as solvent because it acts as a trap for the 
molecular iodine which is a major by-product of this radical process. 
The iodide was again smoothly desilylated by treatment with ~ A F F in 
THF to give the pure iodo-alcohol 163 after chromatography (Scheme 
137). 
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The data found for the iodo-alcohol 163 corresponded exactly 
to that quoted by Mulzer.127 Treatment of the iodo-alcohol 163 with 
trimethylamine in ethanol, at 80°C, for 2 hours, according to the 
literature procedure127 gave (+) muscarine iodide 164, the data for 
which corresponded to that quoted in the literature.127 The final step 
as described by Chastrette et al126 [ie treatment of the iodo-alcohol 
with trimethylamine in methanol for 16 hours at RT] however, could 
not be repeated (Scheme 138). 
Scheme 138 
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The sequence was then repeated using the (S)-epoxy ester 84 
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which was obtained in five steps from (S)-malic acid following the 
procedure of Larcheveque et al.93 ,94 (S)-Malic acid 165 was mono-
esterified by conversion into the anhydride 166 followed by 
methanolysis to give the half-ester 167. 
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This was reduced using sodium borohydride In 
tbutanol/methanol to give the (S)-lactone 168 which is now 
commercially available as either enantiomer. Ring opening of the 
lactone with iodotrimethylsilane and methanol gave the iodohydrin 
169 which, upon treatment with silveri!) oxide in glyme, at reflux, for 
8 hours in the dark, ring closed to give the (S)-epoxide 84 (Scheme 139). 
Extremely careful distillation afforded the epoxide free from 
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Extremely careful distillation afforded the epoxide free from 
the solvent, although losses were incurred during this process. The 
conversion of this epoxide into D-{-)-muscarine proceeded smoothly, 
exactly as described for the racemate above. The chiral iodo-alcohol 
162 exhibited optical rotation close to that reported in the literature.127 
The {S)-epoxide 84 from {S)-malic acid was synthesised rather than the 
{R)-epoxide 84 from {R)-malic acid simply on the grounds of cost, 
because the starting material {S)-malic acid is significantly cheaper. 
The synthesis of natural L-{+)-Muscarine from {R)-malic acid or the 
{R)-epoxide 84, obtained by enzymatic resolution, would be equally 
possible to achieve. 
In summary, the route that has been developed provides the 
required flexible, and reasonably brief, 8 step route to muscarine, and 
possible C-2 analogues. The final product was isolated in a 14.3% 
overall yield from the {S)-epoxide 84. This route was found to be good 
in many respects, but the selectivity of the key cyclisation was 
disappointing, compared to the examples investigated in Chapter Two. 
This is probably due to the reduced steric influence of the methyl 
substituent with respect to the model reactions. A better overall yield 
could therefore be expected in the preparation of C-2 analogues of 
muscarine. The relatively low yield in the Barton decarboxylation step 
was also slightly disappointing, but further optimisation of this step 
has not been carried out. The easy incorporation of C-2 analogues 
makes this a useful synthesis of muscarines. Further improvement 
of this synthesis is still possible; for example, the use of a cheaper 
oxygen protecting group (eg benzyloxy) is under consideration. 
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Approaches To Goniofufurone 
(I) Introduction 
In 1990, McLaughlin et a[143 isolated three novel styryllactones; 
( + )-goniofufurone 170, (+ )-goniopypyrone 171 and (+ )-8-acetyl goniotriol 172 
(Scheme 140). 
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The lactones were isolated from ethanolic extracts of the stem bark 
of Goniothalamus giganteus (Hook. f., Thomas), a Taiwanese lily, and the 
X-ray structures of (+)-goniofufurone 170 and (+)-goniopypyrone 171 were 
determined. The three compounds exhibited activity against human tumor 
cell lines; (+ )-goniopypyrone 171 was the most bioactive, showing EDso values 
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of about 0.67 ~ g / m 1 . . These compounds form part of a family of styryl 
lactones isolated from the stem bark of this plant. It has been proposed143 
that they all originate from a single parent molecule 173 derived in vivo 
from a combination ofshikimate and polyketide pathways (Scheme 141). 
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(II) Synthetic Approaches to Goniofufurone 
(-)-Goniofufurone 174 was synthesised by two groups of researchers 
during early 1992. This enabled the configuration of the natural enantiomer 
to be established as that shown in Scheme 142. 
Scheme 142 
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Shing and Tsui 144 synthesised the unsaturated lactone 175 in 
eleven steps from D-glycero-D-gulo-heptonolactone 176, and then converted it 
into (-)-goniofufurone 174 by a I,B-diazabicyclo[5,4,O]undec-7-ene (DBU)-
catalysed Michael-type cyclisation (Scheme 143). 
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By contrast, Jager and Gracza 145 took the tetrol mixture 177, 
available in five steps from mono acetone D-glucose, and converted it into a 
readily separable mixture of (-)-goniofufurone 174 and (-)-7 -epi -goniofufurone 
178, by a palladium(II)-catalysed cyclisation-carbonylation reaction (Scheme 
144). 
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Four further approaches to goniofufurone have since been reported. 
The first of these was that developed by Prakash and Ra0 146 in which (+)-
Goniofufurone was synthesised from D-glucose in eleven steps. The 
unsaturated lactone 179 was synthesised by a stereocontrolled· Wittig 
addition to the lactol 180. This ester then cyc1ised spontaneously to give 
dibenzylgoniofufurone 181, which was deprotected by hydrogenation to give 
the natural product (Scheme 145). 
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Murphy and Dennison 14 7 used a very similar approach, generating 
the lactone 182, also from D-glucose, and acylating to give the bromoacetate 
183. Intramolecular Wittig reaction gave the unsaturated lactone 184, 
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hydrogenation of which furnished (+ )-goniofufurone 170· thirte In en steps 
overall from D-glucose (Scheme 146). 
Scheme 147 
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Hanaoka et al148 used the homochiral chromium complex 185 in 
an efficient route to (+ )-goniofufurone, the first non-carbohydrate based 
synthesis. The titanium enolate of thioester 186 was reacted with the 
complex 185 to give the aldol product 187. This was converted into the 
aldehyde 188 and reacted with trimethylsilyloxyfuran under chelation 
controlled conditions, to give the lactone 189 which, upon deprotection, 
cyclised spontaneously to give (+)-goniofufurone 170 (Scheme 147). 
Honda et a[149 have used the chirallactonic aldehyde 190 to effect 
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elegant syntheses of (+ )-goniofufurone (+ )-goniopypyrone, (+ )-goniotriol, (+)-8-
acetylgoniotriol and (+ )-altholactone. The aldehyde 190 was treated with an 
equivalent of phenyl anion, under chelation control, to give the alcohol 191. 
This was deprotected with trifluoroacetic acid (TFA) to give the triol 192, 
which was cyclised, via an unexplained base initiated rearrangement, to give 
(+)-goniofufurone 193 (Scheme 148). 
Scheme 148 
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(III) Retrosynthetic Analysis of Goniofufurone 
Retrosynthetic analysis of goniofufurone, soon after its isolation in 
1991, led to the consideration of a synthesis of this molecule using the 
methodology developed earlier in this project (see Chapter Two). At first 
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glance, the hydroxy-THF with an acetic acid ester side chain as the 2-
substituent present in the molecule, makes it look ideally set up for an 
approach using the cyclisation of ( Z ) - ~ - h y d r o x y - o - a l k e n o a t e s . . However, the 
cyclisation of these molecules gives a high selectivity for the 2,5-cis-
stereochemistry. The natural product has a 2,5-trans-stereochemistry so 
an approach via this route is not a viable prospect. The cyclisation of ( E } - ~ ~
hydroxy-o-alkenoates however, gives a very good selectivity for the 2,5-
trans-stereochemistry required. Thus an approach to goniofufurone was 
planned using the iodocyclisation of ( E ) - ~ - h y d r o x y - o - a l k e n o a t e s s to give iodo-
THF acetic acid esters of the desired stereochemistry. This left open a 
number of routes to the natural product skeleton. 
R g ~ O O~ I ~ ~
., 0 ~ ~
Scheme 149 
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It became clear that a dihydrofuran of the type 194 could be a key 
intermediate in such an approach (Scheme 149). 
Simple lactonisation of the acid would allow the skeleton 195 to be 
a s s e ~ b l e d d directly, and it would only remain to alter the functionality at the 
5-position. Stereocontrolled oxidation of the acid to give the epoxide 196 would 
allow acid-catalysed cyclisation to give the target molecule 197. 
Stereoselective osmylation, on either face, would also allow elaboration to the 
target molecule. Osmylation on the same face of the acid moiety, to give the 
dihydroxyacid 198, would allow the specific lactonisation to give the alcohol 
199, which could be inverted by a Mitsunobu reaction to give the target ring 
system 197. Alternatively, osmylation on the opposite face to the acid 
moiety, to give the dihydroxy acid 200, and subsequent formation of the 
bidentate sulphonate ester,150 would yield the target molecule, upon ring 
operung. 
(IV) Model Reactions 
Considering the potential usefulness of the unsaturated acid 194 in 
the approach to the natural product, model work began with the development 
of a route to these acids and then proceeded with investigations of the 
synthesis of the natural product skeleton. 
The ~ - h y d r o x y y ester 53b was readily available in large quantities 
from the vinyl-alanate chemistry described earlier (p 76). Iodocyclisation of 
this molecule was smooth and stereospecific following the earlier procedures, 
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and yielded large quantities of the iodo-THF 54b. Earlier experiments by 
Bedford8o suggested that when the iodo-THFs were heated at too high a 
temperature with sodium azide and 18-crown-6 in DMF, the olefin 201 was 
produced along with the expected azide 202 resulting from ~ 2 2 substitution. 
These results were unexplained, but nevertheless these findings were 
investigated as part of these model reactions. Pleasingly, a high yield of the 
olefin 201 was obtained when the iodo-THF 54b was heated with sodium azide 
in DMF at 110°C for 16 hours; only traces of the azide 202 were isolated. 
DBU was also used to initiate this elimination reaction, but the olefin was 
isolated in much lower yields; this was because ring opening elimination 
reactions competed with the 2,5-dihydrofuran formation (Scheme 150). 
OH 
B U ~ C 0 2 M e e
(53b) 
j) C02Me ....... / 
Bu 0 
I 
Bu 
HO 
Scheme 150 
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,p- ... ,,'/ +5% '(\ .... ,,'\ j) C02Me Ng 
Bu 0 ~ O / / C0 2Me 
(201) Bu (202) 
2,5-Dihydrofurans of controlled stereochemistry are useful 
synthetic intermediates. For example, they have been used in [3+2] 
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cyc1oadditions to give tetrasubstituted THFs.lSl 
There appear to be two possible explanations for this unexpected 
elimination reaction. It is conceivable that sodium azide acts as a mild base, 
abstracting a proton to initiate the elimination. However, the regiospecificity 
of this process suggests that the cyclic decomposition of the azide is also a 
viable mechanism (Scheme 151). 
Scheme 151 
- - - l . ~ ~ ~ . ' I I I R I I + HN3 R ~ O / /
West152 has also observed a similar reaction using sodium azide. 
Unfortunately, further investigation of this process was prohibited by time 
considerations. 
The olefinic ester 201 was saponified successfully using potassium 
hydroxide in methanol to give the acid 203 in high yield. This was a very 
pleasing result as epimerisation and ring opening had been observed in a 
similar system by a previous researcher.so This result also had implications 
in the synthesis of muscarine (see p 99). Both the ester 201 and the acid 203 
were treated with osmium(VIII) tetroxide, under standard conditions.153 It 
was hoped that face selective dihydroxylation might take place in the case of 
the ester 201 on steric grounds or, in the case of the acid 203, by co-ordination 
of the approaching osmium species. Disappointingly, there was little 
stereoselectivity observed in either case (Scheme 152). 
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Selective epoxidation of the acid 203 was considered, possibly by 
formation of the peracid at low temperature followed by intramolecular 
delivery of oxygen.154 However, selective delivery of the oxygen atom from 
below to give the epoxide (the epimer of the epoxide 196) would not allow easy 
elaboration to the natural product. 
Lactonisation of the acid 203 was the next approach adopted. Mercury 
mediated lactonisation was considered, but as the replacement of the alkyl 
mercury function generated to give an alcohol is a radical process (Scheme 
153), the stereocentre produced would be expected to be largely 
stereorandom, and therefore of little use in the context of this sequence. 
Scheme 153 
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Halolactonisation seemed the most reliable alternative, and indeed, 
smooth iodolactonisation of the acid 203 furnished the iodolactone 204 in 
excellent yield (Scheme 154). 
f) C02H .. '"11/ 
Bu ° 
(203) 
Scheme 154 
(204) 
The iodolactone 204 showed considerable similarities to the natural 
product in the lH and l3C NMR spectra. The resonances for the I-H, 4-H, 5-
Hand 8-CH2, for example, showed similar coupling patterns and chemical 
shifts to those reported by McLaughlin143 for goniofufurone. The l3C NMR 
signals for the l-CH, 3-CH, 5-CH, 7-C and 8-CH2 were again consistent with 
the corresponding signals in the natural product. 
Investigations of the possible introduction of oxygen functionality 
began with model reactions on the easily accessible iodo-THF 58. Cesium 
acetate at 100°C in DMF155 was used to give the acetate 205 in moderate 
yield. Slightly better results were obtained using potassium superoxide and 
18-crown-6 in DMF, at RT, to give the alcohol 206 (Scheme 155). 
I ~ , ,
EtX> 
(58) 
E):> 
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Corey156 used this latter method in the presence of an ester group. 
The yields from these reactions are, of course, related to pure compounds 
after chromatography. In the case of these model reactions, the yields were 
possibly reduced by the volatility of the products. 
Kocovsky157 used silver salts with non-nucleophilic counter anions 
to effect substitution of a bromine atom by an oxygen function with overall 
retention of configuration, in the presence of anchimeric assistance from a 
proximal oxygen atom (Scheme 156). 
Scheme 156 
Bartlett158 observed the formation of formate esters, with retention 
of configuration, using silver tetrafluoroborate in DMF on a similar system to 
that used by Kocovsky (Scheme 157). 
Scheme 157 
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Overall retention of configuration would be ideal in our system in 
that it would give the required configuration of the natural product directly. 
The examples which Bartlett used to perform this reaction were six-
membered rings, but, in principle, the use of five-membered rings is not 
precluded. The iodolactone 204 was treated with both potassium 
superoxidelI8-crown-6 in DMF, and with silver tetrafluoroborate in DMF. The 
results were promising in that there was good evidence for substitution in 
both cases (ie formation of a single, more polar spot by tIc). However, there 
was insufficient material to prove this conclusively. 
(V) Incorporation of the Natural Side Chain 
The first approach adopted to the synthesis of natural 
goniofufurone was the elaboration of mandelic acid 207, the (R)- and (8)-
enantiomers of which are both commercially available and relatively 
inexpensive. It was thought that mandelic acid could be an ideal starting 
material with which to attempt the homochiral synthesis of the ~ - h y d r o x y y
ester 208. This could be converted into (+)-goniofufurone by following the 
foregoing model work (Scheme 158). 
Scheme 158 
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Retrosynthetic analysis shows that two of the possible approaches 
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to the ester 208 are: (i) coupling of the vinyl anion 209 to a single enentiomer 
of the epoxy ester 84, and (ii) stereo chemically controlled chiral aldol reaction 
of the aldehyde 210 with a chiral acetate enolate (Scheme 159). 
Scheme 159 
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Natural (+)-goniofufurone would arise from elaboration of the 
(3R,7R)-ester 208 (ie from the coupling of the (R)-mandelic acid derivative 
with the (R)-enantiomer of the epoxy ester 84). Bearing in mind that the (S)-
enantiomer of the epoxy ester 84 had already been synthesised, and was 
derived from the cheaper (S)-enantiomer of malic acid, it was decided to begin 
work on the synthesis of (- )-goniofufurone from the (3S,7S)-ester 208 (ie by 
the coupling of the (S)-mandelic acid derivative with the (S)-enantiomer of the 
epoxy ester 84 (Scheme 160). 
Scheme 160 
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The first work in this area was the synthesis of the vinyl anion 209 
(M = Li) by derivatisation of (S)-mandelic acid. (S)-Methyl mandelate, 
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prepared by literature methods,159 was silylated using TIPS chloride, in dry 
DMF in the presence of imidazole, to give the silyl ether 211. Reduction of 
this silyl ether at -78°C with diisobutylaluminium hydride in hexane:ether160 
gave the aldehyde 212 in high yield. This aldehyde was then homologated 
using the Takai procedure,161 to give the (E)-vinyl iodide 213 exclusively. 
However, extensive modifications to the literature procedure were required as 
the aldehyde 212 reacts much less readily than the examples given by Takai, 
possibly due to the steric effect of the TIPS protecting group. A standard 
procedure, as used by Takai, involved stirring the given aldehyde with 
chromium(II) chloride and iodoform, at O°C, in THF. However, homologation 
of the aldehyde 212 required 16 hours at 60°C. Interestingly, this slower 
reaction gave better stereoselection for the (E)-isomer than that quoted by 
Takai. Separation of the extremely non-polar vinyl iodide 213 from iodoform 
proved difficult, but after two separations eluting with cyclohexane, the pure 
iodide was obtained in 45% yield (Scheme 161). 
OR 
OTIPS 
(213) 
Scheme 161 
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Extensive studies of the halogen-lithium exchange of this molecule 
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with two equivalents of tbutyl lithium showed that, although this process 
normally occurs at -78°C in less than 15 minutes, the lithium exchange of the 
vinyl-iodide 213 only occurs after warming to RT and stirring for 2 hours. 
Quenching of the reaction before this point resulted in recovery of starting 
material; in fact, the molecule did not react with tbutyllithium at all at -7BoC. 
It is essential that diethyl ether, and not THF, is used as solvent for this 
reaction as at DoC tbutyl lithium and THF react together. Once the 
conditions for halogen-lithium exchange had been established, cuprate 
formation was attempted using lithium 2-thienyl-cyanocuprate162 and also 
using copper(I) iodide but in both cases, although it was not shown whether 
cuprate formation had occurred, the major product from the exposure of the 
resulting solutions to the (+ )-epoxide 84 was the (±)-iodohydrin 169. It seems 
that the iodide anion is more nucleophilic than the anionic species generated 
by these procedures. The vinyl iodide was exclusively converted into the 
terminal olefin 214 (Scheme 162). 
Scheme 162 
OTIPS OTIPS OH 
(i) tBuLi, E ~ O , , RT, 2h I 
I .. 
(ii) CuI, Et20, -40°C, Ih MeO 0 
(213) (iii) (±) epoxide 84, -78°C (214) (169) 
With these results in mind, the aldehyde 212 was converted by the 
Corey procedure163 into the dibromide 215, and subsequently the acetylene 
216, in reasonable overall yield. Again, reaction times far in excess of those 
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used in the literature were required. Hydrostannylation of this acetylene 
proceeded in low yield to give exclusively the (E)-vinyl-stannane 217 which 
was purified by column chromatography (Scheme 163). The recently 
developed Hodgson route to (E)-vinyl-stannanes164 directly from aldehydes 
was not used, as the steric restraints of our system seemed likely to prevent 
this method from being appropriate. 
Scheme 163 
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The (E)-vinyl stannane 217 was treated with butyl lithium, for two 
hours at RT, to effect tin-lithium exchange. The vinyl lithium thus formed 
was reacted with copper(1) iodide at -40°C, and then treated with the (±)-
epoxide 84. This time the products were the terminal olefin 214 and the ester 
85 from the action of base upon the epoxy-ester (Scheme 164). This 
suggests that the required cuprate complex was not formed (ie the basic 
vinyl-organometallic extracted a proton from the (±)-epoxide 84). 
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Scheme 164 
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With this discouraging result, investigation of the second 
disconnection of the hydroxyester 208 began. The required aldehyde 210 was 
thought to be accessible by following the work of Nakai et al,165 who used a 
[2.3J-sigmatropic rearrangement to give an unsaturated hydroxy-acid, which 
was cleaved with sodium periodate to give a ~ , ' Y - u n s a t u r a t e d d aldehyde, as 
shown in Scheme 165. 
Scheme 165 
The known aldehyde 220 was synthesised by a route which differed 
from that used by Corey.166 Although the route as described by Corey was 
also attempted, it yielded less of the desired compound than the route which is 
shown in Scheme 166. 
The methoxymethoxy (MOM) ether 218 of (S)-methyl mandelate 
was formed in quantitative yield by treatment with chloromethyl methyl 
ether and ethyldiisopropylamine in dcm. The ester was then reduced to the 
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known diol derivative 219,167 using diisobutylaluminium hydride in toluene, in 
essentially quantitative yield. Swem oxidation 168 of the unprotected primary 
alcohol gave the aldehyde 220 in reasonable yield. 
OH 
OMOM 
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(220) 
Scheme 166 
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The aldehyde 220 was then treated with vinylmagnesium chloride 
to give the allylic alcohols 221, by a partially stereoselective addition reaction 
(approximately 3:1 ratio of isomers). Alkylation of the allylic alcohols 221, 
using sodium hydride in THF to form the alkoxide and treating the resulting 
solution with sodium iodoacetate, gave the acids 222 (Scheme 167). 
OM OM 
: Vinyl-U'CHO .-I magnesium 
." chloride, THF 
(220) 75% 
Scheme 167 
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~ ~ (i)NaH 
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These acids are precursors to the Wittig rearrangement, as 
described by Nakai;165 formation of an anion a to the carboxylate function, at 
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-78°C, using two equivalents of lithium diisopropylamide, allows the thermal 
rearrangement to occur upon warming to room temperature. The hydroxy-
acid 223 was obtained in reasonable yield (Scheme 168). 
Scheme 168 
OMOM 
OMOM HO 
2LDA --. 
(223) 
This hydroxy-acid was treated with sodium periodate but there was 
no aldehyde formation, and significant amounts of the starting material 
decomposed. Reduction of the hydroxy-acid to the diol 224 was then 
attempted, as it was thought that periodate cleavage of this would be more 
facile. However, attempted reduction using LAH gave only a 10% yield of the 
desired diol 224 and the majority of the product was the undesired hydroxy-
THF 225 (Scheme 169). This hydroxy-THF is presumably formed by an ~ 1 ' '
cyclisation as shown in Scheme 170. The reason for this cyclisation is the 
fact that the benzylic centre is now also allylic and this allows great 
stabilisation of a carbocation at this centre. Consequently, loss of the 
methoxymethoxy group is extremely facile under even mildly (Lewis) acidic 
conditions. The extra stability of a conjugated double bond relative to an 
isolated double bond also causes migration to be extremely facile, giving the 
cyclisation observed. Unfortunately, there is little stereoselectivity. in this 
process, otherwise it would comprise an interesting new route to THFs. 
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OR 
This result gave cause for doubts about whether the iodocyclisation 
of the ester 208 would be a smooth reaction, or whether the same process as 
we observed here would occur under the attempted iodocyclisation conditions. 
These problems led to the consideration of the use of another 
disconnection to access the natural product. It was anticipated that the 
addition of a phenyl anion to the aldehyde 226 would give potentially good 
chelation control (Scheme 171). 
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Scheme 171 
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The synthesis of the aldehyde 226 then became a desirable target. 
It was envisaged that this could be approached using the successful model 
chemistry described earlier. The ~ - h y d r o x y y ester 227 became the initial 
target because it was considered that the oxidation of the primary alcohol 
would allow the synthesis of the aldehyde 226. 
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The alcohol 228 was synthesised following the methods of Momose 
et al169 and was subsequently oxidised to give the aldehyde 229 in a 
disappointing yield of 40% by the use of a Swem oxidation (Scheme 172). 
M O M O ~ ~
OH (228) 
Scheme 172 
Swem40% 
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Unfortunately, Moffat oxidation170 gave only the conjugated aldehyde 230, 
and other techniques failed to give any reaction (Scheme 173). 
M O M O ~ ~
OR (228) 
Scheme 173 
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Chiral aldol reaction of the aldehyde 229 was eventually effected 
using the methodology first described by Braun. 171 The lithium enol ate of (S)-
1,1,2-triphenyl-1,2-ethandiol-2-acetate reacted with the aldehyde to give a 
moderate yield of the p-hydroxy ester 231 on a small scale. Subsequent 
hydrolysis of this ester and treatment with diazomethaneI72 furnished what 
appeared to be a small quantity of the desired p-hydroxy ester 227. Time 
restrictions have not allowed these reactions to be repeated on a larger scale 
to confirm these results (Scheme 174). 
Scheme 174 
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This synthesis may well be feasible if the phenyl group is introduced 
at a late stage as shown in Scheme 171, but otherwise the intermediates 
seem to be too sensitive to undergo the desired transformations. 
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Radical Reactions of Tetrahydrofurans 
(I) Introduction 
As part of the ongoing investigation into methods for the 
elaboration of the initial products of the iodocyclisations described in 
Chapter Two, some aspects of the radical chemistry of these 
tetrahydrofurans were investigated. One of the important considerations 
in the design of homologation methods for these trisubsti tuted THF 
systems is the difficulty in the formation of ~ - a n i o n s . . The anticipated 
facile ~ - e l i m i n a t i o n n reaction (Scheme 175) which would be expected to 
occur, allows the stabilisation of the negative charge by transfering it 
from a carbon atom to an oxygen centre. 
Scheme 175 
This is a significant limitation in the chemistry of ~ - i o d o o THF 
systems. Although there are examples of the generation of kinetically 
stable ~ - a n i o n s s in THF systems at extremely low t e m p e r a t ~ r e s 1 7 3 3
(Scheme 176), the usefulness of this process has so far been limited. 
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Scheme 176 
PhO 
The generation of a J3-radical, however, is a potentially 
ex;tremely useful process, as the anticipated kinetic stability of carbon 
centered radicals, relative to oxygen centered species, means that the ~ _ _
elimination process does not take place (Scheme 177). 
Scheme 177 
x • J)-Rl 
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With this knowledge, it was decided to exploit the products of the 
cyclisation reactions described in Chapter Two to attempt to generate 
2,5-disubstituted J3-radicals from these THF systems. It has proven 
possible to illustrate the synthetic potential of this type of intermediate in 
a new approach to the 2-oxabicyclo-[2.2.1]-heptane ring system 232. 
Scheme 178 
~ o o o 
(232) 
Cymathere ether A Cymathere ether B 
During the last decade, much attention has been focused on 
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various physiological activities of cyclopentanoids and derivatives of 
related fused ring systems, especially those of prostacyclines and 
thromboxanes. Expectations of possible biological activity in this area 
are high. The 2-oxabicyclo-[2.2.1]-heptane ring system 232 has recently 
been brought to prominence by the isolation of two fatty acid derived 
oxylipin natural products, the Cymathere ethers A and B shown in 
scheme 178.174 These molecules were isolated from the Marine brown 
algae Cymathere triplicata and appear to be derived by oxidative 
cyclisation of fatty acids. There are only a very few isolated examples of 
ring systems of the 2-oxabicyclo-[2.2.1]-heptane type to be found in the 
chemical literature. The cyclsation of 1-hydroxy-methyl-3,4-
epoxycyclopentanes has been used in two cases to generate the ring 
system (Scheme 179).175-178 
Scheme 179 
OH 
Kakimuna 177 used the electrophilic 5-exo-trig cyclisation of 
Plinol C by both halo- and selenoetherification procedures to obtain the 
substituted 2-oxabicyclo-[2.2.1]-heptanes shown in Scheme 180. The 
stereoselectivity of the thermodynamically controlled iodoetherification, is 
excellent, but the kinetically controlled selenoetherification shows little 
selectivity. The difficulty of obtaining other cyclopentanes suitable for 
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this reaction has meant that only these exampl h b . es ave een earned out. 
Scheme 180 
NIS 
I 
Plinol C PhSeCI 
SePh 
Renaud has used a radical addition to 7-oxabicyclo-[2.2.1]-
heptane to generate this ring system in an isolated example (Scheme 
181).178 
Scheme 181 
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Elaboration of these systems was carried out, but only to a 
limited extent, and there appear to have been no examples of the 
generation of 3,5-disubstituted 2_oxabicyclo-[2.2.1]-heptane systems. 
The related lactone and hemi-acetal ring systems 233 and 234 are 
somewhat better known. The lactone 233 has been generated by the 
Baeyer-Villiger oxidation of the ketone 235 (Scheme 182). 
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By contrast the hemi-acetal234 is derived from ring closure of 
the cis-cyclopentane aldehyde 236 (Scheme 183).179 
Hl{ 
CHO 
(236) 
Scheme 183 
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Bicyclic hemi-acetals of the type described above have also 
been generated by the cyclisation of the cyano-epoxide shown in Scheme 
184.180 
Scheme 184 
OMe _____ - I . ~ ~
HO 
CN 
An interesting radical cyclisation of carbohydrate derived iodo-
hemi-acetals has been used by Fraser-Reid to generate bicyclic hemi-
acetals, in a related ring system, as shown in Scheme 185.181 
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Scheme 185 
OBn OTBS 
BnO 
OPMB 
OTBS 
I 
OBn OPMB 
With these exceptions, the ring system has not been 
approached by organic chemists. 
(II) Radical Chemistry of 2,3,5-Trisubstituted THFs 
It was anticipated that this ring system would be accessible 
from the cyclisation of the a-alkenyl-THF radicals 237, available from 
the 2,3,5-trisubstituted THFs 238. These THFs would, in turn, be 
available from simple elaboration of the cyclisation products described in 
Chapter Two (Scheme 186). 
Scheme 186 
Rl RI 
R 
R 
(237) (238) 
Consequently, when the aldehyde 70 was isolated as a side 
product from the iodocyclisation of the dithiane 68, the opportunity to 
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investigate such cyclisations was presented Th ld h d 7 
. e a eye 0 was 
homologated using methyl triphenylphosphoran l'd y 1 eneacetate In 
dichloromethane to give the (E)-ester 239 in good yield (Scheme 187). 
Scheme 187 
(68) 
Ph 
Ph 
CHO 
''''111/ 
(70) 
Ph3P=CHC02Me 
dcm 80% 
(239) 
When this ester was subsequently treated, on a small scale, 
with triphenyltin hydride and azo-bis-isobutyronitrile (AIBN) in benzene, 
at reflux, using the slow addition conditions recommended by Motherwell 
and erich,182 the desired ring system 240 was isolated in a 70% yield as a 
3:1 mixture of isomers, the stereochemistry of which was not proven 
(Scheme 188). No sign of reduced starting material 241 was observed. 
Slow addition conditions were used to ensure a low concentration of 
hydride radicals, therefore maximising the chance of cyclisation occurring. 
The final product of this reaction sequence was fully characterised, but 
insufficient data were obtained for the intermediates to allow their 
inclusion in the experimental section. 
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Ph 
Scheme 188 
C02Me 
.... IOr PhaSnH, AmN 
.. 
slow addition 
over 2h Ph 
(239) (240) Ph (241) 
70% 0% 
To investigate this encouraging preliminary result, a variety 2-
alkenyl-4-iodo-THFs and 2-alkenyl-4-hydroxy-THFs were synthesised 
containing both conjugated and unconjugated double bonds. The 
cyclisation of the trans-2,5-disubstituted-THF radical 242 showed only 
moderate stereo selectivity. However, upon consideration of the transition 
state from this and from the cyclisation of the corresponding cis-2,5-
disubstituted THF radical 243, it was postulated that the cyclisation of 
the cis-2,5-disubstituted THF radicals might be expected to proceed with 
greater stereoselectivity (Scheme 189), assuming the departed iodine 
atom does not influence these conformations. 
Scheme 189 
(242) (243) 
H 
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The 2-substituent containing the radical acceptor is constrained 
to be in a pseudo-equatorial position so that it is able to cyclise. This 
means that in the case of the trans-2,5-disubstituted-THF radical, the 
5-substituent is in a pseudo-equatorial position and therefore little steric 
effect is exerted upon the cyclisation. In contrast, in the case of the cis-
2,5-disubsti tuted-THF radical, the 5-substituent is constrained to be in a 
pseudo-axial position for cyclisation to take place. This means that this 
substituent could exert a steric effect upon the cYclisation causing a 
higher stereoselectivity to be observed. The availability of both trans-
2,5-disubstituted-THF radicals (from the iodo-THFs) and cis-2,5-
disubstituted-THF (from the Barton deoxygenation of the hydroxy-THFs) 
allowed this theory to be investigated. 
The iodotetrahydrofuran 54b was easily available in multigram 
quantities from the iodoetherification of the ~ - h y d r o x y - o - a l k e n o a t e e 53b. 
Treatment of this compound with diisobutylaluminium hydride in hexanes 
at -78°C over 2 hours gave the aldehyde 244 in good yield. This aldehyde 
was then homologated with various Wittig reagents. Methyl 
triphenylphosphoranylideneacetate in dichloromethane gave a 76% yield 
of the (E)-alkenoate ester 245. Ethyl triphenylphosphonium iodide was 
treated with butyl lithium at -78°C to generate the corresponding ylid, 
which reacted with the aldehyde 244 to give a 46% yield of the (Z)-alkene 
246. Triphenyl-phosphoranylidine-2-propanone reacted with the aldehyde 
to give a 55% yield of the (E)-ketone 247 (Scheme 190). 
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(53b) 
Scheme 190 
NaHCOa 
90% 
C02Me 
I,,, r. ~ " " I \ \ PhaP=CHC02Me Ao/ ·· ... 11 ....... .-.-------
Bu 0 dem 76% 
(245) 
PhaP=CHCHa 
THF, -78-0°C 
46% 
I", 
""r\ C02Me Arf·· .. '''/ 
Bu 0 
(54b) 
DIBAL-H, -78°C, 
hexanes, 75% 
I,,, 
~ " " r \ \ CHO AcI·· .. '''/ 
Bu 0 
(244) 
1 
PhaP=CHC(O)Me 
dem 55% 
o 
~ " ' 1 1 1 / / \ 1;0"" ~ ~ 1"".r\ -BuAC/···"" 
Bu 0 
(246) (247) 
The cyclisations of these molecules were carried out under 
similar conditions to those specified for the preliminary cyclisation of the 
ester 239. In the case of the cyclisation of the ester 245, the earlier 
conditions were closely followed. In the case of the cyclisation of the 
alkene 246, which was carried out on a larger scale, the addition of 
reagents was carried out using a syringe pump. To facilitate the removal 
of non-polar tin residues from the products, which are themselves non-
polar, an aqueous potassium fluoride work up was used in the cyclisations 
of the alkene 246 and the ketone 247, to enable the isolation of the 
products in a pure form.. 182 
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The cyclisation of the ester 245 furnish d 3'1 . ea. mIxture of the 
two isomeric 2-oxabicyclo-[2.2.1]-heptanyl esters 248 and 249 (Scheme 
191), in a satisfying 77% combined yield. 
Scheme 191 
I" ;==/ 
C02Me 
' ~ " ' ( \ ' ' ' I I I I / / Ph3SnH, AIBN 
~ O / / - - - - - - , ! ~ ~ ~ Bu--
Bu 0 Benzene slow 
addition over 2h H 
(245) 77% (248) 
Scheme 192 
R 
J 34= 0-2 Hz , 
where 3-H is 
endo 
J 3,4= 3-5 Hz 
where 3-H is 
exo 
H 
(249) 
Comparative coupling constant data from norbornane systems 
were used to assign the stereochemistries of these products (Scheme 
192).183 
1 H _1 Hand 1 H _13C COSY NMR spectra allowed the assignment 
of the NMR resonances of both isomers. Both exhibited a broad triplet 
due to the 3'-H resonance (assigned by 1H-IH COSY NMR spectrum) 
with J = 6.5 Hz (major isomer 248) and 6.2 Hz (minor isomer 249) due to 
coupling to the butyl side chain. In neither case was coupling to the 4'-H 
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observed. This suggested the assignment of a 3' exo nfi . 
- co guration of the 
butyl side chain in both isomers. In both isomers th l' H d 
' e - occurre as a 
broad singlet in accordance to the literature precedent;174-176 the 4'-H was 
also a broad singlet at ~ ~ = -2 in both isomers Both the 7' H 
. - resonances 
occured separately between 0 1 10 1 70 b d 
= . -. ,as 0 serve in previous 
examples. 176 
Scheme 193 
Bu 
-OHz 
(248) (249) 
A coupling of 3.4 Hz is observed from the 5'-H to the 6'-HA in the 
major isomer; since a coupling of 2.8 Hz is also observed in the resonance 
for the 6'-HA' almost certainly to the 1'-H, this indicates that the 6'-HA is 
endo, the 1'-H fixed and the 5'-H also endo (ie the major isomer 248 
has the 3'-exo, 5'-exo conformation). The relevant resonances for the 
5'-H, 6'-HA and 6'-HB of the minor isomer 249 are obscured but as the 3'-
exo conformation is suggested by the lack of coupling from the 3'-H to 
the 4'-H, the 3'-exo, 5'-endo conformation is the only likely possibility 
remaining (Scheme 193). 
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In the cyclisation of the alkene 246 under the di . same con bons 
three isomeric 2-oxabicyclo-[2.2.1]-heptanes 250,251 and 252 were 
isolated (Scheme 194). 
In"" t=\ .... III \ 
Bu 0 
(246) 
Scheme 194 
PhaSnH, AIBN 
- - - - - I . ~ ~ Bu 
Benzene, slow 
addition over 2h 
by syringe pump 
59% 
H H 
(250) 
Bu 
(251) 
6:2:1 
Bu H 
(252) 
A ratio of 6:2: 1 was observed; careful chromatography allowed 
the minor third isomer 252 to be separated from the two others. Mass 
spectrometry confirmed that these were indeed isomers of the same 
molecular formula, whilst l3C NMR showed that the three isomers had 
discernable differences. Again, in the cases of isomers 250 and 251, 1 H-
1 Hand 1 H _l3C COSY NMR spectra allowed the assignment of the 
resonances for both isomers. The 3-H resonance in both cases was a 
broad triplet of coupling constant 6.5 Hz to the butyl side chain, with no 
coupling apparent to the 4-H, suggesting the assignment of a 3-exo 
configuration to both the isomers 250 and 251. The 4-H again appeared 
as a broad singlet at 0 = -2 in both isomers. As expected from the 
literature data of these systems, both the 7-H resonances occurred 
separately between OH = 1.20-1.50.176 The resonances relating to the 5-
H, 6-HA and 6-HB of both the isomers occur together and are therefore 
obscured. However, since the 3-H has been assigned to the endo 
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position, the 3-exo configuration for the btl b· 
u y su stItuent has been 
demonstrated. This means that the isomers 250 d 251 
an represent the 
3-exo, 5-exo and the 3-exo, 5-endo isomers respect· 1 B Ive y. y analogy 
to the similar cyclisation products, it seems reasonable that the major 
isomer 250 has the 3-exo, 5-exo configuration. 
Bu 
l 4H 
6.5 Hz 3H 0 
OHz 
(250) 
Scheme 195 
2.1 Hz 
(252) 
OHz 
(251) 
The third isomer 252 exhibited a resonance at ~ ~ = 3.78 for the 
3-H which was a triplet of doublets containing couplings of 6.9 Hz to the 
butyl side chain and 2.1 Hz to the 4-H. This suggested that in the isomer 
- ~ ~ -
252, the butyl group has the 3-endo configuration. The other 
information derived from the 1 H NMR spectrum did not allow a firm 
assignment of the 5-H stereochemistry of this single isomer; however, the 
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assumption is made that it is unlikely to be the 3 d 5 do' 
-en 0, -en Isomer 
due to the steric constraints involved in the cyclisation. The fact that 
this isomer is formed to the exclusion of the oth 'bl' er POSSI e Isomer , 
suggests that this has the 3-endo, 5-exo configuration (Scheme 195). 
The cyclisation of the ketone 247 under the earlier conditions led 
to the formation of the three isomeric ketones 253, 254, and 255 in a high 
combined yield (Scheme 196). A ratio of 3:1:1 was observed; separation 
of the third isomer 255 was achieved by careful chromatography. 
1""'1\ 
r--cf· .. II' 
Bu 0 
(247) 
o Scheme 196 
PhaSnH, AIBN 
-----I ... ~ ~ Bu 
Benzene, slow 
addition over 2h 
95% (253) (254) 0 
H 
(255) 
The reduced stereoselectivity of this cyclisation may be due to 
the fact that the cyclisation is faster, as the conjugated ketone used is 
the best radical acceptor tried in this series. This may also explain the 
high overall yield. Mass spectrometry showed that these compounds had 
the same molecular formula, whilst l3C NMR was used to demonstate 
that the three isomers had discemable differences. The 3-H resonance 
for the isomers 253 and 254, was a broad triplet of coupling constant 7.0 
Hz to the butyl side chain, with no apparent coupling to the 4-H, in either 
case. This suggested the assignment of a 3-exo conformation for the 
butyl substituent in both the isomers 250 and 251. The 4-H again 
appeared as a broad singlet at 0 = -2 in both isomers. Both the 7-H 
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resonances occurred separately between ~ ~ - 1 5 . 
OR - . 0-1.60, as In the 
literature examples.176 The resonances relating to th 5 H 
e - , 6-HA and 6-
HB of both the isomers Occur as overlapping mult' I ts d Ip e an are therefore 
obscured. However, since the 3-H has been ass' d t h Igne 0 t e endo 
position, the 3-exo configuration has been demonstrated, 
Scheme 197 
-0 Hz 
(253) (254) 0 1\ 
2.5 Hz .,..,..1,,-
a-
3H /6 
700HZl lr o 
(255) 
This means that the isomers 253 and 254 represent the 3-exo, 
5-exo and the 3-exo, 5-endo isomers respectively. By analogy to the 
similar cyc1isation products, it can be assumed that the major isomer 253 
has the 3-exo, 5-exo configuration. The third isomer 255 exhibited a 
resonance at OR = 3.81 for the 3-H which was a triplet of doublets 
containing couplings of 7.0 Hz to the butyl side chain and 2.5 Hz to the 4-
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H, indicating that the isomer 255 had the 3-endo conformation. The 
other information derived from the 1 H NMR spectrum did not allow a firm 
assignment of the 5-H stereochemistry of this single isomer; as before the 
assumption is made that it is unlikely to be the 3-endo, 5-endo isomer 
due to the steric constraints involved in the cyclisation. The formation of 
the isomer 255 without the formation of the other possible isomer 
suggests that this product has the 3-endo, 5-exo configuration 
(Scheme 197). 
The hydroxy-THF 72 used in the earlier model work, is easily 
obtained in multigram quantities from the iodocyclisation of (Z)-methyl 3-
hydroxydec-5-enoate 71. This hydroxy-THF was silylated in exactly the 
same manner as the corresponding 5'-methyl hydroxy-THF 148, (ie 
using TIPS trifiate, and 2,6-lutidine in dichloromethane) to give the silyl 
ether 256. A somewhat lower yield was obtained, but as this was an 
isolated occurrence the reaction was not optimised further. The TIPS 
protecting group was used in preference to the corresponding TBS 
function as low yields were obtained in the reduction of the silyl ether 138, 
due to the cleavage of the silicon group. However, reduction of the silyl 
ether 256 with diisobutylaluminium hydride in hexane, at -78°C, 
proceeded without removal of the protecting group, to give the aldehyde 
257, in an excellant yield of 85%. This aldehyde was then homologated 
with various Wittig reagents. Methyl triphenylphosphoranylideneacetate 
in dcm gave a 51% yield of the alkenoate ester 258 (Scheme 198). 
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(71) 
(257) 
PH3P=CHMe 
THF,17% 
(259) 
Scheme 198 
HO,,, 
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(72) 
TIPS-Cl 
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O°C 3h. 40% 
CHO TIPSO 
DIBAL-H X > - ' ~ ' . . .C02Me 
.... 
hexane -78°C Bu 0 
85% (256) 
PH3P=CHC02Me 
dcm,51% 
(258) 
TBMSO::r:yC02Me 
Bu 0 
(138) 
Ethyl triphenylphosphonium iodide was treated with butyl 
lithium at -78°C to generate the corresponding ylid, which reacted with 
the aldehyde 257 to give only a 17% yield of the alkene 259. These yields 
are again unoptimised (from a single experiment) and consequently 
disappointing; however, if significantly improved they would offer a 
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comprehensive route to these cyclisation precursors. 
Desilylation of these Wittig products proceeded in relatively good 
yields to give the hydroxy-THFs 260 and 261 (Scheme 199). 
Scheme 199 
C02Me 
TBAF 
~ ~
THF75% 
(258) (260) 
TBAF 
THF40% 
(259) (261) 
The Barton deoxygenation of these alkenes gives the 2,5 cis-
disubstituted-THF radicals which are the direct analogues of the 2,5 
trans-disubstituted THF radicals generated from the iodo-THFs 245 and 
246. This provides an opportunity to test the proposal made earlier in 
this chapter, ie that a better stereoselection would be obtained from the 
2,5 cis-disubstituted THF radicals. 
The thioimidazole esters 262 and 263 of the alcohols 260 and 
261 were formed quantitatively using thiocarbonyldiimidazole in THF at 
reflux (Scheme 200). 
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Scheme 200 
16h reflux 
(260) Bu 
16h reflux 
(261) (263) 
Treatment of these derivatives with tributyltin hydride in 
refluxing toluene resulted in deoxygenation, forming the required 
radicals.184 The alkenoate ester 260 cyclised to give the substituted 2-
oxabicyclo-[2.2.1]-heptanyl ester 264 as the ~ ~ product in 77% yield, 
whereas the alkene 261 was simply deoxygenated to give the 2,5-cis-
THF 265 in 80% yield (Scheme 201). 
Scheme 201 
N ~ ~ ---(8 ~ N N BU3SnH, C02Me 
~ ~ .. 
PhMe ~ , , H 
77% Bu H C0 2Me 
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.. 
P h M e ~ , ,
80% 
(263) (265) 
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The cyclisation of the alkenoate ester 260 was stereospecific 
giving a single isomer. This result is especially pleasing as it provides 
evidence that the reaction path follows that discussed earlier, as greater 
selectivity was predicted on the basis of the transition states described in 
Scheme 189. The substituted 2-oxabicyclo-[2.2.1]-heptanyl ester 264 
exhibited the broad singlet in the lH NMR spectrum at BH = 4.26 
corresponding to the 1'-H. It also showed the characteristic broad singlet 
at ~ ~ = 2.04 from the 4'-H. Mass spectrometry demonstrated that the 
isomer had the same molecular formula and major fragmentation pattern 
as the two isomeric products from the cyclisation of the corresponding 
2,5-trans-THF radical from ester 245. The l3C NMR spectrum showed 
that the isomers 248, 249 and 264 were similar but showed distinct 
differences. Crucially, the 3'-H shows a resonance at ~ ~ = 3.81, which is a 
triplet of doublets showing coupling constants of 7.4 Hz to the butyl side 
chain and 2.6 Hz to the 4'-H. 
Scheme 202 
2.6 Hz 
(264) 
By analogy to the earlier systems, this suggests a 3'-endo 
configuration; although the rest of the coupling constants in this isomer 
159 
are difficult to analyse, the 5'-exo configuration l'S th ht b oug to e more 
likely as the stereoselectivity is almost certain to an's fr th . e om e stenc 
strain involved in the formation of the 3' -endo 5' endo . (S h 
,- Isomer c erne 
202). 
Scheme 202 
2.6 Hz 
(264) 
The deoxygenation of the alkene 261 could perhaps be avoided 
by the use of lower temperatures for the cyclisation process (ie allowing 
less collisions and favouring intramolecular reaction), or by further 
increasing dilution or slowing down the speed of addition of the tributyltin 
hydride. However, time constraints did not allow these trial reactions to 
be carried out. 
Atom transfer cyclisation of the ester 245 was attempted using 
the procedure developed by Curran185 which consists of irradiation of the 
molecule with a 275 W sun lamp, in the presence of 0.1 mol% 
hexabutylditin in benzene. Cyclisation was nm observed, but the iodine 
atom was epimerised to give a 1:1 mixture of the ester 245 and its 7-
epimer 263 (Scheme 203). 
I thank Dr J. A. Murphy and others for helpful discussion at this 
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point, suggesting that there is a low driving force for the cyclisation, which 
can be considered to be an equilibrium process. It is possible that upon 
formation of a small concentration of THF radicals during this process, 
the tributyltin iodide which is also produced can trap the radical before it 
cyclises. This would regenerate the iodo-THF, but without 
stereoselectivity (ie epimerisation at the 7-position would be observed). 
Alternatively, this could occur by a simple Finkelstein exchange between 
the starting material and the tributyltin iodide generated under the 
reaction conditions. 
Scheme 204 
o 
H 
o 
o 
H 
In conclusion, it has been shown that the radical cyclisation of 
2,5-disubstituted-THF radicals having alkenyl side chains provides an 
efficient and, in some cases, highly stereoselective route to the 2-
oxabicyclo-[2.2.1]-heptane ring system. This could, therefore possibly, be 
developed into a viable approach to the Cymathere ethers A and B 
(Scheme 204). There is however a lot of development of the methodology 
required. 
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Similar radical cyclisations could be used to generate other 
interesting ring systems (Scheme 205). This would provide an interesting 
combination of ionic and radical processes in the preparation of bicyclic 
systems. 
R 
Scheme 202 
._----------.-
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CHAPTER SIX 
ExperiInental 
General Experimental 
Melting Points were determined on a Kofler hot stage apparatus 
and are uncorrected. Infra red spectra were recorded on a Perkin Elmer 
1720 FrIR as liquid films or as chloroform solutions. 1 H NMR spectra 
were measured on Briiker WM 250 (250 MHz, PFT), Briiker AM 400 (400 
MHz, PFT), and JEOL EX270 (270 MHz, PFT) instruments. The 
following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; 
m, multiplet; br, broad and dt; doublet of triplets, etc. 13C NMR spectra 
were recorded on Briiker AM 400 (101 MHz, PFT) [indicated by (400)] 
and JEOL EX270 (68 MHz, PFT) [indicated by (270)] instruments. 
Chemical shifts are reported in ppm from tetramethylsilane (or 
chloroform) and are corrected to 0.00 (TMS) and 7.27 (CHCI3) ppm for IH 
NMR and 77.30 (CDCI3) ppm for 13C NMR. Deuteriochloroform was used 
as solvent for NMR measurements unless otherwise stated. Where no 
clear resonances for the OH function of alcohols or acids were observed 
the values have not been quoted. Mass spectra and molecular weights 
were determined using a VG MM7070E or AEI MS 902 spectrometer. 
Molecular formulae quoted for molecular fragment ions are converted to 
+3 mmu. Optical rotations (an) were measured on a JASCO DIP 370 
polarimeter. All reactions using air/moisture sensitive reagents were 
performed in oven-dried or flame-dried apparatus, under atmospheres of 
argon or nitrogen. All solvents and reagents were purified according to 
procedures laid down in "Purification of Laboratory Chemicals" by D. D. 
Perrin and W. L. F. Armarego. All organic solutions were dried by brief 
exposure to anhydrous magnesium sulphate. Chromatography was 
performed using silica gel SORBSIL® C60-H (40-60 J,Lm). 
(±)-Methyl 3-hydroxydec-5-ynoate (00) 
~ C 0 2 M e e
Bu OH 
Hexyne (5.31 g, 64.7 mmol, 1.5 eq) was dissolved in dry 
tetrahydrofuran (80 ml) and treated exactly as in the preparation of 
.compound 146 using the racemic epoxide 8t (2.5 g, 21 mmol, 1.0 
eq), to give an oil (7.7 g) which was chromatographed on silica 
(eluting with 20% ethyl acetate in petrol) to give the alkyne :J) as a 
pale yellow oil (3.5 g, 70%), '\)MAX 3448 (OH), 1738 (C=O), 1437, 1162 
and 1058 cm-I ; Os (250) 0.91 (3H, t, J = 7.1, 10-CH3), 1.37-1.48 (4H, ID, 
8- and 9-CH2), 2.14-2.19 (2H, m, 7-CH2), 2.39-2.42 (2H, ID, 4-CH2), 
2.52 (lH, dd, J = 16.3 and 8.7, 2-CfuHB), 2.67 (lH, dd, J = 16.3 and 
3.8, 2-CHA&), 3.78 (3H, s, OMe) and 4.05-4.20 (lH, ID, 3-CH); Be 
(270) 13.46 (10-Me), 18.23 (CH2), 21.84 (CH2), 26.70 (CH2), 30.89 (4-
CH2), 40.73 (2-CH2), 51.68 (OMe), 66.83 (3-CH), 75.06 (5-C), 83.36 (6-
C) and 172.78 (C=O); mJz 180 (7%, M+-H20), 103 (100),81 (18), 71 (51) 
and 61 (23) [Found: M+-H20, 180.1157. CllH I60 2 requires M, 
180.1350]. 
(±)-Methyl 3-hydroxy-B-phenyl-oct-5-ynoate (:Ill) 
4-Phenylbutyne (0.70 ml, 5 mmol, 1.0 eq) was alkylated with 
the (+)-epoxide 8t (580 mg, 5 mmol, 1.0 eq) exactly as in the 
preparation of compound 146, to give a brown oil (2 g) which was 
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chromatographed on silica (eluting with 25% ethyl acetate in 
petrol) to give, as a colourless oil, the alkyne 3b (0.66 g, 56%), 'l>MAX 
3515 (OH), 1738 (C=O), 1437,1173 and 1058 cm-I; 0H (250), 2.38-2.42 
(2H, m, 4-CH2), 2.43-2.51 (lH, m, 7-CH2), 2.67-2.86 (2H, m, 2-CH2), 
2.81 (2H, t, J = 10.0, 8-CH2), 3.74 (3H, s, OMe), 4.06-4.12 (lH, m, 3-
'CH) and 7.19-7.32 (5H, m, Ph); 0e (270) 29.25 (CH2), 34.03 (CH2), 
35.93 (CH2), 41.05 (CH2), 51.75 (OMe), 66.83 (3-CH), 76.43 (5-C), 82.10 
(6-C), 125.43 (CH), 128.76 (CH), 128.83 (CH), 135.67 (C) and 173.29 
(C=O); mJz 246(5%, M+), 228 (10%, M+-H20), 154(45), 144 (47) and 
129 (100) [Found: M+, 246.3032. CIsHIS02 requires M, 246.1256]. 
(±J-Methyl 3-triisopropylsilyloxydec-5-ynoate (31) 
B u ~ ~ ?TIPS 
~ c o ~ e e
Triisopropylsilyl chloride (366 mg, 1.9 mmol, 1.5 eq) was 
added to a stirred solution of the alkyne :J) (238 mg, 1.2 mmol, 1.0 
eq) and imidazole (211 mg, 3.1 mmol, 2.5 eq) in dimethylformamide 
(6 ml). The resulting solution was stirred at RT for 72h and water 
(100 ml) was added. The resulting mixture was extracted with 
ether (3 x 100 ml) and the combined organic layers dried and 
evaporated to give a yellow oil (600 mg), which was 
chromatographed on silica (eluting with 9% ethyl acetate in petrol) 
to give the silyl derivative 37 as a colourless oil (426 mg, 98%), UMAX 
1736(C=O), 1465, 1109 and 1000 cm-I; 0H (250) 0.89 (3H, t, J = 7.1, 1 ~ ~
CH3), 0.91-1.15 (21H, m, TIPS), 1.31-1.72 (4H, m, 8- and 9-CH2), 
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2.10-2.21 (2H, m, 7-CH2), 2.41-2.43 (2H, m, 4-CH2), 2.60 (lH, dd, J = 
15.0 and 6.3, 2-CHAHB), 2.79 (lH, dd, J = 15.0 and 5.1, 2-CHA&), 
3.74 (3H, s, OMe) and 4.10-4.30 (lH, m, 3-H); oe (270) 12.41 (3 x CH, 
TIPS), 13.58 (10-Me), 17.80 (6 x Me, TIPS), 18.42 (CH2), 21.80 (CH2), 
28.01 (CH2), 30.51 (CH2), 40.01 (2-CH2), 51.37 (OMe), 68.31 (3-CH), 
75.60 (5-C), 84.10 (6-C) and 171.01 (C=O); mJz 311 (7%, M+.iPr), 131 
(35), 103 (29), 71 (100) and 61 (30) 
(±)-(Z)-Methyl 3-triisopropylsilyloxydec-5-enoate ( ~ ) )
Bu 
The silyl derivative ~ ~ (420 mg, 1.2 mmol) was reduced 
exactly as in the preparation of compound 147, to give the alkene ~ ~
as a pale yellow oil (400 mg, 94%), UMAX 1741 (C=O), 1465 and 1103 
cm-1; 0H (250) 0.89 (3H, t,J = 7.1, 10-CH3), 0.92-1.17 (21H,m, TIPS), 
1.31-1.71 (4H, m, 8- and 9-CH2), 2.10-2.13 (2H, m, 7-CH2), 2.41-2.44 
(2H, m, 4-CH2), 2.60 (lH, dd, J = 15.0 and 6.7, 2-CfuHB), 2.79 (lH, 
dd, J = 15.0 and 4.1, 2-CHAl!a), 3.74 (3H, s, OMe), 4.01-4.09 (lH, m, 
3-H), 5.35-5.42 (lH, m, 5-H) and 5.55-5.60 (lH, m, 6-H); oe (270) 12.44 
(3 x CH, TIPS), 13.91 (10-Me), 18.00 (6 x Me, TIPS), 22.43 (CH2), 
27.24 (CH2), 31.86 (CH2), 35.54 (CH2), 42.08 (2-CH2), 51.63 (OMe), 
66.31 (3-CH), 124.35 (5-CH), 132.79 (6-CH) and 171.73 (C=O); rnJz 313 
(4%, M+.iPr), 131 (100), 71 (65), 61 (41) and 55 (47) [Found: M+.iPr, 
313.2180. C16H3103Si requires M, 313.2199]. 
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(±)-(ZJ-3-Triisopropylsilyloxydec-5-enoic acid (3!) 
The alkene 38 (400 mg, 1.2 mmol) was saponified exactly as in 
.the preparation of compound 152, to give the (ZJ-acid 3! as a pale 
yellow oil (380 mg, 95%), ~ A X X 3664 (OH), 1713 (C=O) and 1103 em-!. , 
0H (250) 0.90 (3H, t, J = 7.1, 10-CHa), 1.10-1.13 (21H, m, TIPS), 1.31-
1.71 (4H, m, 8- and 9-CH2), 1.93-2.25 (2H, m, 7-CH2), 2.45-2.46 (2H, 
m, 4-CH2), 2.60 (1H, dd, J = 15.3 and 8.0,2-CHAHB)' 2.65 (lH, dd, J 
= 15.3 and 5.9, 2-CHAHB), 4.01-4.09 (lH, m, 3-H), 5.35-5.42 (lH, m, 5-
H) and 5.55-5.60 (lH, m, 6-H); 0c (270) 12.47 (3 x CH, TIPS), 13.98 
(10-Me), 18.08 (6 x Me, TIPS), 22.39 (CH2), 27.22 (CH2), 31.79 (CH2), 
40.71 (CH2), 41.51 (2-CH2), 69.52 (3-CH), 124.13 (5-CH), 132.99 (6-CH) 
and 175.53 (C=O); mJz 299 (87%, M+JPr), 201 (20), 157 (44), 131 (80) 
and 71 (30) [Found: M+JPr, 299.2017. CI6HaI03Si requires M, 
299.2041]. 
(±)-3-Triisopropylsilyloxydec-5-ynoic acid (:I)) 
The silyl derivative 37 (0.52g, 1.47 mmol, 1 eq) was saponified 
exactly as in the preparation of compound 1.52, to give the alkynoic 
acid :J) as a colourless oil (500 mg, 95%), UMAX 3500 (OH), 1714 
(C=O), 1465, 1109 and 1000 cm-I; 0H (250) 0.89 (3H, t, J = 7.0, 10-
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CHa), 1.05-1.10 (21H, m, TIPS), 1.31-1.47 (4H, m, 8- and 9-CH
2
), 
2.11-2.17 (2H, m, 7-CH2), 2.43-2.46 (2H, m, 4-CH2), 2.58 (lH, dd, J = 
15.1 and 6.6, 2-CfiAHB), 2.78 (lH, dd, J = 15.1 and 5.0, 2-CH
A
Ha) 
and 4.26-4.30 (lH, m, 3-H); Be (270) 12.40 (3 x CH, TIPS), 13.53 (lO-
Me), 17.95 (6 x Me, TIPS), 18.39 (CH2), 21.89 (CH2), 27.82 (7-CH2), 
·30.91 (4-CH2), 41.62 (2-CH2), 68.56 (3-CH), 75.62 (5-C), 83.09 (6-C) 
and 177.18 (C=O); m/z 297 (10%, M+JPr), 131 (65), 85 (45), 71 (100) 
and 61 (37) [Found: M+JPr, 297.1902. CI6H290aSi requires M, 
297.1886]. 
(±}-(E}-3 -Triisopropylsilyloxydec-5-enoic acid (28) 
tButanol (120 mg, 1.47 mmol, 1 eq) was added to a suspension 
of ammonium sulphate (1.94 g,14.7 mmol, 10 eq) and the alkynoic 
acid m (420 mg, 1.2 mmol) in tetrahydrofuran (25 mI). Ammonia 
(50 ml) was condensed into the solution at -78°C and the resulting 
mixture was stirred at -40°C during the addition of lithium chips 
(54 mg, 8.9 mmol, 6 eq). The reaction was stirred at this 
temperature for 2h and then allowed to warm to RT over 16h. 
Water (100 ml) was added and the resulting solution was extracted 
with chloroform (3 x 50 ml) and the combined organic layers dried 
and evaporated to give, as a colourless oil, the (E}-acid 28 (475 mg, 
95%), UMAX 3500 (OH), 1713 (C=O), 1464and 1106 cm-I; 0H (250)0.89 
(3H, t, J = 7.1, 10-CRa), 1.05-1.07 (21R, m, TIPS), 1.31-1.40 (4H, m t 8-
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and 9-CH2), 1.95-1.98 (2H, m, 7-CH2), 2.20-2.29 (2H, m, 4-CH2), 2.47 
(lH, dd, J = 15.2 and 5.9, 2-CfiAHB), 2.57 (lH dd J = 15 2 d 4 1 2-" . an ., 
CHAHa), 4.17-4.27 (lH, m, 3-H), 5.30-5.42 (lH, m, 5-H) and 5.55-5.60 
(lH, m, 6-H); oe (270) 12.42 (3 x CH, TIPS), 13.89 (10-Me), 18.01 (6 x 
Me, TIPS), 22.19 (CH2), 31.47 (CH2), 32.33 (7-CH2), 40.75 (4-CH2), 
41.48 (2-CH2), 69.44 (3-CH), 124.64 (5-CH), 134.52 (6-CH) and 177.45 
(C=O); m/z 299 (2%, M+JPr), 131 (45), 89 (51), 85 (100) and 71 (52) 
[Found: M+JPr, 299.2035. CI6HaI0aSi requires M, 299.2041]. 
(3RS,4SR,6SR)-6-[odo-3-triisopropylsilyloxydecan-5-olide (.f) 
OTIPS 
Bu o 
I 
The (Z)-acid :JZ (130 mg, 0.38 mmol, 1 eq) was iodocyclised 
exactly as in the preparation of compound 5ib,but using 3:1 
acteonitrile:water as solvent, to give a yellow oil (140 mg), which, 
upon chromatography on silica (eluting with 15 % ether in petrol), 
gave the lactone 40 as a colourless oil (100 mg, 57%), ~ A X X 1748 
(C=O), 1464, 1342 and 1248 cm-I; 0H (250) 0.92 (3H, t, J = 6.7, 10-
CHa), 1.05-1.08 (21H, m, TIPS), 1.22-1.45 (4H, m, 8- and 9-CH2), 
1.50-1.65 (lH, m, 7-HA), 1.87 (lH, ddd, J = 14.4, 9.9 and 4.9, 4-
CfuHB), 2.06 (lH, ddd, J = 14.4, 8.3 and 2.6, 4-CHAHB), 2 ' ( ~ 9 - 2 . 1 3 3
(lH, m, 7-HB), 2.61 (lH, dd, J = 17.5 and 3.7, 2-CfuHB), 2.65 (lH, 
dd, J = 17.5 and 5.1, 2-CHAHs), 4.12 (lH, ddd, J = 9.9,4.7 and 2.6,5-
100 
H) and 4.39-4.50 (2H, m, 3- and 6-H); Oc (270) 12.29 (3 x CH, TIPS), 
13.93 (10-Me), 17.72 (6 x Me, TIPS), 21.89 (CH2), 31.91 (CH2), 35.88 
(CH2), 35.93 (CH2), 38.96 (6-CH), 39.41 (2-CH2), 63.59 (3-CH), 77.23 
(5-CH) and 169.41 (C=O); mJz 425 (5%, M+JPr), 297 (10), 157 (100), ffi 
(45) and 57 (40) [Found: M+JPr, 425.0986. ClsHaoIOaSi requires M, 
"425.1011]. 
(3RS,4SR,6RS)-6-Iodo-3-triisopropylsilyloxy-decan-5-olide (41) and 
(3RS,4RS,6SR)-6-iodo-3-triisopropylsilyloxy-decan-5-olide (42) 
Bu 
~ ~ H 
I 
OTIPS 
o Bu 
OTIPS 
o 
I 
The (E)-acid 28 (504 mg, 1.47 mmol, 1 eq) was iodocyclised 
exactly as in the preparation of compound 40, to give a yellow oil 
(900 mg), which, upon chromatography on silica (eluting with 15 
% ether in petro!), gave the trans-lactone 41 as a colourless oil (540 
mg, 78%), 'UMAX 1748 (C=O), 1464, 1342 and 1248cm-1; 0H (250) 0.92 
(3H, t, J = 7.0, 10-CHa), 1.05-1.07 (21H, m, TIPS), 1.13-1.42 (6H, m, 7-
, 8- and 9-CH2), 1.70- 1.90 (2H, m, 4-CH2), 2.67 (2H, app. dd, J = 17.5 
and 5.1, 2-CH2), 4.27-4.37 (2H, m, 6- and 3-H) and 4.48 (lH, ddd, J = 
6.8, 6.8 and 3.5, 5-H); Oc (270) 12.31 (3 x CH, TIPS), 14.14 (10-Me), 
18.24 (6 x Me, TIPS), 22.12 (CH2), 31.81 (CH2), 35.65 (7-CH2), 35.77 
(4-CH2), 39.66 (2-CH2), 41.04 (6-CH), 63.83 (3-CH), 77.79 (5-H) and 
169.34 (C=O); and, as a colourless oil, the cis-lactone 42 (50 mg, 
170 
8%), ~ A X X 1748 (C=O), 1464, 1342 and 1248cm-1; BH (250) 0.93 (3H, t, J 
= 6.7, 10-CHa), 1.05-1.10 (21H, m, TIPS), 1.26-1.36 (4H, m, 8- and 9-
CH2), 1.55-1.62 (2H, m, 4-HA ), 1.72-1.87 (2H, m, 7-CH2), 2.09 (2H, dd, 
J = 17.3 and 8.3, 2-CH2), 2.85 (lH, ddd, J = 17.1,5.2 and 1.2, 4-H
B
), 
3.97 (lH, ddd, J = 11.1, 6.0 and 3.0, 5-H), 4.29 (lH, td, J = 6.2 and 
3.0, 6-H) and 4.30 (lH, app. tt, J = 8.6 and 5.2, 3-H); Be (270) 12.19 (3 
x CH, TIPS), 13.97 (10-Me), 16.02 (6 x Me, TIPS), 21.91 (CH
2
), 31.55 
(CH2), 35.04 (7-CH2), 38.13 (4-CH2), 39.11 (6-CH), 40.37 (2-CH2), 64.25 
(3-CH), 78.90 (5-CH) and 169.41 (C=O). 
(3RS,5SR,6RS)-Methyl 5,6-epoxy-3-triisopropylsilyloxydec-anoate 
( ~ ) )
Bu .... ·· 
H 
Sodium carbonate (16.1mg, 0.16mmol, 1.7 eq)was added toa 
stirred solution of the lactone .f) (45 mg, 0.09 mmol, 1 eq) in dry 
methanol (1.6 mI) and the resulting mixture was stirred for 16hin 
the dark. The solvent was removed in vacuo and the residue 
partitioned between water (1 mI) and ether (3 mI). The organic 
phase was dried and evaporated to give, as a colourless oil, the 
epoxide 43 (18 mg, 76%), UMAX 1741 (C=O), 1463,1381,1170 and 1096 
cm- I ; BH (250) 0.92 (3H, t, J = 6.9, 10-CHa), 1.10-1.27 (21H, m, TIPS), 
1.35-1.60 (6H, m, 7-,8- and 9-CH2), 1.68 (lH, ddd, J = 14.4,7.8 and 
4.1,4-CfuHB), 1.94 (lH, ddd, J = 14.4,6.1 and 3.9, 4-CHAHB), 2.65 
171 
(2H, app. dd, J = 6.4 and 2.2, 2-CH2), 2.92 (lH ddd J = 7 8 4 1 d ' , . , . an 
3.9, 5-H), 3.13 (lH, td, J = 7.9 and 4.1, 6-H), 3.67 (3H, s, OMe) and 
4.55 (lH, tdd, J = 6.4, 6.1 and 4.1, 3-H); Oc (270) 12.45 (3 x CH 
, 
TIPS), 14.00 (10-Me), 18.06 (6 x Me, TIPS), 22.59 (CH
2
), 27.35 (CH
2
), 
27.65 (7-CH2), 35.31 (4-CH2), 41.83 (2-CH2), 51.50 (OMe), 53.05 (5-
-CH), 56.26 (6-CH), 67.78 (3-CH) and 171.59 (C=O); mJz 329 (90%, M+-
ipr), 227 (77), 131 (85), 131 (75) and 75 (100) [Found: M+jPr, 329.2916. 
C17Haa04Si requires M, 329.2148]. 
(3RS,5SR,6SR)-Methyl 5,6-epoxy-3-triisopropylsilyloxydecanoate 
(44) 
Bu 
The trans-lactone 41 (400 mg, 0.85 mmol, 1 eq) was treated as 
in the preparation of compound 43, to give, as a colourless oil, the 
epoxide 44(190mg, 75%), UMAX 1741(C=O), 1463, 1371,1176 and 1000 
c m-1; 0H (250) 0.91 (3H, t, J = 6.9, 10-CHa), 1.05-1.07 (21H, m, TIPS), 
1.36-1.44 (4H, m, 8- and 9-CH2), 1.51-1.62 (2H, m, 7-CH2), 1.68 (lH, 
ddd, J = 14.3, 7.1 and 3.8, 4-CHAHB), 1.94 (lH, ddd, J = 14.3, 6.4 and 
4.3, 4-CHAH B), 2.58-2.71 (3H, m, 6-H and 2-CH2), 2.86 (lH, ddd, J = 
7.1, 4.3 and 2.2, 5-H), 3.66 (3H, s, OMe) and 4.47 (lH, dddd, J = 6.4, 
6.4, 3.8 and 2.6, 3-H); Oc (270) 12.71 (3 x CH, TIPS), 14.25 (10-Me), 
18.33 (6 x Me, TIPS), 22.81 (CH2), 28.39 (CH2), 31.97 (7 -CH2), 39.97 
(4-CH2), 42.07 (2-CH2), 51.79 (OMe), 55.10 (5-CH), 58.55 (6-CH), 67.80 
172 
(3-CH) and 172.22 (C=O); mJz 329(90%, M+_iPr), 227 (77),131 (85), 
131 (75) and 75 (100). 
(3RS,5RS, 6RS)-Methyl 5, 6-epoxy-3-triisopropy l-silyloxydecanoate 
(45) 
BUill'" 
The cis-lactone 42 (40 mg, 0.8 mmol, 1 eq) was treated exactly 
as in the preparation of compound ~ ~ to give, as a colourless oil, 
the epoxide 45 (15 mg, 70%) UMAX 1741 (C=O), 1463,1371,1174 and 
1095 cm- I ; BH (250) 0.92 (3H, t, J = 6.9, 10-CH3), 1.07-1.17 (21H, m, 
TIPS), 1.27-1.45 (6H, m, 7-, 8- and 9-CH2), 1.70-1.72 (lH, ID, 4-CH), 
1.82-1.85 (lH, m, 4-CH), 2.53 (2H, dd, J = 6.3 and 1.7, 2-CH2), 2.66 
(lH, td, J = 5.3 and 2.2, 6-H), 2.79 (lH, ddd, J = 5.6,4.1 and 2.2, 5-H), 
3.67 (3H, s, OMe) and 4.54 (lH, m, 3-H); Be (270) 12.46 (3 x CH, 
TIPS), 13.91 (10-Me), 18.05 (6 x Me, TIPS), 22.48 (CH2), 27.98 (CH2), 
31.63 (7-CH2), 40.07 (4-CH2), 42.70 (2-CH2), 51.48 (OMe), 58.89 (5-
CH), 56.26 (6-CH), 67.91 (3-CH) and 171.68 (C=O); mJz 329 (90%, M+-
iPr), 227 (77), 131 (85), 131 (75) and 75 (100). 
(±)-(E)-Methyl 3-hydroxydec-5-enoate (D» 
B U ~ C ~ M e e
OH 
Diisobutylaluminium hydride (27 ml of a 1M solution, 'lJ 
173 
mmol, 1 eq) was added to 1-hexyne (3.1 ml, 27 mmol, 1eq) in 
hexane (91 ml) at -78°C and the resulting solution was then heated 
at 50°C for 2h, before cooling to -30°C. Methyl lithium (18.5 ml of a 
l.4M solution in ether, 26 mmol, 0.96 eq) and then ether (90 ml) 
were added. The resulting suspension was stirred at O°C for 0.5h 
-and then cooled to -78°C. The (+)-epoxide 8t (3 g, 26 mmol, 0.96 eq) 
followed by boron trifluoride ether ate (3.18 ml, 26 mmol, 0.96 eq) 
were added. The solution was stirred at -78°C for 0.75h. Methanol 
(15 ml) was added and after 10 min, 1M hydrochloric acid (60 ml). 
The resulting mixture was extracted with ethyl acetate (3 x 50 ml) 
and the combined organic phases were dried and evaporated ro 
give a colourless oil (6.4 g). Chromatography on silica (eluting with 
15% ethyl acetate in petrol gave alkene SIJ as a colourless oil (3.28 
g, 63%), UMAX 3417 (OH) and 1732 (C=O) cm-1; bH (250)0.90 (3H, t, J = 
6.4, 10-CH3), 1.20-1.40 (4H, m, 8- and 9-CH2), 2.01-2.05 (2H, fi, 7-
CH2), 2.10-2.14 (2H, m, 4-CH2), 2.45 (lH, dd, J = 15.7 and 9.8,2-
CIiAHB), 2.52 (lH, dd, J = 15.7 and 3.8, 2-CHAHs), 3.71 (3H, s, 
OMe), 4.05-4.20 (lH, m, 3-CH), 5.35-5.45 (lH, m, 5-CH) and 5.55-5.65 
(lH, m, 6-CH); be (270) 13.92 (10-Me), 22.22 (CH2), 31.55 (CH2), 32.32 
(CH2), 39.91 (4-CH2), 40.44 (2-CH2), 51.80 (OMe), 67.75 (3-CH), 124.82 
(5-C), 138.70 (6-C) and 173.26 (C=O); mJz [NH4-CI] 218 (85%, M+ + 
NH4), 201 (20%, MH+), 183 (100), 169 (5) and 151 (10); [Found: C, 
65.4; H, 9.9. CllH200 3 requires C, 66.0; H, 10.1%]. 
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(2'SR,4'SR,5'RSI At h I 
'/ et y (5'-butyl-4'-iodotetrahydrofuran-2'_yl) 
acetate (51)) 
I" 
;0'. C ~ M e e...... / 
Bu 0 
Sodium hydrogencarbonate (4.11 g, 48.9 mmol, 3 eq) was 
added to an ice-cold solution of the alkene Sf> (3.26 g, 16.3 mmol, 1 
eq) in dry acetonitrile (66 ml) and the suspension stirred for 5 
mins. Iodine (12.42 g, 48.9 mmol, 3eq) was added and the resulting 
mixture was stirred at 0-5°C in the dark for 16 h. Ether (100 ml) 
was added and the solution was washed with saturated aqueous 
sodium thiosulphate (120 mI). The separated aqueous phase was 
extracted with ether (3 x 50 mI). The combined organic phases 
were dried and evaporated to give the iodotetrahydrofuran 5tJ as a 
colourless oil (3.98 g, 75%), 'UMAX 1732 (C=O) cm- I ; 0H (250) 1.06 (3H, 
t, J = 6.7, CH3), 1.38-1.90 (6H, m, 3 x CH2), 2.05 (lH, ddd, J = 12.6, 
5.6 and 3.7, 3'-CH), 2.39 (lH, dd, J = 15.5 and 6.5, 2-CfuHB), 2.45 
(lH, ddd, J = 12.6, 6.7 and 6.4, 3'-CH), 2.70 (lH, dd, J = 15.5 and 7.0, 
2-CHAHB), 3.49 (lH, ddd, J = 6.7,3.7 and 3.5, 4'-CH), 3.51 (3H, s, 
OMe), 4.20 (lH, ddd, J = 6.7,6.7 and 3.5, 5'-CH) and 4.39 (lH, dddd, 
J = 7.0, 6.5, 6.4 and 5.6, 2'-CH); oe (270, CsDs) 14.11 (Me), 22.50 (4'-
CH), 22.94 (CH2), 28.34 (CH2), 32.27 (CH2), 40.59 (3'-CH2), 44.76 (2-
CH
2
), 51.06 (OMe), 74.47 (2'-CH), 86.75 (5'-CH) and 170.56 (C=O); 
m/z [NH
4
-CI] 327 (15%, MH+), 281 (30), 221 (43), 207 (36) and 147 
175 
(100) [Found: C, 40.8; H, 5.9. CllH I9I03 requires C, 40.5, 6.0%]. 
(:t)-(Z)-Methyl 3-hydroxy-B-phenyloct-5-enoate (5lb) 
The alkyne :Jh (600mg, 2.4 mmol) was reduced exactly as in 
the preparation of compound 147 to give the alkene 5th as a pale 
yellow oil (510 mg, 85%), UMAX 3505 (OH), 1737 (C=O), 1437,1201 and 
1172 cm-I ; 0H (250) 2.15-2.20 (2H, m, 4-CH2), 2.30-2.40 (2H, m, 6-
CH2), 2.40-2.51 (2H, m, 2-CH2), 2.57 (2H, t, J = 10.1, 8-CH2), 3.70 (3H, 
s, OMe), 3.92-4.00 (lH, m, 3-CH), 5.38-5.45 (lH, m, 5-CH), 5.55-5.62 
(lH, m, 6-CH) and 7.15-7.31 (5H, m, Ph); oe (270) 29.37 (CH2), 34.31 
(CH2), 35.74 (CH2), 40.38 (CH2), 51.74 (OMe), 67.85 (3-CH), 125.37 (5-
CH), 128.36 (CH), 128.39 (CH), 128.46 (CH), 133.80 (6-CH), 141.75 (C) 
and 173.25 (C=O); m/z [NH4-CI] 266 (75%, M++NH4), 249 (100%, 
MH+), 199 (23), 134 (27) and 91 (24). [Found: C, 72.3; H, 8.0. ClsH2003 
requires C, 72.6; H, 8.1%]. 
176 
(.2'SR,4'RS,5'SRI M h 1 ( ~ ~ et y 4'-hydroxy-5'-phenylethyltetrahydro_ 
furan-2'-yl) acetate (sa,) 
The alkene 5lb (SO mg, 0.32 mmol, 1 eq)was treated exactly as 
in the preparation of the preparation 148, to give the hydroxy-
tetrahydrofuran sa, as a colourless oil (60 mg, 70%), l>MAX 3570 
(OH), 1736 (C=O), 1157 and 1084 c m-1; 0H (250) 1.83 (lH, ddd, J = 
13.5, 9.6 and 6.1, 3'-CHA)' 2.03 (lH, ddd, J = 13.5,5.6 and 2.0, 3'-
CHB ), 2.52 (lH, dd, J = 15.6 and 6.2, 2-Cfu CHB), 2.63 (lH, dd, J = 
15.6 and 6.9, 2-CHAC&), 2.48-2.51 (2H, m, 7-CH2), 2.78-2.80 (2H, m, 
6-CH2), 3.70 (3H, s, OMe), 3.75 (lH, ddd, J = 6.1,5.6 and 3.1, 4'-CH), 
4.10 (lH, td, J = 6.3 and 3.1, 5'-CH) and 4.50 (lH, dddd, J = 9.6, 6.9, 
6.2 and 2.0, 2'-CH); Oc (270) 32.14 (CH2), 36.14 (CH2), 40.72 (CH2), 
40.85 (CH2), 51.74 (OMe), 74.16 (4'-CH), 76.57 (2'-CH), 86.43 (5'-CH), 
128.51 (CH), 128.52 (CH), 128.54 (CH), 141.78 (C) and 172.71 (C=O); 
m/z 246 (25%, M+-H20), 191 (37), 104 (65), 98 (95) and 91 (100) 
[Found: M+-H20, 246.1261. ClsHls0a requires M, 246.1259]. 
177 
(2'RS,4'SR,5'RS) Methyl (4'-iodo-5'-phenylethyltetrahydro-furan_2'_ 
ylJ-acetate (54c) 
The methyl ester 92 (60 mg, 0.24 mmol, 1 eq) was iodocyc1ised 
exactly as in the preparation of compound 5IJ, to give an oil (100 
mg) which was chromatographed on silica (eluing with 10% ethyl 
acetate in petrol) to give, as a colourless oil, the iodo-
tetrahydrofuran 54c(170mg, 69%), 'l>MAX 1736 (C=O), 1438, 1202 and 
1030 cm- I ; BH (250) 1.71 (lH, ddd, J = 13.8,4.7 and 3.5, 3'-CH), 2.05 
(lH, m, 3'-CH), 2.48 (lH, dd, J = 15.5 and 6.4, 2-CHAHB), 2.60-2.85 
(5H, m, 2-CHAHB , 6- and 7-CH2), 3.64 (3H, s, OMe), 3.70 (lH, ddd, J 
= 7.4,3.5 and 3.4,4'-H), 3.94 (lH, dt, J = 8.5 and 3.5, 5'-H), 4.35 (lH, 
dddd, J = 6.9, 6.4, 4.7 and 1.4, 2'-H) and 7.08-7.25 (5H, m, Ph); oe 
(270) 21.52 (4'-CH), 32.18 (CH2), 33.93 (CH2), 40.67 (3'-CH2)' 44.52 (2-
CH2), 51.83 (OMe), 74.48 (2'-CH), 85.88 (5'-CH), 125.96 (CH), 128.44 
(CH), 128.46 (CH), 134.45 (C), 141.63 (C=O) and 170.45 (C=O); mJz 246 
(2%, M+-HI), 186 (43), 160 (36), 91 (100) and 55 (100). 
(2RS,3SR)-2-Ethyl-3-iodotetrahydrofuran ( ~ ) )
H 1 l l!:!"l (0 37 1 3 mmol, 1 eq) was iodocyclised (E)-3- exen- -0." . m, 
178 
(over various times: 5-45 mins) exactly as in the preparation of 
compound 5:A>, to give the iodotetrahydro{uran 58 as a colourless 
oil (0.54 g, 80%), which showed data which was identical to 
literature values,36 UMAX 1462, 1384, 1164, 1069 and 1023 cm-I; ~ ~
(250) 0.99 (3H, t, J = 7.4, CH3), 1.49 (lH, ddq, J = 13.9 and 7.4, 7.4, 1'-
HA), 1.72 (lH, ddq, J = 13.9, 7.4 and 7.4, l'-HB)' 2.23-2.27 (lH, m, 4-
HA), 2.46-2.50 (lH, m, 4-HB), 3.79 (lH, ddd, J = 6.9, 5.9 and 4.2, 3-H), 
3.89 (2H, dt, J = 7.1 and 1.2, 5-CH2) and 3.97 (lH, td, J = 7.4 and 4.2, 
2-H); Oe (400) 10.23 (Me), 23.35 (3-CH), 25.91 (CH2), 38.59 (4-CH2), 
66.92 (5-CH2) and 89.48 (2-CH); mJz 198 (16%, M+), 156 (37), 91 (61), 
85 (100) and 57 (92). 
(2SR,3SR)-2-Ethyl-3-iodotetrahydro{uran (00) 
(Z)-3-Hexen-1-o1 59 (0.37 ml, 3 mmol, 1 eq) was iodocyclised 
over 72h in the same way as in the preparation of compound 51> to 
give the iodotetrahydrofuran 00 as a colourless oil (0.41 g, 60%), 
UMAX 1462,1384, 1164 and 1023 cm-I; ~ ~ (250) 0.93 (3H, t, J = 7.5, 
CH3), 1.50 (lH, dqd, J = 13.7 and 7.5,6.6, l'-HA)' 1.76 (lH, dqd, J = 
13.9,7.5 and 6.5, l'-HB)' 2.47 (lH, dddd, J = 14.2, 7.1,2.9 and 1.4,4-
HA), 2.73 (lH, ddt, J = 14.2, 9.2 and 5.6, 4-HB), 2.80 (lH, dt, J = 6.5 
and 3.2, 2-H), 3.79 (lH, ddd, J = 6.9, 5.9 and 4.2, 3-H), 3.91 (lH, ddd, 
J = 9.2,8.3 and 2.9, 5-CHA ), 4.14 (lH, ddd, J = 9.2, 8.3 and 7.2, 5-
CHB) and 4.48 (lH, ddd, J = 5.6, 3.2 and 1.4, 2-H); oe (270) 10.24 
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(Me), 30.46 (CH2), 34.16 (3-CH), 39.10 (4-CH2), 66.00 (5-CH) and 83.49 
(2-CH); mJz 226 (10%, M+), 197 (15), 99 (100), 71 (28) and 57 (95). 
(2SR,3SR,5RS) 2-Butyl-5-ethyl-3-iodotetrahydrofuran (82) 
Et 
Bu 
(Z)-Dec-5-en-3-ol (230 mg, 1.6 mmol, 1 eq) was iodocyclised 
exactly as in the preparation of 5tl, to give the iodo-tetrahydrofuran 
m (270 mg, 60%) as a colourless oil which showed, UMAX 1463 and 
1168 cm-I ; ~ ~ (250) 0.92 (3H, t, J = 7.1, CH3), 0.95 (3H, t, J = 7.4, 
CH3), 1.23-1.39 (4H, m, 2 x CH2), 1.50-1.83 (4H, m, 2 x CH2), 2.31 
(lH, ddd, J = 14.6, 6.4 and 3.0, 4-HB), 2.76 (lH, ddd, J = 6.4,6.4 and 
4.0, 2-H), 2.92 (lH, ddd, J = 14.6, 8.0 and 7.0, 4-HA), 3.86 (lH, dddd, J 
= 8.0,6.4,6.4 and 6.4, 5-H) and (lH, ddd, J = 7.0,4.0 and 3.0, 3-H); 5c 
(400) 10.63 (Me), 14.09 (Me), 22.72 (CH2), 28.02 (CH2), 29.32 (CH2), 30. 
95 (CH2), 32.35 (3-CH), 43.90 (4-CH2), 81.38 (2-CH) and 81.60 (5-CH); 
mJz 253 (M+-Et, 4%), 225 (50), 155 (91), 85 (69) and 69 (100) [Found: 
M+-Et, 253.0172. CSH14IO requires M, 253.0089]. 
(2RS,3SR,5RS) 2-Butyl-5-ethyl-3-iodotetrahydrofuran (61) 
IX)-Et 
B u ~ ~
(E)-Dec-5-en-3-ol (160 mg, 1.02 mmol, 1 eq) was iodocyclised 
exactly as in the preparation of Mb, to give the iodotetrahydro-furan 
m (250 mg, 90%) as a colourless oil which showed, ~ A X X 1680,1540 
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and 1403 cm-I ; ~ ~ (250)0.92 (6H, app. t, J = 7.5, 2 x CH3), 1.22-1.47 
(4H, m, 2 x CH2), 1.51-1.85 (4H, m, 2 x CH2), 1.99 (lH, ddd, J = 12.8, 
10.3 and 8.5, 4-HA), 2.65 (lH, ddd, J = 12.8, 7.3 and 6.2, 4-HB), 3.75 
(lH, ddd, J = 8.7,7.5 and 3.3, 2-H), 3.89 (lH, dddd, J = 8.5,6.4,6.4 
and 6.2, 5-H) and (lH, ddd, J = 10.3, 7.3 and 3.3, 3-H); Oe (400) 10.23 
(Me), 14.28 (Me), 23.05 (CH2), 23.35 (3-CH), 28.48 (CH2), 29.22 (CH2), 
32.32 (CH2), 44.78 (4-CH2), 79.93 (2-CH) and 86.50 (5-CH); mJz 'lS7 
(1 %, M+-Me), 239 (5), 222 (15), 155 (10) and 125 (100). 
(2SR,3RS)-5,5-Dimethyl-2-ethyl-3-iodotetrahydrofuran (8)) 
(E)-2-Methylhept-5-en-2-ol6i (1 g, 7.8 mmol, 1 eq) was 
iodocyclised exactly as in the preparation of compound 51>, to give 
the iodotetrahydrofuran 8> (1.5 g, 76%) as a colourless oil which 
showed, UMAX 1453,1367, 1182and 1099cm-1 ; ~ ~ (250)0.99 (3H, t, J = 
7.5, CH3), 1.23 (3H, s, CH3), 1.33 (3H, s, CH3), 1.42-1.58 (lH, m, 
CfuHBCH3), 1.76-1.88 (lH, m, CHA&CH3), 2.18 (lH, dd, J = 12.9 
and 9.9,4-HA ), 2.39 (lH, dd, J = 12.9 and 6.9, 4-HB), 3.79 (lH, ddd, J 
= 9.9, 6.9 and 3.4, 3-H) and 4.00 (lH, ddd, J = 8.9, 6.9 and 3.4, 2-H); 
oe (270) 9.76 (Me), 22.51 (4-CH), 24.91 (CH2), 28.75 (Me), 29.46 (Me), 
51.34 (3-CH2) and 81.11 (2-CH); mlz 239 (7%, M+-Me), 225 ( 5 ~ ) , , 1Z7 
(33),98 (100) and 69 (85) [Found: M+-Me, 238.9940. C7H12IO requires 
M, 238.9933]. 
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(±)-2,2-Dimethyl-3-iodotetrahydrofuran (m) 
5-Methylpent-4-en-1-olm (lg, 10mmol, 1 eq)was iodocyclised 
-exactly as in the preparation of compound 5t> to give the 
iodotetrahydrofuran m (1.94 g, 85%) as a colourless oil, ~ A X X 1455, 
1384, 1370, 1246, 1126 and 1038 c m-1; ~ ~ (250) 1.33 (3H, s, CR3), 1.39 
(3H, s, CHa), 2.18-2.46 (lH, m, 4-HA), 2.54-2.67 (IH, m, 4-HB), 3.79-
3.98 (3H, m, 4-H and 2-CH2); oe (270) 25.00 (Me), 26.36 (Me), 31.00 (4-
CH), 37.65 (3-CH2), 65.79 (2-CH) and 82.03 (5'-C); mJz 226 (8%, M+), 
211 (31), 99 (89), 84 (41) and 41 (100) [Found: M+, 225.9850. CSHIOIO 
requires M, 225.9854]. 
(±)-(E)-2-(2'-Hydroxy-7'-phenylhept-4'-enyl)-1,3-dithiane «(E) 
, ~ ~
1# OH 
Lithium aluminium hydride bis-tetrahydrofuran (37.7 ml of 
a 1M solution in toluene, 37.7mmol, 2.6eq)was added to a solution 
of the dithiane 00 (4.45 g, 14.5 mmol, 1 eq) in glyme (80 ml). The 
solution was heated at reflux for 16h and then cooled to RT. Water 
(25 ml) was added very cautiously and the resulting mixture was 
extracted with ethyl acetate (3 x 50 ml). The combined organic 
phases were dried and evaporated to give the alkene fB as a 
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colourless oil (3.71 g, 83 %), l>MAX 3430 (OH), 1313,1147, 1052 and 
1030 cm-I; 0H (250) 1.80-1.82 (2H, m, 5-CH2), 1.85-1.93 (2H, m, 1'-
CH2), 2.05-2.25 (2H, m, 3'-CH2), 2.32-2.40 (2H, m, 6'-CH2), 2.70 (2H, 
t, J = 9.0, 7'-CH2), 2.80-2.97 (4H, m, 4 and 6-CH2), 3.82-3.91 (lH, m, 
2'-H), 4.27 (lH, t, J = 8.0, 2-H), 5.32-5.60 (2H, m, 3' and 4'-H) and 
7.20-7.35 (5H, m, Ph); Oc (270) 25.96 (CH2), 30.02 (CH2), 30.36 (CH2), 
34.40 (CH2), 36.58 (CH2), 40.69 (CH2), 42.01 (CH2), 44.18 (2-CH), 
67.58 (2'-CH), 125.87 (4-CH), 125.87 (CH), 126.03 (CH), 128.32 (CH), 
133.86 (3-CH) and 141.71 (C); rnJz [NH4-CI] 326 (63%, M++NH4), 300 
(MH+, 60), 291 (MH+-H20, 40), 119 (100) and 91 (75) [Found: C, 66.1; 
H, 8.0. CI7H240S2 requires C, 66.2, H, 7.8%]. 
(2RS, 4RS ,5RS)-2-( 1, 3-Dithiane-2-yl methyl) -4-iodo-5-(2-
phenylethyl)tetrahydrofuran (00) and (2'RS,4'RS,5'SR)-(4'-iodo-5'-
phenylethyl-tetrahydrofuran-2'-yl)acetaldehyde ('iU) 
. " 1 1 I ' ~ 0 0
S 
CHO 
....... / 
The alkene fB (1.0 g, 3.24 mmol, 1 eq) was treated exactly as 
in the preparation of compound MIl, to give a brown oil (1.9 g) 
which was chromatographed on silica (eluting with 10% ethyl 
acetate in petrol) to give the iodotetrahydrofuran m as a colourless 
oil (270 mg, 34%), U
MAX 
1602, 1496, 1454, 1422, 1376, 1276, 1144, 1074 
and 1031cm-I; 0H (250) 1.70-1.80 (2H, m, 5'-CH2), 1.82-2.05 (6H, m, 
1-,3- and 6-CH2), 2.47-2.95 (6H, m, 4'-,6'- and 7-CH2), 3.72 (lH, ddd, 
J = 6.2, 4.0 and 3.0, 3-H), 3.95 (lH, td, J = 7.0 and 3.0, 5-H), 4.20 (lH, 
dd, J = 12.0 and 8.0, 2'-H), 4.32 (lH, m, 2-H) and 7.15-7.30 (5H, m, 
Ph); oe (270) 21.75 (CH2), 29.98 (CH2), 30.32 (CH2), 31.93 (CH), 32.24 
(CH2), 33.67 (CH2), 41.71 (CH2), 44.05 (4-CH), 44.58 (CH2), 66.39 (2'-
-CH), 74.57 (2-CH), 85.23 (5-CH), 125.80 (CH), 128.30 (CH), 128.36 
(CH) and 141.60 (C); and also the aldehyde 70 (100 mg, 15%) as a 
colourless oil which showed, 0H (250) 1.75 (lH, ddd, J = 13.0,4.7 and 
3.5,3'-H), 2.05 (lH, ddd, J = 13.0,6.0 and 2.1, 3-H), 2.70-2.90 (6H, m, 
2-, 6- and 7-CH2), 3.73 (lH, ddd, J = 6.2, 4.0 and 3.0, 4'-H), 4.03 (lH, 
dd, J = 7.0 and 3.0, 5'-H), 4.42-4.52 (lH, m, 2'-H) and 7.15-7.30 (5H, 
m, Ph). 
(±)-(Z)-Methyl 3-hydroxydec-5-enoate (71) 
The alkyne m (430mg, 2.1 mmol) was reduced exactly as in 
the preparation of compound 147, to give the alkene 71 as a pale 
yellow oil (410 mg, 97%), 'l>MAX 3442 (OH), 1736 (C=O), 1438,1163 and 
1060 cm-I ; 0H (250) 0.90 (3H, t,J = 7.1, 10-CHa), 1.27-1.40 (m, 6H,3 x 
CH2), 2.0-2.1 (2H, m, 7-CH2), 2.20-2.37 (2H, m, 4-CH2), 2.45 (lH, dd, 
J = 16.2 and 8.7, 2-CHAHB), 2.76 (lH, dd, J = 16.2 and 3.8, 2-
CHAHB), 3.25 (lH, br, OH), 3.71 (3H, s, OMe), 4.01-4.09 (lH, m, 3-
CH), 5.35-5.42 (lH, m, 5-CH) and 5.55-5.60 (lH, fi, 6-CH); oe (270) 
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14.23 (10-Me), 22.63 (CH2), 27.41 (CH2), 32.02 (CH2), 34.65 (4-CH2), 
40.72 (2-CH2), 52.01 (OMe), 68.25 (3-CH), 124.40 (5-CH), 133.80 (6-
CH) and 173.55 (C=O); mJz 182 (6%, M + - H ~ ) , , 103 (100), 71 (95),61 
(44) and 55 (95) [Found: M+-H20, 182.2469. CllHIS0 2 requires M, 
182.2469]. 
(2'SR,4'RS,5'SR) Methyl (5'-butyl-4'·hydroxytetrahydrofuran.2'. 
yl)acetate (72) 
HO" 
". C ~ M e e
Bu 
The alkene 71 (1. 75g, 8.75 mmol, 1 eq) was iodocyclised 
exactly as in the preparation of compound 148, to give the hydroxy· 
tetrahydrofuran 72 as a colourless oil (1.80 g, 95%), l>MAX 3500 (OH) 
and 1738 (C=O) cm-I ; 0H (250) 0.90 (3H, t, J = 6.3, Me), 1.1-1.5(6H, 
m, 3 x CH2), 1.76 (lH, ddd, J = 12.7, 9.6 and 6.1, 3'-CH), 1.97 (lH, 
ddd, J = 12.7, 6.6 and 3.9, 3'-CH), 2.50 (IH, dd, J = 15.6 and 6.2, 2-
CHA CHB), 2.62 (lH, dd, J = 15.6 and 6.9, 2-CHA CHB), 3.75 (3H, s, 
OMe), 3.85 (lH, td, J = 6.3 and 3.1, 5'-CH), 4.01 (IH, ddd, J = 6.6,6.1 
and 3.1, 4'-CH) and 4.49 (lH, dddd, J = 9.6,6.9,6.2 and 3.9, 2'·CH); 
Oc (270) 13.99 (Me), 22.71 (CH2), 27.96 (CH2), 34.10 (CH2), 40.78 (2-
CH2), 51.69 (OMe), 73.90 (2'-CH), 76.28 (4'·CH), 87.10 (5'·CH) and 
171.62 (C=O); mJz 198 (2%, M+·H20), 130 (19), 117 (18), 98 (100) and 
57 (61) [Found: M+-H20, 198.2640. CllH IS0 3 requires M, 198.2643]. 
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(I)-Methyl 6-methyl-3-oxahept-6-enoate (8) 
o 
1,1'-Carbonyldiimidazole (4.36 g, 27 mmol, 1.01 eq) was added 
to a stirred solution of 4-methylpent-3-enoic acid 81 (3.0 g, 26mmol, 
1.0 eq), prepared following the procedure of Smith,88 in 
tetrahydrofuran (20 mI) and the resulting solution was stirred for 
16h at RT. The resulting solution was then added dropwise to the 
magnesium chelate form of the methyl hydrogen malonate 
dianion (27 ml of a 1M solution in tetrahydrofuran, 27 mmol, 1eq). 
The resulting mixture was stirred for 24h and saturated aqueous 
ammonium chloride was added (50 mI). The resulting solution 
was extracted with ethyl acetate (3 x 100 ml) and the combined 
organic phases were washed with saturated aqueous sodium 
bicarbonate (50 mI) and brine (50 mD, dried and evaporated to give 
a brown oil (2 g) which was chromatographed on silica (eluting 
with 15% ethyl acetate in petroI), to give the keto-ester 8) as a 
colourless oil (1.05 g, 45%), which showed, UMAX 1750 (C=O), 1438, 
1377 and 1108 cm-1; OH (250) 1.38 (6H, d, J = 9.0, 2 x CH3), 1.65-1.80 
(2H, m, 4-CH2), 2.41-2.60 (2H, m, 2-CH2), 3.75 (3H, s, OMe) and 
5.10-5.15 (lH, m, 5-H); Oe (400) 25.61 (Me), 29.20 (Me), 30.71 (4-CH2), 
45.23 (2-CH2), 51.54 (OMe), 125.39 (5-CH), 131.95 (6-C), 173.61 (C=O) 
and 200.91 (C=O); m/z 170 (2%, M+), 143 (46), 101 (39),97 (69) and m 
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(100). 
(I)-Methyl 3-hydroxy-6-methylhept-6-enoate ( ~ ) )
OR 
Butylamine-borane complex (502 mg, 10, mmol, 1.05 eq) was 
added to a stirred solution of the keto-ester 8) (1.7 g, 10 mmol, 1 eq) 
and 1M citric acid (7ml) in methanol (30 ml) and the resulting 
solution was stirred for 1h at RT. The solution was then diluted 
with water (30 ml) and extracted with ether (3 x 100 ml). The 
combined organic phases were dried and evaporated to give a 
brown oil (1.9 g), which was chromatographed on silica (eluting 
with 20% ethyl acetate in hexane) to give the hydroxy-ester ~ ~ as a 
colourless oil (1.37 g, 80%), UMAX 3490 (OH), 1744 (C=O) and 1643cm-
1; ~ ~ (250) 1.64 (6H, d, J = 4.6, 2 x CH3), 2.20-2.43 (2H, m, 4-CH2), 
2.46 (2H, dd, J = 15.1 and 8.7, 2-CfuHB), 2.51 (2H, dd, J = 15.1 and 
6.3, 2-CHA&), 3.72 (3H, s, OMe), 4.02-4.05 (lH, m, 3-H) and 5.23-
5.24 (lH, m, 5-H); Oe (400) 25.64 (Me), 29.30 (Me), 31.57 (4-CH2), 
42.10 (2-CH2), 51.59 (OMe), 63.91 (3-CH), 126.00 (5-CH), 131.49 (6-C) 
and 172.59 (C=O); m/z 172(1%, M+), 154(30),101(100), 70 (64) and 55 
(43). 
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(2'SR,4 'SR) Methyl (5',5' -dimethyl-4' -iodotetrahydrofuran-2'-
yl)acetate (SJ) 
The hydroxy-ester 82 (150 mg, 0.9 mmol, 1 eq) was 
iodocyclised exactly as in the preparation of compound 51>, to give 
the iodo-tetrahydrofuran SJ as a colourless oil (160 mg, 59%) which 
showed, UMAX 1462, 1384,1164 and 1023 cm-1; ~ ~ (250) 1.64 (3H, s, 
eH3), 1.40 (3H, s, eH3), 1.83-1.91 (lH, m, 3-HA ), 2.22 (lH, ddd, J = 
13.0 and 10.8, 9.1, 3'-HB),2.53 (lH, dd, J = 15.4, and 6.7, 2-HA), 2.65 
(lH, dd, J = 15.4, and 6.5, 2-HB)' 3.69 (3H, s, OMe), 4.02 (lH, dd, J = 
10.8 and 6.8, 4'-HB) and 4.33 (lH, dddd, J = 9.1,6.7,6.7 and 6.5,2'-
H); oe (400) 25.66 (Me), 29.23 (Me), 29.96 (4'-eH), 41.58 (3'-CH2)' 
43.66 (4-eH2), 51.79 (OMe), 73.93 (2'-eH), 82.74 (5'-C) and 171.46 (6-
e). 
(::t;)-2-(2' -Hydroxy-7'-phenylhept-4'-ynyl)-1,3-dithiane (00) 
A solution of 4-phenylbutyne (6.67 g, 0.05 mol,1.5 eq) in tetra-
hydrofuran (60 ml) was alkylated exactly as in the preparation of 
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146 with 2-(2,3-epoxypropan-1-yl)-1,3-dithiane 8J (6.02g, 0.033 mol, 
1.0 eq), prepared by the method of Seebach, 103 to give a yellow oil (9 
g), which was chromatographed on silica (eluting with 10% ethyl 
acetate in petro!), to give, as a pale yellow oil, the dithiane 90 (5.8 g, 
55%), UMAX 3437 (OH), 1453,1423,1276,1075 and 1(3) cm- l ; BH (250) 
"1.85-1.95 (2H, m, 5-CH2), 2.10-2.20 (2H, m, l'-CH2), 2.30 (lH, ddt, J = 
14.7, 6.3 and 2.0,3'-CIiAHB), 2.40 (lH, ddt, J = 14.7,4.0 and 2.0, 3'-
CHA&), 2.48 (2H, tt, J = 9.0 and 2.0, 6'-CH2), 2.81 (2H, t, J = 9.0, 7'-
CH2), 2.85-2.94 (4H, m, 4 and 6-CH2), 3.95-4.03 (lH, m, 2'-H), 4.25 
(lH, dd, J = 11.0 and 9.2, 2-H) and 7.20-7.35 (5H, m, Ph); Be (270) 
20.85 (CH2), 25.89 (CH2), 27.65 (CH2), 29.84 (CH2), 30.22 (CH2), 35.14 
(CH2), 41.47 (CH2), 43.86 (2'-CH), 66.75 (2-CH), 76.37 (4'-C), 82.70 (3'-
C), 126.25 (CH), 128.36 (CH), 128.38 (CH) and 140.62 (C); mJz [NH4-
CI] 324 (100%, M+ + NH4), 307 (MH+, 90), 199 (87), 161 (65) and 119 
(91), [Found: C, 66.3; H, 7.3; S, 20.5. C17H220S2 requires C, 66.6; H, 
7.2; S, 20.9%]. 
(±)-(E)-3-Hydroxy-B-phenyloct-5-enal (91) 
CHO 
Methyl iodide (4.4 ml, 70.2 mmol, 8 eq) was added to a 
• LXJ (271 8 8 mmol 1 eq) and sodium suspenSIon of the alkene {U • g,. , 
70 2 I 8 eq) in acetone (300 ml) and hydrogencarbonate (5.9 g, . mmo, 
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water (15 mI). The resulting suspension was refluxed for 5h. 
Further portions of methyl iodide were added, until the reaction 
was complete by tic., water (500 ml) was added, and the cooled 
mixture extracted with ethyl acetate (3 x 300 ml). The combined 
organic phases were dried and evaporated to give an oil (1.6 g), 
'which was chromatographed on silica (eluting with 40% ethyl 
acetate in petroI), to give the aldehyde 91 (1.6 g, 87%) ~ A X X 1721 
(C=O) cm-\ OH (250) 2.12-2.21 (2H, m, 4-CH2), 2.30-2.41 (2H, m, 7-
CH2), 2.47-2.50 (2H, m, 2-CH2), 2.62-2.73 (2H, m, 8-CH2), 4.05-4.12 
(IH, m, 3-H), 5.30-5.60 (2H, m, 5- and 6-H), 7.15-7.31 (5H, m, Ph) 
and 9.80 (IH, t, J = 0.7, I-H); oe (270) 34.42 (CH2), 35.67 (CH2), 40.33 
(CH2), 40.95 (CH2), 68.04 (3-CH), 125.76 (5-CH), 128.45 (CH), 128.56 
(CH), 128.95 (CH), 134.67 (6-CH), 141.54 (C) and 200.14 (C=O). 
(:!:;)-(E)-Methyl 3-hydroxy-B-phenyloct-5-enoate (W) 
Pyridinium dichromate (2.27 g, 6 mmol, 6 eq) was added to a 
solution of the aldehyde 91 (218 mg, 1 mmol, 1 eq) in dimethyl-
formamide (2 ml) and methanol (2.0 ml, 6 mmol, 6 eq).105 The 
resulting suspension was stirred for 16h before being diluted with 
water (100 mI) and extracted with ether (3 x 25 mI). The combined 
organic phases were dried and evaporated to give an oil (300 mg) 
which was chromatographed on silica (eluing with 40% ethyl 
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acetate in petrol) to give, as a colourless oil, the methyl ester 92 (170 
mg, 69%) 'l>MAX 1737 (C=O) cm-1; 0H (250) 2.14 (2H, t, J = 6.5, 7-CH
2
), 
2.31 (lH, dd, J = 16.5 and 8.0, 2-CfiAHB ), 2.35 (2H, m, 4-CH2), 2.63 
(2H, t, J = 6.5, 8-CH2), 2.67 (lH, dd, J = 16.5 and 3.3, 2-CHAHa), 3.65 
(3H, s, OMe), 3.91-3.93 (lH, m, 3-H), 5.27-5.55 (2H, m, 5- and 6-H) 
'and 7.09-7.25 (5H, m, Ph); oe (270) 34.43 (CH2), 35.79 (CH2), 39.63 
(CH2), 40.44 (CH2), 51.79 (OMe), 67.71 (3-CH), 125.89 (CH), 128.36 
(CH), 128.53 (CH), 134.54 (C), 141.80 (CH) and 173.22 (C=O); mJz 2.'J) 
(15%, M+-H20), 199 (27), 146 (40) 134 (30) and 91 (100) 
(2'SR,4'RS,5'SR) Methyl (5'-butyl-4'-tbutyldimethylsilyloxy-
tetrahydrofuran-2'-yl) acetate (138) 
TBDMSOI. 
'-.. 
Bu 
Imidazole (1.79 g, 26 mmol, 2.5 eq) was added to a stirred 
solution of the hydroxytetrahydrofuran 72 (2.22 g, 10.5 mmol, 1 eq) 
and tbutyldimethylsilyl chloride (3.95 g, 26 mmol, 2.5 eq) in dry 
dimethylformamide (12 ml). The resulting solution was stirred at 
RT for 72h. Water (200 ml) was added and the resulting solution 
was extracted with hexane (3 x 80 ml). The combined organic 
phases were dried and evaporated to give an oil (5 g), which was 
chromatographed on silica (eluting with 5% ethyl acetate in petrol) 
to give the silyloxytetrahydrofuran 138 as a colourless oil (4.2 g, 
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54%), 1>MAX 1738 (C=O); ~ H H (250) 0.05 (6H, m, 2 x MeSi), 0.85 (9H, s, 
tBuSi), 0.9 (3H, t, J = 6.4, Me), 1.23-1.50 (6H, m, 3 x CH2), 1.71 (lH, 
ddd, J = 12.7,9.2 and 6.4, 3'-CH), 1.97 (IH, ddd, J =12.7,5.9 and 2.7, 
3'-CH), 2.45 (IH, dd, J = 15.2 and 6.4, 2-CIiA CHB), 2.60 (lH, dd, J = 
15.2 and 6.6, 2-CHAC&), 3.75 (3H, s, OMe), 3.6-3.7 (lH, td, J = 6.4 
and 3.1, 5'-CH), 3.95 (IH, ddd, J = 6.4, 5.9 and 3.1, 4'-CH) and 4.42 
(IH, dddd, J = 9.2, 6.6, 6.4 and 2.7, 2'-CH); Be (270) -4.58 (MeSi), 
-4.78 (MeSi), 13.95 (Me), 17.91 (MesCSi), 22.70 (CH2), 25.73 (tBu), 
28.00 (CH2), 33.77 (CH2), 40.60 (3'-CH2), 41.06 (2-CH2), 51.57 (OMe), 
73.84 (CH), 76.53 (CH), 86.88 (5'-CH) and 171.55 (C=O); mlz 2S1 
(47%, M+-tBu), 187 (37),173 (87), 147 (100) and 89 (52) 
(2' SR,4 'RS,5' SR)-5' -Butyl-4' _t butyldimethylsilyloxytetrahydro-
furan-2'-yl) acetaldehyde (139) 
TBDMSO" 
". CHO 
Bu 
Diisobutylaluminium hydride (3.7 ml of a 1.0 M solution in 
hexanes, 3.7 mmol, 1 eq) was added to a solution of the 
silyloxytetrahydrofuran 138 (1.17 g, 3.7 mmol, 1 eq) in hexane (2 
ml) at -78°C, and the resulting solution was stirred at this 
temperature for 2h. Methanol (2 ml) was then added and after 10 
min, 2M hydrochloric acid (20 mI). The resulting mixture was 
extracted with ethyl acetate (3 x 50 ml) and the combined organic 
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phases dried and evaporated. The resulting oil (1.1 g) was 
chromato-graphed over silica (eluting with 5% ethyl acetate in 
hexane) to give the aldehyde 139 as a colourless oil (400 mg, 38%), 
'l>MAX 1735 (C=O); 0H (250) 0.10 (6H, 2 x MeSi), 0.90 (12H, m, tBu), 1.2-
1.5 (6H, m, 3 x CH2), 1.72 (1H, ddd, J = 12.7,9.0 and 6.3, 3'-CH), 1.95 
"(1H, ddd, J = 12.7,5.7 and 2.4, 3'-CH), 2.61 (lH, dd, J = 10.2 and 5.6, 
2-Cfu CHB ), 2.63 (1H, dd, J = 10.2 and 3.4, 2-CHA CHB), 3.68 (lH, td, 
J = 6.3 and 3.2, 5'-CH), 3.98 (1H, ddd, J = 6.3, 3.2 and 2.4, 4'-CH), 
4.51 (1H, dddd, J = 9.0, 5.7, 5.6 and 3.4, 2'-CH) and 9.55 (lH, s, 
CHO); oe (270) -4.62 (MeSi), -4.81 (MeSi), 13.91 (Me), 17.90 (Me3CSi), 
22.63 (CH2), 25.70 (tBu), 28.02 (CH2), 33.73 (CH2), 41.28 (3'-CH2), 
49.29 (2-CH2), 72.62 (CH), 76.48 (CH), 87.05 (5'-CH) and 201.13 
(C=O); m/z 286 (13%, M+-Me), 216 (100), 173 (87),99 (50) and 75 (52). 
, 
(2'SR,4'RS,5'SR)-5'-Butyl-4- tbutyldimethylsilyloxytetrahydro-furan-
2' -yl) acetic acid (141) 
TBDMSO" 
I •• COOH 
Bu 
Trifluoroacetic anhydride (0.12 ml, 87 mmol, 2.5 eq) was 
·d 91 
added dropwise to a stirred solution of urea-hydrogen perOXl e 
(0.325 g, 3.46 mmol, 10 eq), disodium hydrogen phosphate (Q.368g, 
8.7 eq, 2.7 mmol) and the aldehyde 139in dichloromethane (2.2 ml). 
The resulting suspension was refluxed for 1h and then poured into 
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saturated aqueous sodium carbonate (10 mI). The resulting 
mixture was then neutralised with 1M hydrochloric acid (5 ml) 
and extracted with dichloromethane (3 x 2> ml), and the combined 
organic phases were dried and evaporated. The acid 141 was 
obtained as a pale yellow oil (70 mg, 66%), ~ A X X 3400 (OH) and 1712 
'(C=O); 0H (250)0.02 (6H, 2 x MeSi), 0.82 (12H, s, tBu), 1.15-1.40 (6H, 
m, 3 x CH2), 1.81 (lH, ddd, J = 12.8,9.6 and 6.0, 3'-CH), 2.02 (lH, 
ddd, J = 12.8, 5.8 and 2.3, 3'-CH), 2.65 (2H, d, J = 5.6, 2-CH2), 3.91 
(lH, td, J = 6.3 and 2.9, 5'-CH), 4.06 (lH, ddd, J = 6.0,2.9 and 2.3,4'-
CH) and 4.48 (lH, dddd, J = 9.6, 5.8, 5.6 and 5.6, 2'-CH); Oc (270)-
4.56 (MeSi), -4.78 (MeSi), 13.96 (Me), 17.95 (Me3CSi), 22.70 (CH2), 
25.75 (tBu), 28.03 (CH2), 33.78 (CH2), 40.54 (2-CH2), 41.04 (3'-CH2)' 
73.80 (CH), 76.44 (CH), 87.24 (5'-CH) and 175.01 (C=O); m/z 259 
(47%, M+-tBu), 187 (100), 131 (60), 75 (60) and 57 (70) [Found: M+-tBu, 
259.1289. C12H2304Si requires M, 259.1366]. 
(2'SR,4'RS,5'SR)-2-Aminomethyl-5-butyl-4-hydroxytetrahydro-
furan (142) 
HQ, 
I, 
'. N ~ ~
Bu 
Triethylamine (0.032 ml, 0.23 mmol, 1 eq) was added to a 
'd 141 (63 023 mmol 1 eq) in dry toluene (5 solution of the act mg,. , 
ml) and diphenylphosphoranyl azide (0.049 ml, 0.23 mmol, 1 eq) 
was added. The resulting solution was slowly warmed to 80°C and 
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stirred at this temperature for 2h. The solution was then cooled to 
RT, water (5 ml) was added and the mixture was stirred for a 
further 16h at this temperature. The resulting mixture was 
extracted with chloroform (3 x 10 ml) and the combined organic 
phases were dried and evaporated to give a brown oil (70 mg). The 
. oil was chromatographed on silica (eluting with 50% ethyl acetate 
in hexane) to give the amino-alcohol 142 as a pale yellow oil (16 mg, 
38%),1>MAX 3530 (NH2/0H); 0H (250)0.85 (3H, t, J = 6.6, Me), 1.20-1.50 
(6H, m, 3 x CH2), 1.73 (lH, ddd, J =13.3, 9.6 and 6.2, 3-CH), 1.82 (lH, 
ddd, J = 13.3, 6.2 and 2.7, 3-CH), 3.18 (lH, dd, J = 14.0, and 6.1 
CfuHBNH2), 3.49 (lH, dd, J = 14.0, and 6.2 CHA&NH2), 3.66 (lH, 
td, J = 6.6 and 3.1, 5-CH), 4.02 (lH, ddd, J = 6.2, 6.2 and 3.1, 4-CH) 
and 4.16 (lH, dddd, J = 9.6,6.1, 6.2 and 2.7, 2-CH); oe (270) 13.98 
(Me), 22.64 (CH2), 28.02 (CH2), 33.95 (CH2), 37.68 (CH2NH2), 44.44 
(3-CH2), 76.13 (CH), 76.29 (CH) and 86.97 (5-CH); mlz 173 (5%, M+), 
143 (100), 99 (66), 81 (87) and 69 (58) 
195 
(B)-Methyl 3,4,-epoxybutanoate ( ~ ) )
The epoxide ~ ~ was obtained in quantities from 0.5-2.5g 
following exactly the methods of Larcheveque et al. 93 for the 
preparation of the corresponding ethyl epoxy-ester from (S)-malic 
acid the epoxide ~ ~ showed, [a]n = -11.0 [c, 1.3 (CH2CI2)]. Oit) [a]o = 
+10.7 [c, 1.8 (CHCI3)].; the intermediate iodohydrin 116 showed, 
UMAX 3471 (OH), 1732, 1434 and 1372 cm-1; 0H (250) 2.54 (lH, dd, J = 
16.3 and 7.9, 4-CHAHBI), 2.65 (lH, dd, J = 16.3 and 4.3, 4-CHAHBl), 
3.24 (lH, dd, J = 14.4 and 10.3, 2-CHAHB), 3.24 (lH, dd, J = 14.4 and 
5.7, 2-CHAHB), 3.67 (3H, s, OMe) and 3.9-4.1 (lH, m, 3-CH); oe (270) 
12.20 (4-CH2), 40.83 (2-CH2), 51.30 (OMe), 67.49 (3-CH) and 171.79 
(CH); mJz 226 (5%, M+- H20), 117 (100), 99 (18), 85 (25) and 71 (22) 
[Found: M+-H20, 225.9507. CSH7I02 requires M, 225.9490]; [a]o = -
196 
(R)-Methyl 3-hydroxyhept-5-ynoate (146) 
Propyne (-8 ml) was condensed under an atmosphere of 
nitrogen, dissolved in dry tetrahydrofuran (60 ml), and the solution 
-cooled to -78°C before butyl lithium (21.5 ml of a 1.6M solution in 
hexanes, 34.4 mmol, 1.5 eq) was added. The resulting solution was 
stirred for 0.5 h at this temperature and then boron trifluoride 
etherate (2.83 ml, 23.0 mmol, 1.0 eq) was added. After a further 10 
min at -78°C, (S)-methyl 3,4,-epoxybutanoate 8i (2.64 g, 23 mmol, 
1.0 eq) was added. The mixture was stirred at this temperature for 
4h and then poured into saturated aqueous ammonium chloride 
(200 ml). The resulting mixture was extracted with ethyl acetate 
(3 x 50 ml), and the combined organic phases were dried and 
evaporated to give a pale yellow oil (4.4 g), which was 
chromatographed on silica (eluting with 15% ether in petrol) to 
give the alkyne 146 as a pale yellow oil (2.9 g, 80%), UMAX 3452 (OH), 
2221, 1736(C=O), 1672, 1439, 1162 and 1059 cm- l ; 0H (250) 1.79 (3H, t, 
J = 2.6, 7-CH3)' 2.38-2.40 (2H, m, 4-CH2), 2.47 (lH, dd, J = 16.2 and 
8.6, 2-CHAHB), 2.71 (lH, dd, J = 16.2 and 3.8, 2-CHAHB), 3.71 (3H, s, 
OMe) and 4.12-4.20 (lH, m, 3-CH); oe (270) 3.22 (7-Me), 26.54 (4-
CH2), 39.91 (2-CH2), 51.56 (OMe), 66.65 (3-CH), 74.31 (5-C), 78.35 (6-
C) and 172.67 (C=O); rn/z 138 (7%, M +-H20), 103 (100), 81 (15), 71 (56) 
and 61 (22) [Found: M+-H20, 138.0685. CaHI002 requires M, 
138.0681]; [a]n = -13.16 [c, 7.1 (CH2CI2)] . 
197 
(R)-(Z)-Methyl 3-hydroxyhept-5-enoate (147) 
5% Palladium on barium sulphate (63.2 mg) was suspended 
in dry ethyl acetate (2.1 ml) and quinoline (58J.1.l) was added.s2 The 
suspension was stirred for 10 min before the acetylene 146 (329 mg, 
2.1 mmol) in ethyl acetate (2.1 ml) was added. The mixture was 
stirred in the dark under an atmosphere of hydrogen until no 
more gas was absorbed (O.75h) and then filtered through celite. 
The filtrate was washed with 1M hydrochloric acid (10ml), 
saturated aqueous sodium bicarbonate (10 ml) and brine (10 ml), 
before being dried and evaporated to give the alkene 147 as a pale 
yellow oil (290 mg, 87%), UMAX 3417 (OH), 1732 (C=O), 1438, 1371, 
1259,1202, 1163 and 1058 cm-I ; 0H (250) 1.84 (3H, dd, J = 7.3 and 0.5, 
7-CH3), 2.40 (2H, m, 4-CH2), 2.52 (lH, dd, J = 16.2 and 8.7, 2-
CHAHB), 2.76 (lH, dd, J = 16.2 and 3.9, 2-CHAHB), 3.25 (IH, d, J = 
4.2, OH), 3.73 (3H, s, OMe), 4.15 (lH, m, 3-CH), 5.43 (IH, m, 5-CH) 
and 5.64 (lH, m, 6-CH); oe (270) 12.99 (7-Me), 34.16 (4-CH2), 40.70 
(2-CH2), 51.77 (OMe), 68.01 (3-CH), 125.41 (5-CH), 127.15 (6-CH) and 
173.29 (C=O); mJz 140 (11 %, M-H20), 103 (100), 81 (22), 71 (95) and 61 
(41) [Found: M+-H20, 140.0846. CSH I202 requires M, 140.0837]; [a]o 
= -22.70 [c, 2.7 (CH2C12)]· 
1.98 
(2'R,4'S,5'R)-Methyl (5'-methyl-4'-hydroxytetrahydrofuran_2'_yLJ 
acetate (148) 
Sodium hydrogencarbonate (810 mg, 9.6 mmol, 3 eq) was 
added to an ice-cold solution of the alkene 147 (450 mg, 3.2 mmol, 
1 eq) in dry acetonitrile (7 mI) and the suspension stirred for 5 
mins. Iodine (2.44 g, 9.6 mmol, 3eq) was added and the resulting 
mixture was stirred at 0-5°C, in the dark, for 72 h. Ether (10 mI) 
was added and the solution was washed with saturated aqueous 
sodium thiosulphate (120 mI). The separated aqueous phase was 
extracted with ether (3 x 50 mI). The combined organic phases 
were dried and evaporated to give the hydroxytetrahydrofuran 148 
as a colourless oil (350 mg, 63 %), UMAX 3402 (OH) and 1734 (C=O), 
1653, 1440, 1371, 1163 and 1078 c m-1; 0H (250) 1.27 (3H, d, J = 6.4, 5'-
CH3), 1.87 (lH, ddd, J = 13.2, 9.4 and 6.4, 3'-CH), 2.02 (lH, ddd, J 
=13.2,6.0 and 2.6, 3'-CH), 2.52 (lH, dd, J= 15.6 and 6.2, 2-CHA CHB), 
2.66 (lH, dd, J= 15.6 and 6.9, 2-CHA CHB), 3.69 (3H, s, OMe), 3.87 
(lH, qd, J = 6.4 and 3.4, 5'-CH), 4.00-4.03 (lH, ro, 2'-CH) and 4.47 
(lH, ddd, J = 9.4, 6.0 and 3.4, 4'-CH); Oc (270) 19.75 (5'-Me), 40.47 (3'-
CH2), 40.68 (2-CH2), 51.74 (OMe), 73.99 (2'-CH), 77.21 (4'-CH), 82.08 
(5'-CH) and 173.29 (C=O); mJz 156 (5%, M +-H20), 101 (51), 98 (100), 
74 (57) and 57 (61) [Found: M+-H20, 156.0791. CSH120 3 requires M, 
156.0786]; [ex]n = +14.8 [c, 0.4 (CH2CI2)]· 
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(2 'R,4 'S,5'R)-Methyl (5'-methyl-4 '-triisopropylsilyloxy-tetrahydro-
furan-2'-yl) acetate (150) 
TIPSUtI : C02Me 
. . ... ,"/ 
...... 0 
~ ~
2,6-Lutidine (154 mg, 1.44 mmol, 2.5 eq) was added to a 
solution of the hydroxytetrahydrofuran 148 (100 mg, 0.57 mmol, 
1 eq) in dry dichloromethane (0.63 ml) maintained at O°C. 
Triisopropylsilyl trifluoromethanesulphonate (0.23 ml, 0.86 mmol, 
1.5 eq) was added dropwise and the resulting mixture stirred at 
O°C for 3 h. Brine (20 ml) was added and the resulting mixture 
extracted with dichloromethane (2 x 25 ml). The combined organic 
phases were dried and evaporated to give a colourless oil (360 mg) 
which was chromatographed on silica (eluting with 7% ethyl 
acetate in petrol) to give the silyloxytetrahydrofuran 150 as a clear 
oil (140 mg, 74%), UMAX 1729 (C=O), 1464,1382,1268,1163, 1108 and 
1040 cm-!; 0H (250) 1.09-1.11 (21R, m, TIPS) 1.27 (3H, d, J = 6.4, 5'-
CR3), 1.80 (lH, ddd, J = 13.6, 9.3 and 6.4,3'-CH), 2.05 (lH, ddd, J = 
13.6, 5.9 and 2.7, 3'-CR), 2.54 (lH, dd, J = 15.3 and 6.6, 2-Cfu CHB), 
2.65 (lH, dd, J = 15.3 and 6.4, 2-CRACHB), 3.67 (3H, s, OMe),3.85 
(lR, qd, J = 6.4 and 3.1, 5'-CR), 4.05 (lR, ddd, J = 6.4, 3.1 and 2.7,4'-
CH) and 4.50 (lH, dddd, J = 9.3 6.6, 6.4 and 5.9, 2'-CH); oe (270) 
12.04 (6 x Me, TIPS), 17.92 (3 x CR, TIPS), 19.87 (5'-Me), 40.60 (3'-
CH
2
), 41.24 (2-CH2), 51.63 (OMe), 74.11 (2'-CH), 78.17 (4'-CH), 83.36 
ax> 
(5'-CH) and 171.50 (C=O); mJz 287 (14%, M +.iPr), 187 (100), 113 (21), 
103 (31) and 75 (35) [Found: M+.iPr, 287.1669. CI4R2704Si requires 
M, 287.1679]; [a]n = +16.2 [c, 1.6 (CR2C12)]. 
(2 'R,4 'S,5'R) -(5' -Methyl-4' -triisopropylslyloxytetrahydrofuran-2'-
yl)acetic acid (152) 
Potassium hydroxide (2.04 g, 36.4 mmol, 8 eq) was added to a 
solution of the methyl ester 150 (1.5 g, 4.4 mmol, 1 eq) in methanol 
(18.2 mI). The resulting solution was stirred at room temperature 
for 16h. The solvent was removed under vacuum, the oil obtained 
was dissolved in water, and the solution washed with ether (25 
mI). 2M Hydrochloric acid (16 ml) was added to the solution which 
was then extracted with chloroform (3 x 50 mI). The combined 
organic phases were dried and evaporated to give the acid 152 as a 
clear oil (1.40 g, 97%), UMAX 3368 (OH), 1717 (C=O), 1507,1419,1163, 
1109 and 1040 em-I; 8H (250) 1.03-1.05 (21R, m, TIPS), 1.20 (3R, d, J 
= 6.2, 5'-CH3)' 1.80 (lH, ddd, J = 12.8, 9.6 and 6.0, 3'-CH), 2.02 (lH, 
ddd, J = 12.8, 5.8 and 2.3, 3'-CH), 2.65 (2H, d, J = 6.3, 2-CH2), 3.91 
(lH, qd, J = 6.2 and 2.9, 5'-CH), 4.06 (lH, ddd, J = 6.0, 2.9 and 2.3,4'-
CH) and 4.48 (lH, dddd, J = 9.6, 6.3, 6.3 and 5.8, 2'-CH); 86 (270) 
12.51 (6 x CH3-TIPS), 18.45 (3 x CH-TIPS), 20.38 (5'-Me), 40.90 (3'-
CH
2
), 41.69 (2-CH2), 74.45 (2'-CH), 78.56 (4'-CH), 84.29 (5'-CH) and 
an 
175.97 (C=O); mJz 317(11%, M+), 273(24%, M+JPr), 187(100),131 
(58) and 75 (64) [Found: M+_iPr, 273.1517. C13H2S04Si requires M, 
273.1522]; [a]n = +17.1 [c, 1.0 (CH2C12)]. 
(2' SR,4' RS,5' SRJ-2 -Aminomethyl-5-methyl-4-triisopropylsilyl_ 
oxytetrahydrofuran (lm) 
TIPSO, 
I, 
.. NH2 
Me 
The acid 152 (130 mg, 0.41 mmol) was treated exactly as in the 
preparation of the amine 142, to give a brown oil (300 mg), which 
was chromatographed on silica (eluting with 30% ethyl acetate in 
hexane) to give the amine 153 as a pale yellow oil (l06 mg, 90%), 
UMAX 3430 (NH2); 0H (250) 1.10 (21H, m, TIPS), 1.27 (3H, t, J = 6.4, 5-
Me), 1.73 (lH, ddd, J = 13.1, 9.4 and 6.2, 3-CH), 1.82 (lH, ddd, J = 
13.1, 6.1 and 2.7, 3-CH), 3.18 (lH, ddd, J = 14.0 and 6.1, 
CHAHBNH2), 3.49 (lH, dd, J = 14.0,and 6.4, CHAHBNH2), 3.66 (lH, 
td, J = 6.4 and 3.1, 5-CH), 4.02 (lH, ddd, J = 6.2,6.1 and 3.1, 4-CH) 
and 4.16 (lH, dddd, J = 9.4, 6.4,6.1 and 2.7, 2-CH); 0e (270) 12.02 (5-
Me), 17.90 (6x Me-TIPS), 19.84 (3x CH-TIPS), 37.95 (3-CH2), 44.42 
(CH2NH2), 76.52 (CH), 78.11 (CH) and 83.88 (5-CH); mlz 234 (5%, 
M +_iPr), 143 (100), 81 (93), 57 (70) and 49 (32). 
al2 
(2SR,4RS,5SR)-2-Chloromethyl-5-methyl-4-triisopropylsilyl-
oxytetrahydrofuran (100) 
T I P S ~ ~ Cl 
.... l)·· .. ..1 
\\\" 0 
The racemic acid 152 (100 mg, 0.32 mmol, 1 eq) was dissolved 
in dry benzene (5 ml) and the resulting solution was cooled to O°C 
before pyridine (1 drop) and dimethylformamide (1 drop) were 
added. The resulting solution was stirred during the dropwise 
addition of oxalyl chloride (0.15 ml, 0.32 mmol, leq) and stirring 
was continued for a further 3h. The solvent was then removed in 
vacuo. The crude oil thus obtained was azeotroped with dry 
benzene (5 ml) before being dissolved in dry carbon tetrachloride (3 
ml) and added to a refluxing suspension of 2-mercaptopyridine-N-
oxide sodium salt (57 mg, 0.38 mmol, 1.2 eq) and catalytic 4-
dimethylaminopyridine (2 mg) in carbon tetrachloride (15 ml). 
The resulting suspension was heated for 1.5h before being cooled 
and filtered through celite. The filtrate was evaporated to give a 
brown oil (300 mg), which was chromatographed on silica (eluting 
with 5% ethyl acetate in petrol) to give the chloride 160 as a clear oil 
(72 mg, 73%), UMAX 1402,1371,1249, 1106 and 1058 cm-
I
; 0H (250) 
1.05-1.07 (21H, m, TIPS), 1.20 (3H, d, J = 6.2, 5-CH3), 1.93-1.96 (2H, 
m, 3-CH
2
), 3.59 (2H, d, J = 4.8, CH2Cl), 3.95 (lH, qd, J = 6.4 and 3.1, 
5-CH), 4.07 (lH, ddd, J = 4.1, 3.6 and 3.1, 4-CH) and 4.39 (lH, tdd, J 
= 6.2,4.8 and 2.1, 2-CH); oe (270) 11.97 (6 x CH3, TIPS), 17.94 (3 x 
CH, TIPS), 20.46 (5-Me), 38.83 (3-CH2), 47.17 (CH2Cl), 77.34 (CH), 
77.92 (CH), 83.52 (5-CH); mJz 263 (29%, M+JPr), 187 (77), 131 (100), 
97 (40) and 75 (33) [Found: M+JPr, 263.1198. C 1 2 H 2 4 C l O ~ i i requires 
M, 263.1234]. 
(2SR,4RS,5SR) 2-Chloromethyl-4-hydroxy-5-methyltetrahydro_ 
furan (161) 
H0'r---\. CI 
..... lj .... ".1 
,\\" 0 
The chloride 160(48 mg, 0.15 mmol, 1eq) was dissolved in dry 
tetrahydrofuran (1 ml) and tetrabutylammonium fluoride (0.3 ml 
of a 1M solution in tetrahydrofuran, 0.3 mmol, 2 eq) was added. 
The resulting solution was stirred at RT for 40h, before the solvent 
was removed in vacuo to give a viscous oil, which was 
chromatographed on silica (eluting with 20% ethyl acetate in 
petrol) to give the chloro-alcohol 161 as a clear oil (15 mg, 60%), 
UMAX 3430 (OH), 1645, 1444, and 1350 c m-1; 0H (250) 1.25 (3H, d, J = 
6.2, 5-CH3), 2.05 (2H, m, 3-CH2), 3.59 (2H, d, J = 5.0, CH2Cl), 4.02-
4.05 (2H, fi, 4- and 5-CH) and 4.39 (lH, tdd, J = 5.0, 2.8 and 2.0,2-
CH); oe (270) 19.52 (5-Me), 38.08 (3-CH2), 46.99 (CH2Cl), 77.21 (CH), 
77.34 (CH) and 82.93 (5-CH); mJz 115 (17%, M +-Cl), 101 (71), 7.1 (53), 
70 (32) and 57 (100). [Found: M+-Cl, 115.0078. C6H l10 2 requires M, 
115.0759]. 
(2R,4S,5R)-2-[odomethyl-5-methyl-4-triisopropylsilyloxytetra-
hydrofuran (162) 
T I P S U ~ ~
- I 
. . ... "'/ 
,.- 0 
"" 
The acid 152 (20.5 mg, 0.065 mmol, 1 eq) was dissolved in dry 
benzene (1 ml) and the resulting solution was cooled to O°C before 
pyridine (1 drop) and dimethylformamide (1 drop) were added. The 
resulting solution was stirred during the dropwise addition of 
oxalyl chloride (0.03 ml, 0.065 mmol, 1eq) and stirring was 
continued for a further 3h. The solvent was then removed in 
vacuo. The crude oil thus obtained was azeotroped with dry 
benzene (1 ml) before being dissolved in cyc10hexene (2 mI) and 
added to a refluxing suspension of iodoform (28 mg, 0.07 mmol, 1.1 
eq), 2-mercaptopyridine-N-oxide sodium salt (11 mg, 0.07 mmol, 
1.1 eq) and catalytic 4-dimethylaminopyridine (1 mg) in 
cyc10hexene (5 mI). The resulting suspension was heated for 15h 
before being cooled and filtered through celite. The filtrate was 
evaporated to give a brown oil (60 mg), which was 
chromatographed on silica (eluting with 5% ethyl acetate in petrol) 
to give the iodide 163 as a clear oil (8.9 mg, 40%), UMAX 1445, 1250, 
1156 and 1071 cm-1; 0H (250) 1.00-1.02 (21H, m, TIPS), 1.25 (3H, d, J 
= 6.3, 5-CH3), 1.74 (lH, ddd, J = 12.7, 6.5 and 2.9, 3-CH), 1.93 (lH, 
a>5 
ddd, J = 12.7,6.0 and 2.9, 3-CH), 3.22 (2H, d, J = 4.8, CH
2
l), 3.92 
(lH, qd, J = 6.3 and 3.2, 5-CH), 4.02 (lH, ddd, J = 6.0, 3.2 and 2.9, 4-
CH) and 4.39 (lH, dtd, J = 6.5, 4.8 and 2.9, 2-CH); oe (270) 11.04 
(CH2I), 12.00 (6 x CHa-TIPS), 17.92 (3 x CH-TIPS), 19.88 (5-Me), 
41.78 (3-CH2), 77.00 (CH), 78.10 (CH) and 83.86 (5-CH); mJz 355 (3%, 
.. -M+JPr), 187 (100), 141 (35), 127 (40) and 75 (15) [Found: M+)Pr. 
355.0512. C 1 2 H 2 4 I O ~ i i requires M, 355.0590]; [a]n = +24.6 [c, 8.7 
(CH2CI2)]· 
(2R,4S,5R) 4-Hydroxy-2-iodomethyl-5-methyltetrahydro{uran (1m) 
HUt! - I 
. . .. ",,/ 
.' 0 .... , ~ ~
The iodide 162 (32 mg, 0.10 mmol, 1 eq) was dissolved in dry 
tetrahydrofuran (0.5 ml) and tetrabutylammonium fluoride (0.2 m I 
of a 1M solution in tetrahydrofuran, 0.2 mmol, 2 eq) was added. 
The resulting solution was stirred at RT for 40h, before the solvent 
was removed in vacuo to give a viscous oil, which was 
chromatographed on silica (eluting with 20% ethyl acetate in 
petrol) to give the iodo-alcohol 1m as a clear oil (10 mg, 60%), \}MAX 
3400 (OH), 1447,1353,1061 and 1028 cm-I; 0H (250) 1.26 (3H, d, J = 
6.4,5-CHa), 1.91 (lH, ddd, J = 13.3,8.6 and 6.2, 3-CH), 2.05 (lH, ddd, 
J = 13.3,6.2 and 3.0, 3-CH), 3.34 (lH, dd, J = 10.2 and 6.2, CHAHBI) , 
3.31 (lH, dd, J = 10.2 and 4.9, CHAHBI), 3.97 (lH, qd, J = 6.4 and 3.2, 
5-CH), 4.05 (lH, ddd, J = B.6, 6.2 and 3.2, 4-CH) and 4.16 (lH, dddd, 
~ ~
J = 6.2, 6.2, 4.9 and 3.0, 2-CH); Oc (270) 10.42 (CH2l), 19.79 (5-Me), 
41.06 (3-CH2), 77.17 (CH), 77.59 (CH), 83.34 (5-CH); m/z 242 (2%, 
M+), 115 (31), 101 (100), 71 (70) and 57 (49); [a]n = +20.5 [c, 2.0 
(CHCla)]; Git) [a]n = +26.5 [c, 1.8 (CHCla)] for the enantiomer. 
(-J- Muscarine iodide (1&) 
H H ~ ~ WMeaI-
.. LJ··"'"/ 
, .. ' 0 M ~ ' '
Trimethylamine (0.05 ml) was added to a solution of the iodo-
alcohol un (10 mg, 0.04 mmol, 1 eq) in ethanol (0.2 ml) and the 
resulting solution was heated at 70°C in a sealed tube over 4h. 
Cooling was allowed over 16h. and the solvent was evaporated to 
give a solid residue (8 mg) which was crystallised from acetone to 
give muscarine iodide 1& (5 mg, 60%) which showed spectral data 
identical to the literature values: m.p. 135-137°C [lit127 m.p. 138-
142°C; 0H (250) 1.23 (3H, d, J = 6.5, 5-CHa), 2.04 (lH, ddd, J = 14.0, 
10.0 and 5.5, 3-CH), 2.17 (lH, ddd, J = 14.0,6.0 and 2.0, 3-CH) 3.29 
(9H, s, NMea), 3.49 (lH, dd, J = 14.0 and 9.2, CHAHBN), 3.63 (lH, 
dd, J = 14.0 and 2.0, C H A ~ l ) , , 4.13 (lH, qd, J = 6.5 and 2.5, 5-CH), 
4.24 (lH, ddd, J = 5.5, 2.5 and 2.0) and 4.72 (lH, m, 2-CH). 
2fJ7 
(2'R,5'RS)-Methyl (5'-butyl-2',5'-dihydrofuran-2'-yl)acetate (ml) 
~ ~ C ~ M e e)-/""",,/ 
Bu 
Sodium azide (1.32 g, 20.2 mmoI, 2 eq) was added to a 
___ solution of the iodotetrahydrofuran MIl (3.31 g, 10.1 mmol, 1 eq) in 
dry dimethylformamide (35 ml) and the solution was heated to 
110°C for 16h and then cooled to RT before diluting with water (150 
ml). The resulting mixture was extracted with ether (3 x 100 ml). 
The combined organic phases were dried and evaporated to give an 
oil (2 g) which was chroroatographed on silica (eluting with 10% 
ethyl acetate in hexane) to give the dihydrofuran IDl as a 
colourless oil (0.93 g, 47%), '\)MAX 1736 (C=O), 1437, 1163 and l068cm-
1; 0H (250) 0.87 (3R, t, J = 6.8, CH3), 1.20-1.60 (6H, ro, 3 x CH2), 2.47 
(lR, dd, J = 15.3 and 6.2, 2-CfuHB), 2.59 (lH, dd, J = 15.3 and 7.0,2-
CRAHs), 3.68 (3R, s, OMe), 4.85 (lH, dt, J = 5.9 and 0.5, 5'-CH), 5.19 
(lR, ddd, J = 7.0, 6.2 and 0.5, 2'-CH) and 5.80 (2H, ro, 3'- and 4'-
CH); oe (270) 14.02 (Me), 22.77 (CH2), 27.19 (CH2), 35.55 (CH2), 41.04 
(2-CH2), 51.65 (OMe), 81.76 (2'-CH), 85.85 (5'-CH), 128.75 (3'-CH), 
131.05 (4'-CH) and 171.45 (C=O); mlz 198 (16%, M+), 156 (37), 91 (61), 
85 (100) and 57 (92) [Found: M+, 198.1236. CllH1S0 3 requires M, 
198.1256]. 
'2'SR,5'RSJ-5'-Butyl-2',5'-dihydrofuran-2'-yl) acetic acid (an) 
~ ~ C ~ H H)-rl···"'/ 
Bu 
The dihydrofuran all (500 mg, 2.52 mmol, 1 eq) was treated 
exactly as in the preparation of compound 1.52 to give the acid an 
as a colourless oil (400 mg, 86%), '->MAX 3300 (OR), 1715 (C=O), 1424, 
1259 and 1069 em-I; 0H (250) 0.87 (3R, t, J = 6.5, CRa), 1.30-1.70 (6H, 
m, 3 x CR2), 2.60 (lR, d, J = 7.0, 2-CR2), 4.85 (lH, dt, J = 5.9 and 0.7, 
5'-CH), 5.20 (lH, dt, J = 7.0 and 0.7, 2'-CH) and 5.90 (2H, m, 3' and 
4'-CH); 0e (270) 14.02 (Me), 22.75 (CH2), 27.19 (CH2), 35.44 (CH2), 
40.77 (2-CH2), 81.51 (2'-CR), 86.16 (5'-CR), 128.36 (3'-CR), 131.27 (4'-
CH) and 176.10 (C=O); mJz 184 (10%, M+), 139 (41), 127 (43), 81 (44) 
and 57 (57) [Found: M+, 184.1509. ClOH I60 a requires M, 184.1099]. 
3-Butyl-4-iodo-2,6-dioxabicyclo-[3,3,Ol-7-one ( ~ ) )
o 
The acid an (15 mg, 0.1 mmol, 1 eq) was treated exactly as in 
the preparation of compound 5ib, to give the iodo-ester ~ ~ as a 
colourless oil (21 mg, 75%), UMAX 1787 (C=O), 1467, 1185, 1148 and 
1047 em-I; 0H (250) 0.91 (3R, t, J = 7.0, CRa), 1.20-1.80 (6H, m, 3 x 
CH
2
), 2.73 (lH, dd, J = 17.8 and 8.4, 8-CHAHB), 2.59 (lR, dd, J = 17.8 
and 6.2,8-CHAHB), 3.18 (lH, dt, J = 6.4 and 3.0, 3-CH), 4.51 (lH, d, 
!n) 
J = 3.0, 4-CH), 5.10 (lH, ddd, J = 8.4, 6.2 and 4.4, 1-CH) and 5.37 
(lH, d, J = 4.4, 5-CH); Oc (270) 13.91 (Me), 22.52 (CH2), 27.68 (CH2), 
34.77 (4-CH), 46.08 (8-CH2), 75.68 (CH), 77.12 (CH), 90.60 (5-CH), and 
176.59 (C=O); mJz 310 (3%, M+), 253 (100), 183 (99), 127 (30),85 (31) 
and 57 (73) [Found: M+, 310.0146. CloH15I03 requires M, 310.0066]. 
(2RS,3RS)-3-Acetoxy-2-ethyltetrahydrofuran (ax» 
AC0'1'\ 
E t ~ O / /
Cesium acetate (127 mg, 0.66 mmol, 1.5 eq) was added to a 
stirred solution of the iodotetrahydrofuran 58 (100 mg, 4.4 mmol, 1 
eq) in dimethylformamide (0.5 ml). The resulting mixture was 
heated at 80°C for 14h and then water (25 ml) was added. The 
mixture was extracted with ether (3 x 20 ml) and the combined 
organic phases were dried and evaporated to give a brown oil 
(50 mg) which was chromatographed on silica (eluting with 5% 
ethyl acetate in petrol) to give, as a colourless oil, the 
acetoxytetrahydrofuran ID) (20 mg, 35%), which showed data 
identical to literature values,186 'l>MAX 1741 (C=O), 1242,1106 and 
1025 cm-I ; OH (250) 0.87 (3H, t, J = 7.6, CH3), 1.40-1.55 (2H, m, 1'-
CH2), 1.85-2.03 (lH, m, 4-HA)' 2.17-2.29 (lH, m, 4-HB), 3.57 (lH, td, J 
= 7.3 and 3.7, 2-H), 3.72 (lH, td, J = 8.7 and 5.3, 5-HA), 3.95 (lH, dt, J 
= 8.0 and 7.6 , 5-HB) and 5.23 (lH, ddd, J = 6.0, 4.3 and 1.5, 3-H). 
210 
(2RS,3RS)-2 -Ethy 1-3-hydroxytetrahydrofuran (m;) 
Potassium superoxide (344mg, 4.8 mmol, 1.1 eq) was added 
.. _ to a stirred solution of the iodotetrahydrofuran ~ ~ (1 g, 4.4 mmol, 1 
eq) and 18-crown-6 (0.1 ml) in dimethylformamide (1 ml). The 
resulting mixture was stirred for 16h at RT and water (50 ml) was 
added. The mixture was extracted with ether (3 x 20 ml) and the 
combined organic phases were dried and evaporated to give a 
brown oil (500 mg), which was chromatographed on silica (eluting 
with 20% ethyl acetate in petrol) to give the hydroxy-
tetrahydrofuran ax; as a colourless oil (104 mg, 25%), which 
showed data identical to literature values,I09 'l>MAX 3542 (OH), 1375, 
1150 and 1023 cm-I; OR (250) 0.94 (3H, t, J = 7.6, CH3), 1.40-1.55 (2H, 
m, l'-CH2), 1.84-1.90 (lH, m, 4-HA ) , 2.09-2.18 (lH, m, 4-HB), 3.42 
(lH, td, J = 6.8 and 3.1, 2-H), 3.79 (lH, td, J = 8.9 and 4.6, 5-HA), 3.97 
(lH, m, 5-HB) and 4.16-4.17 (lH, m, 3-H). 
(S)-Methyl 2-phenyl-2-(triisopropylsilyloxy)acetate (211) 
OTIPS 
• i Vco.Me 
Triisopropylsilyl chloride (10.6 ml, 50 mmol, 1.1 eq-) was 
added dropwise to a stirred solution of (S)-methyl mandelate (7.5 g, 
45.1 mmol, 1.0 eq) and imidazole (6.14 g, 90.2 mmol, 2 eq) in 
211 
dimethylformamide (25 ml) at RT. The resulting solution was 
stirred for 26h and then poured into water (300 ml). The resulting 
mixture was extracted with petrol (3 x 100 ml) and the combined 
organic phases dried and evaporated to give the silyl ether 211 as a 
colourless oil (14.95 g, 97%), ~ ~ 1732 (C=O), 1465,1206 and 1074 
--·'-cm-1; ~ ~ (250) 0.90-1.10(21H,m, TIPS), 3.70 (3H, s, OMe), 5.32 (lH, 
s, 2-H) and 7.30-7.60 (5H, m, Ph); Be (270) 11.88 (TIPS, 3 x CH), 17.54 
(TIPS, 6 x CHa), 51.67 (OMe), 74.36 (2-CH), 126.13 (CH), 127.89 (CH), 
128.07 (CH), 139.27 (C) and 172.31 (C=O), mJz 279 (76%, M+JPr), ID2 
(15), 77 (100), 71 (56) and 51 (53); [a]n = + 80.2 [c, 1.0 (CH2CI2)]. 
(S)-Methyl 2-phenyl-2-(triisopropylsilyloxy)acetaladehyde (212) 
OTIPS , 
V CHO 
The silyl ether 211 (1.0 g, 3.1 mmol, 1 eq) was dissolved in dry 
hexane (10 mD and dry ether (10 ml) and was reduced as in the 
preparation of compound 244 to give the aldehyde 212 as a 
colourless oil (0.57 g, 63%), 'l>MAX 1730 (C=O), 1464, 1291 and 1117 
c m-1; BH (250) 1.00-1.30 (21H, m, TIPS), 5.32 (lH, d, J = 1.0, 2-H), 
7.30-7.60 (5R, ro, Ph) and 9.55 (lR, d, J = 1.0, CHO); Be (270) 12.04 
(TIPS, 3 x CH), 17.81 (TIPS, 6 x CHa), 80.09 (2-CH), 126.43 (CH), 
128.34 (CH), 128.41 (CH), 132.85 (C) and 199.64 (C=O); [a]o = + 11.5 
[c. 1.1 (CH2CI2)]. 
212 
(lE,3S)-1-Iodo-3-phenyl-3-triisopropylsilyloxyprop_l_ene (213) 
OTIPS 
en 
I 
To a suspension of chromium(I1) chloride (5 g, 40.7 mmol, 
6 eq) in dry tetrahydrofuran (100 mI) was added dropwise a 
solution of iodoform (5.34 g, 13.6 mmol, 2 eq) and aldehyde 212 (1.98 
g, 6.78 mmol, 1 eq) in dry tetrahydrofuran (8 mI). The resulting 
solution was refluxed in the dark for 24h, under an atmosphere of 
argon, before being cooled and poured into water (250 mI). The 
resulting mixture was extracted with ether (3 x 200 ml), and the 
combined organic phases were dried and evaporated to give a 
purple oil, which was chromatographed twice on silica (eluting 
with cyclohexane) to give the vinyl iodide 213 as a colourless oil 
(1.10 g, 42%), UMAX 1600, 1463,1197 and 1114cm-1; 0H (250) 0.90-1.20 
(21H, m, TIPS), 5.20 (lH, dd, J = 5.5 and 1.1, 3-H), 6.37 (lH, dd, J = 
14.4 and 1.1, 1-H), 6.45 (lH, dd, J = 14.4 and 5.5, 2-H) and 7.30-7.60 
(5H, m, Ph); oe (270) 12.11 (TIPS, 3 x CH), 17.85 (TIPS, 6 x CH3), 
75.65 (3-CH), 77.34 (l-CH), 125.89 (CH), 127.39 (CH), 128.27 (CH), 
137.24 (C) and 148.95 (2-CH); mJz 416 (5%, M+), 373 (100%, M+)Pr), 
245 (29), 213 (35) and 116 (57) [Found: M+)Pr, 373.0536. C1sH22IOSi 
requires M, 373.0485]; [a]n = -15.4 [c. 1.0 (CH2CI2)]· 
213 
(S)-1,1-Dibromo-3-phenyl-3-triisopropylsilyloxyprop_l_ene (215) 
OTIPS , 
O'J Br Br 
Zinc dust (3.58 g, 55 mmol, 2 eq) was added to a stirred 
- solution of carbon tetrabromide (18.17 g, 55 mmol, 2 eq) and 
triphenylphoshine (14.4 g, 55 mmol, 2 eq)163 in dry 
dichloromethane (200 ml) at RT, and the resulting solution was 
stirred for 24h. The aldehyde 212 (8 g, 27 mmol, 1 eq) was added 
and the resulting solution was stirred for 80h at RT and then 
poured into petrol (300 ml) and the mixture filtered. The filtrate 
was evaporated to give a clear oil, which was chromatographed on 
silica (eluting with 10% dichloromethane in petrol) to give the 
dibromide 215 as a colourless oil (9.2 g, 75%), UMAX 1630,1464 and 
1063 cm-\ 0H (250) 1.00-1.40 (21H, m, TIPS), 5.40 (lH, d, J = 14.0, 3-
H), 6.55 (lH, d, J = 14.0, I-H), and 7.20-7.60 (5H, m, Ph); oe (270) 
12.11 (3 x CH-TIPS), 17.85 (3 x CH3-TIPS), 74.89 (3-CH), 88.62 (I-C), 
128.25 (CH), 128.34 (CH), 128.41 (CH), 136.75 (C) and 141.96 (2-CH); 
[a]D = -62.3 [c, 1.0 (CH2CI2)]. 
(S)-3-Phenyl-3-triisopropylsilyloxypropyne (216) 
OTIPS 
.. 
• ~ ~
Butyl lithium (7.4 ml of a 1.6 M solution in hexane, 11.9 
214 
mmol, 2 eq) was added to a solution of the dibromide 215 (2.68 g, 
5.95 mmol, 1 eq) in dry tetrahydrofuran (25 ml) at -78°C. The 
resulting solution was stirred at this temperature for 8h, and then 
allowed to warm to RT over 20h. Saturated aqueous ammonium 
chloride (10 ml) was added and the mixture was extracted with 
-ethyl acetate (2 x 20 ml). The combined organic phases were dried 
and evaporated to give a brown oil (2.7 g), which was 
chromatographed on silica (eluting with petrol) to give acetylene 
216 as a colourless oil (900 mg, 53%), ~ A X X 2200, 1630, 1464, and 1063 
cm- I ; 0H (250) 1.00-1.20 (21H, m, TIPS), 2.52 (IH, d, J = 2.3, I-H), 
5.55 (lH, d, J = 2.3, 3-H) and 7.26-7.60 (5H, m, Ph); Oc (270) 12.11 (3 x 
CH, TIPS), 17.85 (6 x Me, TIPS), 76.45 (2-C), 74.89 (3-CH), 88.62 (1-
C), 128.25(Ph-CH), 128.34(Ph-CH), 128.41 (CH) and 136.75 (C); m/z 
245 (100%, M+.iPr), 220 (27),131 (60), 71 (35) and 55 (100) [Found: M+-
ipr, 245.1367. CI5H2IOSi requires M, 245.1361]. 
(38, lE)-3 _Phenyl-3-triisopropylsilyloxy-l-tributyl-stannylprop-l-ene 
(217) 
OTIPS , 
~ ~ SnBus 
A solution of azo-bis-isobutyronitrile (49.8 mg, 0.028 mmol, 
0.28 eq) in dry benzene (3 ml) was added slowly to a refluxing 
solution of acetylene 216 (292 mg, 1.01 mmol, 1 eq) and tributyltin 
hydride (0.3 ml, 1.12 mmol, 1.1 eq) in dry benzene (15 ml). The 
resulting solution was refluxed in the dark for 15h, under an 
215 
atmosphere of argon, before the solvent was evaporated to give an 
oil, which was chromatographed on silica (eluting with petrol) to 
give the vinyl stannane 217 as a colourless oil (100 mg, 17%), ~ A X X
1596, 1463, l096and 1067 cm- I ; BH (250) 0.70 (9H, t, J = 7.0,3 x Me), 
1.00-1.05 (21H, m, TIPS), 1.20-1.70 (18H, m, 9 x CH2), 5.20 (lH, dd, J 
.. -= 5.5 and 0.8, 3-H), 5.99 (lH, dd, J = 18.9 and 5.5, 2-H), 6.23 (lH, dd, 
J = 18.9 and 0.8, I-H) and 7.20-7.40 (5H, m, Ph); Be (270) 9.44 (3 x 
CH2Sn), 13.70 (3 x CH, TIPS), 14.35 (3 x Me), 18.06(6 x CHa, TIPS), 
27.23 (3 x CH2), 29.08 (3 x CH2), 78.85 (3-CH), 77.34 (l-CH), 125.97 
(CH), 126.34 (CH), 126.65 (CH), 127.96 (C) and 151.36 (2-C); mlz 5Z3 
(100%, M+-Bu), 521 (75%, M+-Bu), 117 (88), 115 (48) and 55 (59); [a]n 
= - 7.1 [c, 0.7 (CH2CI2)]. 
(S)-Methyl 2-methoxymethoxyphenylacetate (218) 
OMOM , Uco.Me 
Chloromethyl methyl ether (6 ml, 78.9 mmol, 5 eq) was added 
dropwise to a stirred solution of (S)-methyl mandelate (2.62 g, 15.8 
mmol, 1.0 eq) and ethyldiisopropylamine (4.12 ml, 23.7 mmol, 1.5 
eq) in dichloromethane (10 ml) at RT. The resulting mixture was 
stirred for 19h and the poured into water (50 ml). The resulting 
solution was extracted with dichloromethane (3 x 30 ml) and the 
combined organic phases were dried and evaporated to give the 
ether 218 as a yellow oil (3.58 g, 100%), which showed data 
corresponding exactly to literature values,167 'UMAX 1735 (C=O) cm- I ; 
216 
0H (250) 3.46 (3H, s, OMe), 3.79 (3H, s, C02Me), 4.80 (2H, s, 
OCH20Me), 5.26 (lH, s, 2-CH) and 7.40-7.60 (5H, m, Ph); Be (270) 
52.60 (MeO), 56.22 (Me ester), 76.89 (2-CH), 95.25 (OCH
2
0Me), 
127.71 (CH), 128.94 (CH), 129.03 (CH), 136.35 (C) and 171.50 (C=O). 
___ ,_ (S)-2-Methoxymethoxy-2-phenylethanol (219) 
OMOM , 
ObH 
Diisobutylaluminium hydride (38.1 ml of a 1.5 M solution in 
toluene, 57 mmol, 4 eq) was added to a stirred solution of the ester 
218 in dry toluene (10 ml) at -78°C and the resulting solution 
allowed to warm to RT over 1.75h. The resulting solution was 
cooled to O°C during the cautious addition of 2M hydrochloric acid 
(15 ml). The resulting mixture was then extracted with ethyl 
acetate (3 x 25 ml) and the combined organic phases were dried 
and evaporated to give the pure alcohol 219 as a colourless oil (2.45 
g, 94%), which showed data in accordance with literature 
values,167 'UMAX 3600 (OH) c m-1; BH (250) 2.80-3.05 (lH, br, OH), 3.38 
(3H, s, OMe), 3.64 (lH, dd, J = 11.9 and 4.0, CfuHBOH), 3.73 (lH, 
dd, J = 11.9 and 8.0, CHAHBOH), 4.63 (2H, dd, J = 8.0 and 4.0, 2-H), 
5.26 (lH, s, OCfu0Me) and 7.20-7.40 (5H, m, Ph); Be (270) 55.33 
(OMe), 67.01 (CH20H), 79.93 (2-CH), 94.74 (OCH20Me), 126.83(CH), 
127.98 (CH), 128.35 (CH) and 138.26 (C); [a]n = + 190 [c, 2.0 
(CH2Cl2)]; (lit); +196 [c. 2.7 (CHCl3)]· 
217 
(S)-2-Methoxymethoxyphenylacetaldehyde (200) 
QMOM 
. H ur 
A solution of dimethyl sulphoxide (1.25 ml, 17.5 mmol, 2.5 eq) 
in dichloromethane (6 ml) was added dropwise to a solution of 
oxalyl chloride (0.8 ml, 8.7 mmol, 1.1 eq) in dichloromethane at -
60°C at such a rate that the temperature was kept below -55°C. 
After 0.25h, the alcohol 219 (1.45 g, 8 mmol, 1 eq) was added and 
after a further 5 min, triethylamine (5.6 ml, 40 mmol, 5 eq) was 
added slowly and the resulting mixture allowed to warm to 10°C 
over 0.5h before water (12 ml) was added. The resulting mixture 
was extracted with dichloromethane (2 x 30 ml) and the combined 
organic phases were washed with brine (20 ml), 1M hydrochloric 
acid (3 x 30 ml) and brine (30 ml) and then dried and evaporated ro 
give the aldehyde 200 as a yellow oil (1.02 g, 71%), whieh showed 
data in accordance to literature values,166 U MAX 1730 (C=O) em-I; 0H 
(250) 3.35 (3H, s, OMe), 4.65 (2H, s, OCH20Me), 5.26 (lH, d, J = 0.4, 
2-H), 7.20-7.40 (5H, m, Ph) and 9.53 (lH, d, J = 0.4, I-H); oe (270) 
56.01 (OMe), 73.16 (2-CH), 94.72 (OCH20Me), 127.61 (CH), 128.94 
(CH), 129.03 (CH), 133.49 (C) and 195.88 (C=O); [a]n = + 105 [c, 2.0 
(CH2CI2)]; (lit) +112 [c, 1.0 (CHCI3)]· 
218 
(3RS, 4S)-4-Methoxymethoxy-4-phenylbut-l-en-3-ol (221) 
OMOM 
Vinylmagnesium chloride (10 ml of a 107M solution in tetra-
hydrofuran, 17 mmol, 3 eq) was added to a solution of the aldehyde 
200 (1.02 g, 5.6 mmol, 1 eq) in dry tetrahydrofuran (5 ml) at O°C. 
The resulting solution was stirred at RT for 16h. Saturated 
aqueous ammonium chloride (10 ml) was added and the mixture 
was extracted with ethyl acetate (2 x 20 ml). The combined organic 
phases were dried and evaporated to give a brown oil (1 g), which 
was chromatographed on silica (eluting with 20% ethyl acetate in 
petrol) to give the alcohols 221 as a yellow oil (1.02g, 71%), l>MAX 3300 
(OH) c m-\ 0H (250) 3.46 (3H, s, OMe), 4.37 (lH, dd, J = 7.5 and 6.6,3-
H), 4.51 (lH, d, J = 7.5, 4-H), 4.69 (2H, s, OCH20Me), 5.17 (lH, dd, J 
= 10.5 and 1.5, I-H), 5.30 (lH, dd, J = 17.2 and 1.5, I-H), 5.73 (lH, 
ddd, J = 17.2, 10.5 and 6.6, 2-H) and 7.30-7.42 (5H, m, Ph); 0c (270) 
55.41 (OMe), 75.60 (4-CH), 81.80 (3-CH), 94.56 (OCH20Me), 116.41 (1-
CH2), 127.51 (CH), 127.91 (CH), 128.01 (CH), 135.81 (2-CH) and 
137.36 (C); and also the 3-epimer which showed, 0H (250) 3.45 (3H, 
s, OMe) and 5.80 (lH, ddd, J = 16.6, 9.4 and 6.0, 2-CH) [other peaks 
obscured]; a ratio of ca. 3:1 between the two isomers was observed. 
219 
(4RS,5SJ-4-Ethenyl-5-methoxymethoxy-5-phenyl_3_oxapentanoic 
acid (222) 
QMOM 
Sodium hydride (249 mg of a 60% suspension in mineral oil, 
6.5 mmol, 1.5 eq) was added to a solution of the alcohols 221 (900 
mg, 4.3 mmol, 1 eq) in dry tetrahydrofuran (5 mI) at DoC. The 
resulting solution was stirred at RT for 1h before solid sodium 
iodoacetate (1.87, 6.5 mmol, 1.5 eq) was added. The resulting 
suspension was refluxed for 16h. 2M Sodium hydroxide (30 ml) 
was added to the cooled mixture which was then washed with 
ethyl acetate (2 x 30 mI). The aqueous phase was acidified with 2M 
hydrochloric acid and extracted with chloroform (2 x 30 ml). The 
combined chloroform phases were dried and evaporated to give the 
acids 222 as a yellow oil (0.75 g, 68%), uMAX 3450 (OH) and 1715 (C=O) 
cm-\ 0H (250) 3.41 (3H, s, OMe), 3.96 (lH, dd, J = 9.6 and 7.4, 4-H), 
4.02 (lH, d, J = 17.4, 2-CHAHB), 4.30 (lH, d, J = 17.4, 2-CHAHB), 4.62 
(2H, s, OCH20Me), 4.65 (lH, d, J = 9.6, 5-H), 5.05-5.15 (2H, m, 2'-
CH2), 5.45 (lH, ddd, J = 17.5, 10.0 and 6.6, l'-H), and 7.20-7.42 (5H, 
m, Ph); oe (270) 55.74 (OMe), 66.54 (4-CH), 79.91 (5-CH), 85.62 (2-
CH2), 93.80 (OQH20Me), 119.62 (2'-CH2), 127.89 (CH), 128.36 (CH), 
128.49 (CH), 132.49 (l'-CH), 136.32 (C) and 172.76; and also the 4-
epimer which showed, 0H (250) 3.38 (3H, s, OMe), 5.20-5.25 (2H, m, 
2'-CH2) and 5.66 (lH, ddd, J = 17.8,10.4 and 2.7, l'-H) [other peaks 
obscured]. 
(4E,2RS,6SJ-2-Hydroxy-6-methoxymethoxy-6_phenylhex_4_enoic 
-acid (2'm) 
OMOM OH 
Butyl lithium (3.76 ml of a 106M solution in hexane, 6.02 
mmol, 2.0 eq) was added to a solution ofdiisopropylamine (1.05ml, 
7.52 mmol, 3 eq) in dry tetrahydrofuran (5 ml) at -78°C. The 
resulting solution was stirred at -10°C for 0.5h before being cooled 
to -78°C. A solution of the acids 222 (BOO mg, 3.01 mmol, 1 eq) in dry 
tetrahydrofuran (5 ml) was added. After 8h at -78°C, the mixture 
was allowed to warm to RT before adding saturated aqueous 
ammonium chloride (50 mI). The resulting mixture was extracted 
with chloroform (3 x 50 ml) and the combined organic phases were 
dried and evaporated to give, as a brown oil (460 mg, 58%), the 
hydroxy-acid 2m (460 mg, 58%), UMAX 3400 (OH) and 1709cm-1; 0H 
(250) 2.41-2.43 (lH, m, 3-HA), 4.30 (lH, m, 3-HB), 3.29 (3H, s, OMe), 
2.53-2.60 (lH, m, 2-H), 4.70 (2H, s, OCH20Me), 5.20 (lH, d, J = 6.0, 
6-H), 5.60-5.75 (2H, m, 4 and 5-H) and 7.20-7.52 (5H, m, Ph); 0c (270) 
36.50 (3-CH2), 54.50 (OMe), 69.75 (2-CH), 77.50 (6-CH), 93.50 
221 
(OCH20Me), 119.27 (5-CH), 126.76 (CH), 127.9 (CH), 128.34 (CH), 
128.48 (C), 141.29 (4-CH) and 176.05 (C=O). 
(4E,2RS,6S)-6-Methoxymethoxy-6-phenylhex-4-en_l,2_diol (224) and 
(2RS,4RS) and (2RS,4SR)-4-hydroxy-2-[(1EJ-2-styryl}-tetrahydro_ 
furan (225) 
OR 
OMOM OR 
OR 
Lithium aluminium hydride bis-tetrahydrofuran (0.97 ml of 
a 1.0M solution in toluene, 0.97 mmol, 2.6 eq) was added to a 
solution of the hydroxy-acid 223 (100 mg, 0.37 mmol, 1 eq) in dry 
toluene (1 ml) and the resulting solution stirred at RT for 1.5h. 
Saturated aqueous ammonium chloride (5 ml) was added and the 
resulting mixture was extracted with chloroform (3 x 60 ml). The 
combined organic phases were dried and evaporated to give a 
brown oil (120 mg) which was chromatographed on silica (eluting 
with 50% ethyl acetate in petrol) to give, as a colourless oil, the diol 
224 (14 mg, 15%), UMAX 3455 (OH) c m-1; 0H (250) 2.40-2.46 (2H, m, 3-
CH2), 3.40 (3H, s, OMe), 3.55-3.60 (lH, m, 2-H), 3.70-3.73 (lH, m, 
CliAHBOH), 3.80-3.82 (lH, m, CHAHBOH), 4.68-4.70 (lH, m, 6-CH), 
4.80 (2H, s, OCfu0Me), 5.75-5.80 (2H, fi, 4 and 5-H) and 7.15-7.30 
(5H m Ph) ·, and also, as a colourless oil, the , , 
222 
hydroxytetrahydrofurans 225 (87 mg, 74%), ~ A X X 3420 cm-I; 0H (250) 
2.17 (lH, ddd, J = 13.3, 5.7 and 1.2, 3'-HA)' 2.48 (lH, ddd, J = 13.3, 
6.2 and 1.9, 3'-HB)' 3.63 (lH, dddd, J = 6.2,3.4, 2.2, 1.2, CH and 1.9, 
4'-H), 3.93 (lH, dd, J = 8.4 and 1.6, 5'-H), 4.15 (lH, dd, J = 9.8 and 
_ 4.3, 5'-H), 6.21 (lH, dd, J = 16.0 and 6.9, 2-H), 6.63 (lH, d, J = 16.0, 
I-H) and 7.20-7.50 (5H, m, Ph); 0e (270) 42.87 (3'-CH2), 57.63 (2'-
CH), 76.31 (5'-CH2)' 79.81 (4'-CH), 126.97 (2-CH), 128.16 (Ph-CH), 
128.27 (Ph-CH), 129.00 (l-CH), 129.76 (Ph-CH), 131.75 (C) and 148.95 
(2-C); mJz 190 (61%, M+), 151 (37), 104 (58), 91 (40) and 45 (100); 
[Found: M+, 190.1001. CI2HI402 requires M, 190.0993]. 
(2'SR,4 'RS,5'SR)-2-(5' -Butyl-4' -iodotetrahydrofuran-2' -yl)acet-
aldehyde (244) 
I ~ X > >I,.. CHO 
."''"/ 
Bu 0 
Diisobutylaluminium hydride (8.8 ml of a 1.0M solution in 
hexanes, 8.8 mmol, 1 eq) was added quickly to a solution of the 
iodotetrahydrofuran 5G> (2.88 g, 8.78 mmol, 1 eq) in petrol (10 rol) at 
-780C and the resulting solution was stirred at this temperature for 
3h. Methanol (3 ml) was added followed by 1M hydrochloric acid (8 
ml) and the resulting mixture extracted with ethyl acetate (3 x 00 
ml). The combined organic phases were dried and evaporated to 
give the iodo-aldehyde 244 as a colourless oil (2.15 g, 82%), UMAX 1725 
(C=O), 1454, 1379 and 1068 c m-I; 0H (250) 0.81 (3H, t, J = 7.0, CH3), 
223 
1.19-1.43 (6H, m, 3 x CH2), 1.91 (lH, m, 3'-HA), 2.50-2.70 (3H, m, 2-
CH2 and 3'-HB)' 3.71- 3.91 (lH, m, 4'-H), 4.02 (lH, td, J = 7.8 and 3.0, 
5'-H), 4.30-4.42 (lH, m, 2'-H) and 9.30 (lH, br-s, I-H); oe (270) 13.87 
(CH3), 21.49 (4'-CH), 22.59 (CH2), 28.00 (CH2), 31.93 (CH2), 44.73 (3'-
.. .9H2), 49.62, (2-CH2), 72.83 (2'-CH), 86.23 (5'-CH) and 200.27 (C=O); 
mJz 239 (33%, M+-Bu), 125 (43), 84 (41), 68 (27) and 55 (100) [Found: 
M+-Bu, 238.9566. CsHsI02 requires M, 239.8569]. 
(5SR,7RS,BSR,2E)-Methyl 7-iodo-5,B-oxadodec-2-enoate (245) 
Methyl triphenylphosphoranylidineacetate (271 mg, 0.8 
mmol, 1.2 eq) was added to a solution of the iodo-aldehyde 244 
(200 mg, 0.67 mmol, 1 eq) in dichloromethane (5 ml) at RT and the 
resulting solution stirred at this temperature for 16h. The solvent 
was removed in vacuo and the solid residue was chromatographed 
on silica (eluting with 5% ethyl acetate in petrol) to give the iodo-
alkene 245 as a colourless oil (180 mg, 76%), UMAX 1723 (C=O), 1659, 
1436,1326, 1274 and 1175 cm- I ; 0H (250) 0.82 (3H, t, J = 7.0, 12-CH3), 
1.23-1.48 (6H, ffi, 9-, 10- and 11-CH2), 1.99 (lH, ddd, J = 14.5,3.0 and 
1.0, 6-HA), 2.30-2.52 (2H, m, 4-HA and 6-HB), 2.63 (lH, ddd, J = 14.0, 
6.6, 1.3, 4-HB), 3.69 (3H, s, OMe), 3.68-3.71 (lH, ro, 7-H),3.90-4.10 
(2H, ffi, 5- and 8-H), 5.84 (lH, dt, J = 15.7 and 1.3, 2-H) and 6.88 (lH, 
224 
dt, J = 15.7 and 6.6 3-H); Be (270) 14.22 (12-Me), 22.19 (7-CH), 22.95 
(CH2), 28.32 (CH2), 32.24 (CH2), 38.82 (6-CH2), 44.67 (4-CH2), 51.72 
(OMe), 76.78 (5-CH), 86.96 (8-CH), 123.68 (2-CH), 144.65 (3-CH) and 
166.85 (C=O); mJz 239 (51%, M+-CH2CH=CHC02Me), 125 (45), 107 
.. (18), 74 (64) and 55 (100) [Found: M+-CH2CH=CHC02Me, 253.0106. 
CSH14IO requires M, 253.0089]. 
(5SR,7RS,BSR,2Z)-7-Iodo-5,B-oxadodec-2-ene (246) 
Butyl lithium (5.03 m1 of a 1.6 M solution, 8.14 mmol, 1.2 eq) 
was added to a solution of ethyltriphenylphosphonium iodide (3.36 
g, 8.1 mmol, 1.2 eq) in dry tetrahydrofuran (10 ml) at -78°C and the 
resulting solution stirred at O°C for 0.5h and then recooled to -78°C. 
A solution of the iodo-aldehyde 244 (2 g, 6.7 mmol, 1 eq) in dry 
tetrahydrofuran (5 mD was added and the resulting solution was 
allowed to warm to RT over 16h. The solvent was removed in vacuo 
and the solid residue obtained was chromatographed on silica 
(eluting with 5% ethyl acetate in petrol) to give the iodo-alkene 246as 
a colourless oil (1.10 g, 46%), ~ A X X 1436, 1377,1264, 1149,1057 and 
1015 cm-1; BH (250) 0.89 (3H, t, J = 6.8, CH3), 1.21-1.47 (5H, m, 9-HA 
and 10- and 11-CH2), 1.61 (3R, d, J = 6.8, 1-CH3), 1.72-1.98 (lH, m, 9-
HB), 2.01 (lH, ddd, J = 8.9, 2.6 and 1.9,6-HA), 2.11-2.44 (2H, m, 4-HA 
225 
and 6-HB), 2.60 (lH, m, 4-HB), 3.68-3.72 (lH, m, 7-H), 3.90-4.15 (2H, 
m, 5- and 8-H), 5.25-5.41 (lH, m, 2-H) and 5.47-5.62 (lH, m, 3-H); oe 
(270) 12.99 (CH3), 14.16 (1-CH3), 23.06 (7-CH), 23.25 (CH2), 28.18 
(CH2), 32.17 (CH2), 33.48 (6-CH2), 44.62 (4-CH2), 77.93 (5-CH), 86.52 
~ 8 - C H ) , , 125.57 (2-CH) and 126.77 (3-CH); mlz 308 (1%, M+), 253 (100), 
125 (47),81 (50) and 69 (57) [Found: M+, 308.0688. CI2H2IIO requires 
M, 308.0637]; and also 5% of the (E)-isomer which showed, oe (270) 
125.51 (CH) and 128.21 (CH). 
(6SR,BRS,9SR,3E)-B-Iodo-6,9-oxatridec-3-en-2-one (247) 
Triphenylphosphoranylidine-2-propanone (152 mg, 0.47 
mmol, 1.5 eq) was added to a solution of the iodo-aldehyde 244 (95 
mg, 0.32 mmol, 1 eq) in dichloromethane (0.5 ml) at RT and the 
resulting solution was stirred at this temperature for 16h. The 
solvent was removed in vacuo and the solid obtained was 
chromatographed on silica (eluting with 5% ethyl acetate in petrol) 
to give the ketone 247 as a colourless oil (53 mg, 55%), UMAX 1675 
(C=O), 1629, 1455, 1360, 1254 and 1176 cm-I ; 0H (250) 0.89 ( 3 H ~ ~ t, J = 
7.0, 13-CH3), 1.23-1.43 (6H, m, 9-,10- and 11-CH2), 2.04 (lH, ddd, J = 
13.2, 9.8 and 1.5, 7-HA), 2.16 (lH, ddd, J = 13.2, 6.1 and 2.6, 7-HB), 
226 
2.27 (3H, s, 1- CHa), 2.29-2.74 (2H, m, 5-CH2), 3.77 (lH, ddd, J = 11.2, 
9.8 and 2.6, 8-H), 4.01-4.29 (2H, m, 6- and 9-H), 6.14 (lH, dt, J = 16.0 
and 1.3, 3-H) and 6.78 (IH, dt, J = 16.0 and 7.2, 4-H); oe (270) 13.95 
(CHa), 21.87 (CH2), 22.19 (8-CH), 26.96 (1-CHa), 28.07 (CH2), 31.95 (7-
.. .9H2), 38.78 (CH2), 44.39 (5-CH2), 51.72 (OMe), 76.53 (6-CH), 86.81 (9-
CH), 133.44 (3-CH), 144.23 (4-CH) and 199.72 (C=O); mJz 337 (1%, 
M+), 125 (100), 107 (36), 81 (64) and 55 (95) [Found: M+, 337.0625. 
ClaH22I02 requires M, 337.0664]. 
(3'-exo,5'-exo)-Methyl 2-(3'-butyl-2'-oxabicyclo-[2.2.1]-heptan-5'-yl) 
acetate (248) and (3'-exo,5'-endo)-methyl 2-(3'-butyl-2'-oxabicyclo-
[2.2.1]-heptan-5'-yl) acetate (249) 
H 
Triphenyltin hydride (17 ml of a 0.02M solution in dry 
benzene, 0.34 mmol, 1.5 eq) and azo-bis-isobutyronitrile (11.3 ml of a 
0.006M solution in dry benzene, 0.068 mmol, 0.3 eq) were added to a 
solution of the iodo-alkene 245 (80 mg, 0.23 mmol, 1 eq) in dry 
benzene (27 ml) at 80°C, over a period of 2h, under an atmosphere of 
argon. The resulting solution was heated for a further 2h and then 
cooled to RT before evaporating to give a clear oil (150 mg), which 
was chromatographed on silica (eluting with 5% ethyl acetate in 
petrol) to give the esters 248 and 249 as a colourless oil (40 mg, 77%, 
as a 3:1 ratio), which showed l>MAX 1738 (C=O), 1434 and 1153 cm- l ; 
mJz 226 (3%, M+), 169 (45), 137 (100), 125 (33) and 67 (41)[Found: M+, 
226.1549. ClaH220a requires M, 226.1569]; for the isomer 248 0H (250) 
0.82 (3H, t, J = 6.8, CHa), 1.08 (lH, ddd, J = 13.8, 3.4 and 2.8, 6'-HA)' 
1.21-1.34 (7H, fi, 7'-HA and 3 x CH2), 1.53 (lH, br s, 7'-HB)' 1.92-2.01 
(lH, fi, 6'-HB)' 2.01 (lH, br s, 4'-H), 2.16 (lH, ddd, J = 8.4, 8.0 and 
3.4, 5'-H), 2.31 (lH, dd, J = 14.9 and 8.0, 2-HA), 2.46 (lH, dd, J = 14.9 
and 8.4, 2-HB), 3.43 (lH, t, J = 6.5, 3'-H), 3.61 (3H, s, OMe) and 4.22 
(lH, br s, l'-H); oe (270) 13.68 (CHa), 22.35 (CH2), 27.65 (CH2), 31.17 
(7'-CH2), 34.91 (CH2), 39.59 (2-CH2), 44.72 (4'-CH), 51.19(OMe), 75.91 
(l'-CH), 83.27 (3'-CH) and 173.42 (C=O); for the isomer 249 0H (250) 
0.82 (3H, t, J = 6.8, CHa), 1.08 (lH, ddd, J = 13.8, 3.4 and 2.8, 6'-HA)' 
1.21-1.34 (7H, ro, 7'-HA and 3 x CH2), 1.53 (lH, br s, 7'-HB)' 1.92 (lH, 
fi, 6'-HB)' 2.01 (lH, br s, 4'-H), 2.16 (lH, ddd, J = 8.4,8.0 and 3.4, 5'-
H), 2.29 (lH, dd, J = 14.9 and 8.0, 2-HA), 2.45 (lH, dd, J = 14.9 and 8.4, 
2-HB), 3.60 (3H, s, OMe), 3.68 (lH, t, J = 6.2, 3'-H) and 4.18 (lH, br s, 
l'-H); Oe (270) 13.68 (CHa), 22.35 (CH2), 27.65 (CH2), 31.17 (7'-CH2), 
34.70 (5-CH), 34.98 (CH2), 35.25 (6'-CH2), 37.14(2-CH2), 44.05 (4'-CH), 
51.19 (OMe), 75.57 (l'-CH), 76.58 (3'-CH) and 173.42 (C=O). 
228 
(3-exo,5-exo)-3-Butyl-5-ethyl-2-oxabicyclo-[2.2.1]_heptane (250), (3-
exo,5-endo)-3-butyl-5-ethyl-2-oxabicyclo-[2.2.1]_heptane (251) and (3-
endo,5-exo)-3-butyl-5-ethyl-2-oxabicyclo-[2.2.1]-heptane (252) 
-""-H 
H H 
Triphenyltin hydride (146 ml of a 0.02M solution in dry 
benzene, 2.93 mmol, 1.5 eq) and azo-bis-isobutyronitrile (97 ml of a 
0.006M solution in dry benzene, 0.58 mmol, 0.3 eq) were added by 
syringe pump to a solution of the iodo-alkene 246 (600 mg, 1.95 
mmol, 1 eq) in dry benzene (240 ml) at 80°C, under an atmosphere of 
argon, over a period of 2h. The resulting solution was heated for a 
further 2h and then cooled to RT. Carbon tetrachloride (100 ml) was 
added and the resulting solution was treated with iodine (-100 mg) 
until the colour just persisted. Evaporation gave a clear oil (400 mg) 
which was dissolved in ethyl acetate (50 ml) and washed with 
saturated aqueous potassium fluoride until there was no further 
precipitation. The combined organic phases were dried and 
evaporated to give a colourless oil (200 mg), which was 
chromatographed on silica (eluting with 1% ethyl acetate in petrol) 
to give the alkanes 2&) and 251 as a colourless oil (151 mg, 43%, as a 
3:1 ratio) which showed UMAX 1468, 1327 and 1063 cm-1; mJz 181 (8%, 
M +), 155 (29), 77 (17), 69 (24) and 57 (23); for isomer 2fJO, 0H (250) 0.83 
229 
(6H, t, J = 6.8,2 x CHa), 1.15-1.20 (lH, m, 6-HA) , 1.21-1.34 (10H, m, 5-
H, 7-HA and 4 x CH2), 1.52 (lH, br s, 7-HB), 1.79-1.82 (lH, m, 6-HB) , 
2.03 (lH, br s, 4-H), 3.41 (lH, t, J = 6.4, 3-H) and 4.25 (lH, br s, I-H); 
oe (270) 12.69 (CHa), 14.28 (CHa), 23.02 (CH2), 28.39 (CH2), 28.86 
.. ~ C H 2 ) ' ' 31.74 (CH2), 35.64 (7-CH2), 38.83 (6-CH2), 43.63 (5-CH), 45.03 
(4-CH), 76.55 (l-CH) and 84.21 (3-CH); and for isomer 251, 0H (250) 
0.83 (6H, t, J = 6.8, 2 x CHa), 1.11-1.13 (lH, m, 6-HA) , 1.21-1.34 (10H, 
m, 4 x CH2), 1.40-1.42 (lH, m, 7-HA) , 1.70 (lH, br s, 7-HB), 1.78-1.82 
(2H, m, 5-H and 6-HB), 2.17 (lH, br s, 4-H), 3.77 (lH, t, J = 6.5, 3-H) 
and 4.23 (lH, br s, I-H); oe (270) 13.40 (CHa), 14.28 (CHa), 24.17 (CH2), 
29.76 (CH2), 31.51 (CH2), 35.76 (CH2), 36.41 (7-CH2), 37.81 (6-CH2), 
40.95 (5-CH), 44.08 (4-CH), 75.85 (l-CH) and 77.40 (3-CH); and b) the 
alkane 252 (46 mg, 13%), which showed, 1>MAX 1468,1327 and 1063 
c m-l ; 0H (250) 0.85 (3H, t, J = 6.9, CHa), 0.87 (3H, t, J = 7.0, CHa), 1.05 
(lH, dd, J = 12.1 and 2.0, 6-HA) , 1.15-1.40 (10H, m, 7'-CH2 and 4 x 
CH2), 1.78-1.80 (lH, m, 5-H), 1.87 (lH, dd, J = 12.1 and 1.0, 6-HB), 
2.13 (lH, br s, 4-H), 3.78 (lH, td, J = 6.9 and 2.1, 3-H) and 4.24 (lH, br 
s, I-H); oe (270) 12.08 (CHa), 14.05 (CHa), 22.31 (CH2), 28.64 (CH2), 
31.76 (CH2), 34.12 (CH2), 34.62 (5-CH), 35.77 (7-CH2), 39.23 (6-CH2), 
43.85 (4-CH), 77.22 (l-CH) and 81.66 (3-CH); mJz 182 (1 %, M+), 125 
(42%, M+-Bu), 96 (22), 67 (100) and 55 (30) [Found: M+-Bu, 125.0965. 
CaHlaO requires M, 125.0966]. 
(3-exo,5-exo)-3-Butyl-5-(2-oxapropylJ-2-oxabicyclo_[2.2.1]-heptane 
(2SJ), (3-exo,5-endo)-3-butyl-5-(2-oxapropYl)-2-oxabi_cyclo_[2.2.1]-
heptane (25i) and (3-endo,5-exo)-3-butyl-5-(2-oxa-propyl)-2-
oxabicyclo-[2.2.1]-heptane (255) 
H 
H H o 
Triphenyltin hydride (12 ml of a 0.02M solution in dry 
benzene, 0.24 mmol, 1.5 eq) and azobis isobutyronitrile (8 ml of a 
0.006M solution in dry benzene, 0.047 mmol, 0.3 eq) were added to a 
solution of the iodo-alkene 247 (53 mg, 0.16 mmol, 1 eq) in dry 
benzene (18 ml) at 80°C, under an atmosphere of argon, over a 
period of 2h. The resulting solution was heated for a further 2h and 
then cooled to RT. Carbon tetrachloride (20 ml) was added and the 
resulting solution was treated with iodine (-15 mg) until the colour 
just persisted. Evaporation gave a clear oil (100 mg) which was 
dissolved in ethyl acetate (20 ml) and washed with saturated 
aqueous potassium fluoride until there was no further 
precipitation. The combined organic phases were dried and 
evaporated to give a colourless oil (90 mg) which was 
chromatographed on silica (eluting with 4% ethyl acetate in petrol) 
to give a) the ketones 253 and 254 as a colourless oil (26 mg, 77%, as 
a 3:1 ratio), which showed 'UMAX 1713 (C=O), 1462, 1357,1155 and 1041 
231 
c m-
1; m/z 210 (8%, M +), 153 (35), 135 (34), 95 (41), 66 (46) and 43 (100) 
[Found: M+, 210.1602. C13H2202 requires M, 210.1620]; for isomer 
253, 0H (250) 0.87 (3H, t, J = 6.7, CH3), 1.00-1.40 (7H, m, 6-HA and 3 x 
CH2), 1.53-1.65 (2H, ro, 7-CH2), 1.83-1.89 (2H, m, 5-H and 6-HB), 2.04 
.. i1H, br s, 4-H), 2.13 (3H, s, 1'- CH3), 2.41-2.47 (lH, m, 3'-CHA), 2.64 
(lH, dd, J = 6.5 and 1.6,3'-CHB), 3.49 (lH, t, J = 7.0, 3-H) and 4.23 
(lH, br s, I-H); 0e (270) 14.29 (CH3), 22.97 (CH2), 25.39 (CH2), 28.23 
(CH2), 31.84 (1'-CH3), 35.49 (CH2), 36.46 (5-CH), 38.87 (6-CH2), 45.24 
(4-CH), 49.95 (3-CH2), 76.46 (l-CH) and 83.95 (3-CH); and for isomer 
254, 0H (250) 0.89 (3H, t, J = 6.7, CH3), 1.00-1.40 (7H, ro, 6-HA and 3 x 
CH2), 1.53-1.65 (2H, ro, 7-CH2), 1.83-1.89 (2H, ro, 5-H and 6-HB), 2.01 
(lH, br s, 4-H), 2.15 (3H, s, l'-Me), 2.32-2.52 (2H, m, 3'-CH2), 3.70 
(lH, t, J = 7.0, 3-H) and 4.26 (lH, br s, I-H); oe (270) 14.28 (CH3), 24.00 
(CH2), 28.29 (CH2), 30.24 (CH), 31.94 (CH3), 35.60 (CH2), 36.40 (CH2), 
38.41 (CH2), 45.03 (CH), 76.42 (l-CH) and 77.46 (3-CH); and b) the 
ketone 255 (6 mg, 20%), which showed UMAX 1713 (C=O), 1462,1357, 
1155 and 1041 c m-1; 0H (250) 0.92 (3H, t, J = 6.8, CH3), 1.06 (lH, m, 6-
HA ), 1.25-1.40 (4H, m, 2 x CH2), 1.52-1.68 (5H, m, 5'-H, 7-CH2 and 1 x 
CH2), 1.91 (lH, m, 6-HB), 2.11 (lH, br s, 4-H), 2.14 (3H, s, 1'- CH3), 
2.39 (lH, dd, J = 12.4 and 4.3, 3'-CHA ), 2.47 (lH, dd, J = 12.4 and 4.8, 
3'-CHB)' 3.81 (lH, td, J = 7.0 and 2.5, 3-H) and 4.25 (lH, br s, l'-H); oe 
(270) 14.05 (Me), 22.84 (CH2), 27.87 (CH2), 28.55 (CH2), 3 0 . 1 ~ ~ (Me), 
31.31 (CH2), 35.97 (CH2), 39.30 (5-CH), 44.13 (4-CH), 49.81 (3-CH2), 
77.20 (l-CH) and 81.38 (3-CH); mJz 210(3%, M+), 124(41%, M+-Bu), gj 
(38),66 (75) and 43 (100); [Found' M + 210 1602 C H 0 . M 
. , . . 13 22 2 reqwres , 
210.1619]. 
(2 'SR,4 'RS,5'SR)-Methyl (5' -butyl-4' -triisopropylsilyloxytetra-
hydrofuran-2' -y1) acetate (256) 
TIPSO" I •• 
Bu 
The hydroxytetrahydrofuran ?2 (3.50 g, 16.5 mmol, 1 eq) was 
silylated exactly as in the preparation of compound 150, to give an 
oil (5 g) which was chromatographed on silica (eluting with 3% 
ethyl acetate in petrol) to give the silyloxy-tetrahydrofuran 256 as a 
colourless oil (2.33 g, 40%), U MAX 1739 (C=O), 1464, 1437, 1382, 1329, 
1246, 1107 and 1048 em-I; 0H (250) 0.87 (3H, t, J = 6.4, CH3), 1.00-1.10 
(21H, m, TIPS), 1.21-1.47 (6H, m, 3 x CH2), 1.67 (lH, ddd, J = 12.7,9.8 
and 5.7, 3'-H), 1.94 (lH, ddd, J =12.7, 6.2 and 2.8, 3'-H), 2.45 (lH, dd, 
J = 15.2 and 6.3, 2-CfuCHB), 2.59 (lH, dd, J = 15.2 and 6.6, 2-
CHACHB), 3.63 (3H, s, OMe), 3.70 (lH, td, J = 6.4 and 3.1, 5'-H), 4.07 
(lH, ddd, J = 9.8,3.1 and 2.8, 4'-H) and 4.42 (lH, dddd, J = 6.6, 6.3, 
6.2 and 5.7, 2'-H); oe (270) 12.20 (3 x CH, TIPS), 13.80 (CH3), 17.56 (6 x 
CH
a
, TIPS), 22.54 (CH2), 27.89 (CH2), 34.09 (CH2), 40.41 (3'-CH2), 
41.24 (2-CH
2
), 51.39 (OMe), 73.93 (CH), 77.46 (CH), 87.35 (5'-CH) and 
171.46 (C=O); m/z 329 (20%, M+_iPr), 229(31),131(92),103(83) and 75 
(100) [Found: M+jPr, 329.2158. CI7H3304Si requires M, 329.2148]. 
(2'SR,4'RS,5'SR)-(5'-Butyl-4'-triisopropylsilyloxytetrahydro-furan-2'-
ylJacetaldehyde (251) 
TIPSO" I •• 
eRO 
Bu 
The silyloxytetrahydrofuran 256 (2.33 g, 6.3 mmol, 1 eq) was 
reduced exactly as in the preparation of compound 244, to give the 
aldehyde 291 as a colourless oil (1.83 g, 85%), UMAX 1731 (C=O) em-I; 
0H (250) 0.87 (3H, t, J = 6.4, CH3), 1.00-1.10 (21H, m, TIPS), 1.21-1.47 
(6H, m, 3 x CH2), 1.52 (lH, ddd, J = 12.7,8.7 and 6.3, 3'-H), 2.02 (lH, 
ddd, J = 12.7, 6.0 and 2.4, 3'-H), 2.61 (lH, dd, J = 10.2 and 5.6, 2-
CllA CHB), 2.61 (lH, dd, J = 10.2 and 3.4, 2-CHA CHB), 3.68 (lH, td, J 
= 6.3 and 3.2, 5'-H), 4.09 (lH, ddd, J = 6.3, 3.2 and 2.4, 4'-H), 4.51 (lH, 
dddd, J = 8.7,6.0, 5.6 and 3.4, 2'-H) and 9.55 (lH, br.s, CHO); oe (270) 
12.58 (3 x CH, TIPS), 14.23 (CH3), 17.97 (6 x CH3, TIPS), 22.93 (CH2), 
28.36 (CH2), 34.49 (CH2), 41.92 (3'-CH2), 49.58 (2-CH2), 73.17 (CH), 
77.05 (CH), 87.82 (5'-CH) and 201.65 (C=O); mJz 299 (44%, M+JPr), 
229 (100), 131 (93),99 (74) and 75 (81) [Found: M 329.2158. CI7H3304Si 
requires M, 329.2148]. 
(5SR, 7RS,BSR,2E)-Methyl 7_triisopropylsilyloxy-5,B-oxadodec-2-
enoate (258) 
The aldehyde 2fi1 (800 mg, 2.34 mmol, 1 eq) was treated 
exactly as in the preparation of compound 245, to give the alkenoate 
258 as a colourless oil (475 mg, 51%), 1>MAX 1729 (C=O), 1659,1463, 
1270, 1161 and 1056 cm-I ; BH (250) 0.85 (3H, t, J = 7.0, CH3), 1.01-1.10 
~ 2 1 H , , m, TIPS), 1.25-1.47 (6H, m, 3 x CH2), 1.63 (lH, ddd, J = 12.6, 5.B 
and 3.0, 6-H), 1.87 (lH, ddd, J =12.6, 5.5 and 2.1, 6-H), 2.44 (lH, m, 4-
CH2), 3.72 (3H, s, Me ester), 3.73-3.82 (lH, m, B-H), 4.0B-4.12 (lH, m, 
7-H), 4.13-4.28 (lH, m, 5-H), 5.84 (lH, dd, J = 15.7 and 1.3, 2-H) and 
6.88 (lH, dt, J = 15.7 and 7.2, 3-H); Be (270) 12.11 ( 3 x CH, TIPS), 
13.96 (CH3), 17.97 (6 x CH3, TIPS), 22.54 (CH2), 27.89 (CH2), 34.09 
(CH2), 40.41 (6-CH2), 41.24 (4-CH2), 51.39 (OMe), 73.93 (CH), 77.46 
(CH), 87.35 (B-CH), 122.97 (3-CH), 145.43 (2-CH) and 171.46 (C=O); 
m/z 355 (25%, M+JPr), 229 (100), 131 (34), 103 (38) and 75 (53)[Found: 
(5SR, 7RS,8SR,ZJ-7-Triisopropylsilyloxy-5,8-oxadodec-2-ene (259) 
TIPSQ", 
'. 
Bu 
The aldehyde 2fi1 (800 mg, 2.34 mmol, 1 eq) was subjected w 
Wittig olefination exactly as in the preparation of compound 246, w 
give the alkene 259 as a colourless oil (140 mg, 17%), U MAX 1464, 1245, 
1118 and 1091 cm- I ; BH (250) 0.87 (3H, t, J = 7.0, 12-CH3), 0.97-1.12 
(21H, m, TIPS), 1.20-1.47 (6R, m, 9-, 10- and 11-CR2), 1.61 (3R, d, J = 
6.5, 1-CH3), 1.75 (lH, ddd, J = 10.7,5.7 and 1.7, 6-HA), 1.80-2.03 (lH, 
m, 6-HB), 2.12-2.49 (2H, m, 4-CH2), 3.65-3.73 (lH, m, 8-H),4.01-4.19 
(2H, m, 5- and 7-H) and 5.27-5.69 (2H, m, 2- and 3-H); oe (270) 12.11 (3 
x CH, TIPS), 12.96(1-CH3), 13.96 (CH3), 17.95 (6 x CH3, TIPS), 22.67 
___ . ~ C H 2 ) ' ' 28.14 (CH2), 34.22 (CH2), 40.99 (6-CH2), 41.23 (4-CH2), 76.52 
(CH), 77.14 (CH), 87.10 (8-CH), 125.84 (2-H) and 126.07 (3-H); m/z 311 
(20%, M+JPr), 229 (100), 131 (73), 81 (25) and 59 (21) [Found: M+)Pr, 
311.2424. CIsH3S02Si requires M, 311.2406]. 
(5SR,7RS,BSR,2E)-Methyl 7-hydroxy-5,B-oxadodec-2-enoate ( ~ ) )
The silyl-alkenoate 258 (374 mg, 0.94 mmol, 1 eq) was treated 
exactly as in the preparation of compound 1m, to give the hydroxy-
alkenoate ~ ~ as a colourless oil (171mg, 75%), '\)MAX 3414 (OH), 1726 
(C=O), 1659,1437, 1271,1163 and 1091 em-I; 0H (250) 0.90 (3H, t, J = 
6.4, 12-CH3), 1.20-1.47 (6H, m, 9-, 10- and 11-CH2), 1.80 (1H, ddd, J = 
13.2,6.8 and 3.8, 6-H), 1.92 (lH, ddd, J =13.2,5.7 and 2.2, 6-H), 2.41 
(lH, ddd, J = 7.4, 6.1 and 1.0, 4-CH2), 3.60 (3H, s, Me ester), 3.90-4.22 
(3H, m, 5-, 7- and 8-H), 5.86 (1H, dt, J = 15.4 and 1.0, 2-H) and 6.91 
(lH, dt, J = 15.4 and 7.4, 3-H); oe (270) 14.45 (CH3), 23.15 (CH2), 28.47 
(CH
2
), 34.45 (CH2), 38.58 (6-CH2), 41.24 ( 4 - C ~ ) , , 51.36 (OMe), 76.95 
(CH), 77.42 (CH), 88.43 (8-CH), 123.59 (2-H), 143.21 (3-H) and 171.46 
(C=O); m/z 144 (100%, M+-CH2CH=CHC02Me), 100 (43),99 (47),81 
(40) and 55 (34) [Found: M+-CH2CH=CHC02Me, 142.0997. CSH1402 
requires M, 142.0993]. 
(5RS,7RS,BSR,2Z)-7-Hydroxy-5,B-oxadodec-2_ene (2m) 
The silyl-alkene 259 (136 mg, 0.38 mmol, 1 eq) was treated 
exactly as in the preparation of compound un, to give the hydroxy-
alkene an as a colourless oil (30 mg, 40%), U MAX 3445 (OH), 1659, 
1462, 1260, 1158 and 1050 c m-1; BH (250) 0.93 (3H, t, J = 6.5, 12-CH3), 
1.21-1.52 (6H, m, 9-, 10- and 11-CH2), 1.62 (3H, dd, J = 6.2 and 0.8, 1-
CH3), 1.72 (lH, ddd, J = 13.2, 9.7 and 6.4, 6-HA ), 1.88 (lH, ddd, J = 
13.2,5.7 and 2.3, 6-HB), 2.13-2.30 (lH, m, 4-HA), 2.37-2.53 (lH, m, 4-
HB), 3.69 (lH, td, J = 6.1 and 3.1, 8-H), 4.01-4.19 (2H, m, 7- and 5-CH) 
and 5.33-5.63 (2H, m, 2- and 3-H); Be (270) 12.96 (1-CH3), 13.98 (CH3), 
22.72 (CH2), 28.02 (CH2), 32.94 (CH2), 34.07 (6-CH2), 40.49 (4-CH2), 
76.53 (CH), 77.47 (CH), 86.81 (8-CH), 125.75 (2-H) and 126.11 (3-CH); 
m/z 143 (100%, M +-Bu), 99 (69), 81 (76), 57 (71) and 55 (65)[Found: M +-
Bu, 142.1035. CSH 1402 requires M, 142.0993]. 
Z37 
(3' -endo,5' -exo)-Methyl 2-(3'-butyl-2'-oxabicyclo[2.2.1]-heptan_5'_yl) 
acetate ( ~ ) )
H 
Thiocarbonyldiimidazole (378 mg, 2.1 mmol, 3 eq) was added 
to a solution of the hydroxy-alkenoate an (171 mg, 0.71 mmol, 1eq) 
in dry tetrahydrofuran (5 ml) and the resulting solution was heated 
at reflux for 16h. The resulting solution was cooled and evaporated 
and the residue filtered through silica (eluting with 
dichloromethane), to give the thioimidazole ester ~ ~ (220 mg). This 
derivative was dissolved in toluene (70 ml) and the solution heated 
at reflux while a solution oftributyltin hydride (280J,Ll, 1.05 mmol, 
1.5 eq) in toluene (15 ml) was added dropwise over 8h. The solution 
was then cooled and evaporated to give an oil (500 mg), which was 
chromatographed on silica (eluting with 5% ethyl acetate in petrol) 
to give the ester ~ ~ as a colourless oil (121 mg, 77%), ~ A X X 1738 
(C=O), 1434 and 1153 c m-\ 0H (250) 0.89 (3H, t, J = 6.8, CHa), 1.05-
1.12 (lH, m, 6'-HA)' 1.21-1.53 (8H, m, 7'-CH2 and 3 x CH2), 1.82-1.95 
(lH, m, 6'-HB)' 2.04 (lH, br s, 4'-H), 2.17 (lH, br s, 5'-H), 2.29 (2H, dd, 
J = 7.8 and 4.5, 2-CH2), 3.68 (3H, s, Me ester), 3.81 (lH, td, J = 7.0 and 
2.6, 3'-H) and 4.26 (lH, br s, l'-H); oe (270) 13.85 (CHa), 17.85 (CH2), 
23.31 (CH2), 27.85 (CH2), 28.14 (CH2), 29.85 (CH2), 36.15 (CH), 39.90 
(2-CH2), 40.03 (4'-CH), 51.54 (OMe), 77.10 (l'-CH), 81.31 (3'-CH) and 
173.41 (C=O); mJz 226 (6%, M+), 169 (66),140 (62), 108 (92) and 67 (100) 
[Found: M+, 226.1632. ClaH220a requires M, 226.1569]. 
···'15SR,BSR,Z)-5,B-Oxadodec-2-ene ( ~ ) )
The hydroxy-alkene 261 (30 mg, 0.15 mmol, 1 eq), was treated 
exactly as in the preparation of compound ~ , , to give a clear oil (90 
mg) which was chromatographed on silica (eluting with 5% ethyl 
acetate in petrol) to give the tetrahydrofuran ~ ~ as a clear oil (23 
mg, 80%), UMAX 1462, 1378 and 1090cm-1; 0H (250) 0.93 (3H, t, J = 6.8, 
12- CHa), 1.25-1.54 (6H, m, 9-, 10- and 11-CH2), 1.65 (3H, d, J = 6.2, 1-
CHa), 1.83-1.96 (4H, m, 6- and 7-CH2), 2.12-2.49 (2H, m, 4-CH2), 3.72-
3.92 (2H, m, 5- and 8-CH) and 5.35-5.63 (2H, m, 2- and 3-H); oe (270) 
12.98 (CHa), 14.03 (CHa), 22.81 (CH2), 28.36 (CH2), 29.99 (CH2), 30.48 
(CH2), 33.44 (CH2), 35.80 (CH2), 76.52 (8-CH), 77.18 (5-CH), 125.71 (2-
H) and 126.36 (3-CH); mJz 127(100%, M+-Pr), 109(100),83 (29),67(58) 
and 57 (33) [Found: M+-Pr, 127.1112. CSH150 requires M, 127.1123]. 
(5SR,7RS,BSR,2E)-Methyl 7-iodo-5,B-oxadodec-2-enoate (245) and 
(5SR,7SR,-BSR,2E)-methyl 7-iodo-5,B-oxadodec-2-enoate ( ~ ) )
:o .... " j c o ~ e e
Bu 0 
A stirred solution of the iodo-alkene 245 (180 mg, 0.51 mmol, 1 
eq) and hexabutylditin (30 mg, 0.026 ml, 0.1 eq) in dry, degassed 
benzene (20 ml), at reflux, was irradiated from a distance of 14 cm 
with a 275 W sun lamp for 65 mins, under an atmosphere of argon. 
1,8-Diazabicyclo-[5,4,0]-undec-7-ene (0.15 ml) was added and, after 5 
mins, iodine was added until the colour just persisted. The 
resulting solution was filtered through silica (washing with ether) 
and evaporated to give the iodo-alkenes 245 and ~ , , free of tin 
residues, as a colourless oil (180 mg, 76%), UMAX 1723 (C=O), 1659, 
1436, 1326, 1274 and 1175 c m-1; 0H (250) 0.82 (3R, t, J = 7.0, 12-CH3), 
1.23-1.48 (6R, m, 9-, 10- and ll-CH2), 1.99 (IH, ddd, J = 14.5,3.0 and 
1.0, 6-HA), 2.30-2.52 (2H, m, 4-HA and 6-RB), 2.63 (IH, ddd, J = 14.0, 
6.6, 1.3, 4-HB), 3.69 (3H, s, Me ester), 3.68-3.71 (lH, m, 7-H),3.90-4.10 
(2H, m, 5- and 8-H), 5.84 (IH, dt, J = 15.7 and 1.3, 2-H) and 6.88 (lH, 
dd, J = 15.7 and 6.63-H); oe (270) 14.22 (12-Me), 22.19 (7 -CH), 22.95 
(CH2), 28.32 (CH2), 32.24 (CH2), 38.82 (6-CH2), 44.67 (4-CH2), 51.72 
(OMe), 76.78 (5-CH), 86.96 (8-CH), 123.68 (2-CH), 144.65 (3-CH) and 
166.85 (C=O) and for iodo-alkene ~ , , oe (270) 13.89 (12-Me), 22.63 
(CH
2
), 23.47 (7-CH), 27.93 (CH2), 31.92 (CH2), 37.67 (6-CH2), 43.13 (4-
CH
2
), 51.43 (OMe), 76.35 (5-CH), 88.98 (8-CH), 123.38 (2-CH), 144.33 
(3-CH) and 166.58 (C=O). 
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